{"doc_id": 0, "doc": {"person_id": 115968289, "visit_occurrence_id": 180707418, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2021-06-20 12:23:34", "visit_end_datetime": "2021-06-20 13:13:32", "visit_length_in_hours": 0.8327777777777777, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2020-01-10 00:00:00", "patient_last_visit_date": "2022-10-21 13:54:00", "end_obs_date": "2022-06-20", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 6569, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 12:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 10:51:00, ended at 2020-02-20 14:11:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-02-20, presumably until 2020-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Raised prostate specific antigen\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-21 09:54:00, ended at 2020-02-21 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Neoplasm of uncertain behavior of prostate\n- Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:56:20, ended at 2020-08-06 10:06:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-13 13:54:00, ended at 2020-08-13 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)\n- Venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)\n\n### Condition\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Primary malignant neoplasm of prostate\n- Spermatocele\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- cefazolin 1000 MG Injection, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- ketamine 100 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-14 10:44:00, ended at 2020-08-15 14:51:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Body height: 5' 11.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n\n### Procedure\n- Excision of spermatocele, with or without epididymectomy\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed\n- Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy\n\n### Condition\n- Illness\n- Hydrocele of tunica vaginalis\n- Major depression, single episode\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Obstructive sleep apnea syndrome\n- Spermatocele\n- Primary malignant neoplasm of prostate\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2021-08-15, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 6 hours\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- cefazolin 1000 MG Injection, started on 2020-08-15, presumably until 2020-08-15\n- sodium chloride 9 MG/ML Injection, started on 2020-08-15, presumably until 2020-08-15\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2020-08-14, presumably until 2020-08-15\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-15\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2020-08-15, presumably until 2020-08-15\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-30 00:00:00, ended at 2020-09-30 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 0.67 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-11 00:00:00, ended at 2020-10-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-27 00:00:00, ended at 2020-11-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-24 00:00:00, ended at 2020-12-24 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.02 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 08:18:34, ended at 2021-01-06 08:49:37\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-07, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n- tadalafil 5 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-07 09:15:17, ended at 2021-01-07 09:33:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-10 09:45:13, ended at 2021-01-10 11:37:05\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.496\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2022-09-15, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 4 Tabs (1,000 mg total) by mouth daily . Swallow tablets whole with water on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 07:58:27, ended at 2021-04-07 08:24:07\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2022-04-07, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-07 00:00:00, ended at 2021-05-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 472 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.36 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2534 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.6 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 21 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1046 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 459 (cells per microliter)\n- Nucleated erythrocytes [#/volume] in Blood: 0 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-13 15:14:07, ended at 2021-05-13 16:14:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 12:10:00, ended at 2021-06-10 14:26:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.3 (nanogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 483 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 11.3 (microgram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 14:27:00, ended at 2021-06-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Raised prostate specific antigen\n- Abnormal findings on diagnostic imaging of lung\n- Imaging of musculoskeletal system abnormal\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-17 12:05:23, ended at 2021-06-17 12:39:30\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 12:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 10:51:00, ended at 2020-02-20 14:11:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-02-20, presumably until 2020-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Raised prostate specific antigen\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-21 09:54:00, ended at 2020-02-21 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Neoplasm of uncertain behavior of prostate\n- Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:56:20, ended at 2020-08-06 10:06:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-13 13:54:00, ended at 2020-08-13 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)\n- Venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)\n\n### Condition\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Primary malignant neoplasm of prostate\n- Spermatocele\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- cefazolin 1000 MG Injection, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- ketamine 100 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-14 10:44:00, ended at 2020-08-15 14:51:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Body height: 5' 11.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n\n### Procedure\n- Excision of spermatocele, with or without epididymectomy\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed\n- Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy\n\n### Condition\n- Illness\n- Hydrocele of tunica vaginalis\n- Major depression, single episode\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Obstructive sleep apnea syndrome\n- Spermatocele\n- Primary malignant neoplasm of prostate\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2021-08-15, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 6 hours\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- cefazolin 1000 MG Injection, started on 2020-08-15, presumably until 2020-08-15\n- sodium chloride 9 MG/ML Injection, started on 2020-08-15, presumably until 2020-08-15\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2020-08-14, presumably until 2020-08-15\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-15\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2020-08-15, presumably until 2020-08-15\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-30 00:00:00, ended at 2020-09-30 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 0.67 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-11 00:00:00, ended at 2020-10-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-27 00:00:00, ended at 2020-11-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-24 00:00:00, ended at 2020-12-24 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.02 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 08:18:34, ended at 2021-01-06 08:49:37\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-07, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n- tadalafil 5 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-07 09:15:17, ended at 2021-01-07 09:33:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-10 09:45:13, ended at 2021-01-10 11:37:05\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.496\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2022-09-15, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 4 Tabs (1,000 mg total) by mouth daily . Swallow tablets whole with water on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 07:58:27, ended at 2021-04-07 08:24:07\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2022-04-07, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-07 00:00:00, ended at 2021-05-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 472 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.36 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2534 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.6 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 21 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1046 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 459 (cells per microliter)\n- Nucleated erythrocytes [#/volume] in Blood: 0 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-13 15:14:07, ended at 2021-05-13 16:14:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 12:10:00, ended at 2021-06-10 14:26:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.3 (nanogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 483 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 11.3 (microgram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 14:27:00, ended at 2021-06-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Raised prostate specific antigen\n- Abnormal findings on diagnostic imaging of lung\n- Imaging of musculoskeletal system abnormal\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-17 12:05:23, ended at 2021-06-17 12:39:30\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c481ef563b30a2b17b7f1475d3c02917a852c9c6bfa8f4133c30241b30d96a54", "prompt_hash": "60284ff5ef4568b6e38ef4515296d45cdfb61b5576d8e44d6f829106a953acab", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
{"doc_id": 1, "doc": {"person_id": 115969254, "visit_occurrence_id": 171987962, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-02-20 09:21:49", "visit_end_datetime": "2021-02-20 09:32:39", "visit_length_in_hours": 0.18055555555555555, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-02-20 09:21:49, ended at 2021-02-20 09:32:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of breast\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 96, "patient_first_visit_date": "2009-03-18 00:00:00", "patient_last_visit_date": "2023-01-20 00:00:00", "end_obs_date": "2022-02-20", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 23, "cumulated_visit_num": 23, "cumulated_approximate_token_count": 4563, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-18 00:00:00, ended at 2009-03-18 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Prothrombin time (PT): 13.1 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-27 00:00:00, ended at 2009-03-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 337 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.92 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.99 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Prothrombin time (PT): 12.5 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 16.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-03-28 13:22:00, ended at 2009-03-29 11:50:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.5 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 6' 3.197\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- digoxin 0.25 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth daily.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-03-29, presumably until 2009-03-29\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-28\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth.\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth daily.\n- codeine sulfate 30 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-28\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth daily.\n- camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion, through Topical route, started on 2009-03-29, presumably until 2009-03-29\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2009-03-29, presumably until 2009-09-22, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2009-03-28, presumably until 2009-03-29\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-03-29, presumably until 2009-05-05, with quantity of 12.0, with intended 1 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-29 00:00:00, ended at 2009-04-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-22 14:59:34, ended at 2009-12-22 15:35:38\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-30 14:56:20, ended at 2010-03-30 15:29:38\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-04-26 00:00:00, ended at 2011-04-26 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2011-04-26, presumably until 2019-02-27, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-31 00:00:00, ended at 2012-01-31 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, started on 2012-01-31, presumably until 2012-01-31, with intended 0 refill(s). Instructions: take 1 capsule by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-24 00:00:00, ended at 2013-03-24 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, started on 2013-03-24, presumably until 2013-03-24, with intended 12 refill(s). Instructions: take 1 capsule by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-16 09:41:27, ended at 2016-03-16 10:16:34\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Disorder of bone\n- Primary diagnosis: Thyrotoxicosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-15 15:52:00, ended at 2017-02-15 16:37:41\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute maxillary sinusitis\n- Acute bronchitis\n- Pure hypercholesterolemia\n- Essential hypertension\n- Disorder of kidney and/or ureter\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2017-02-15, presumably until 2017-03-10, with intended 0 refill(s). Instructions: take 5-10 mL by mouth 3 times a day as needed for Cough\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2017-02-15, presumably until 2017-02-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day for 3 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-10 10:21:02, ended at 2017-03-10 10:59:19\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n- Primary diagnosis: Essential hypertension\n- Multiple congenital cysts of kidney\n- Pure hypercholesterolemia\n- Disorder of kidney and/or ureter\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-02-18, presumably until 2018-10-03, with intended 0 refill(s). Instructions: take 50 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-16 09:54:53, ended at 2017-06-16 10:24:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic atrial fibrillation\n- Multiple congenital cysts of kidney\n- Primary diagnosis: Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-18 10:39:02, ended at 2017-10-18 11:11:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Multiple congenital cysts of kidney\n- Pure hypercholesterolemia\n- Disorder of kidney and/or ureter\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-14 10:35:48, ended at 2018-02-14 11:03:32\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Multiple congenital cysts of kidney\n- Pure hypercholesterolemia\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-06 10:17:54, ended at 2018-06-06 10:58:42\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Chronic atrial fibrillation\n- Primary diagnosis: Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-03 10:37:51, ended at 2018-10-03 11:08:47\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Pure hypercholesterolemia\n- Chronic atrial fibrillation\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-27 10:33:48, ended at 2019-02-27 11:19:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Acute upper respiratory infection\n- Chronic atrial fibrillation\n- Disorder of kidney and/or ureter\n- Pure hypercholesterolemia\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, started on 2018-03-10, presumably until 2018-03-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2021-11-06, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 1 Capsule (180 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-22 16:29:37, ended at 2019-05-22 17:11:52\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n- Essential hypertension\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of prostate\n- Primary diagnosis: Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-21 09:38:20, ended at 2019-08-21 11:05:55\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n- Primary diagnosis: Olecranon bursitis\n- Pure hypercholesterolemia\n- Disorder of shoulder\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-07 09:33:44, ended at 2020-03-07 10:23:33\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Persistent atrial fibrillation\n- Primary diagnosis: Impacted cerumen\n- Pure hypercholesterolemia\n\n### Drug\n- digoxin 0.25 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2021-12-31, with intended 0 refill(s). Instructions: take 0.25 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-20 09:21:49, ended at 2021-02-20 09:32:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of breast\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-18 00:00:00, ended at 2009-03-18 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.9 (picogram)\n- Prothrombin time (PT): 13.1 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.7 (second)\n- Anion gap in Serum or Plasma: 2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-27 00:00:00, ended at 2009-03-27 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 337 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.92 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.99 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Prothrombin time (PT): 12.5 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 16.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-03-28 13:22:00, ended at 2009-03-29 11:50:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.5 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.03 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Prothrombin time (PT): 14.1 (second)\n- Body height: 6' 3.197\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- digoxin 0.25 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth daily.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-03-29, presumably until 2009-03-29\n- warfarin sodium 7.5 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-28\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth.\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth daily.\n- codeine sulfate 30 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-28\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2009-03-28, presumably until 2009-03-29. Instructions: take by mouth daily.\n- camphor 5 MG/ML / menthol 5 MG/ML Topical Lotion, through Topical route, started on 2009-03-29, presumably until 2009-03-29\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2009-03-29, presumably until 2009-09-22, with quantity of 60.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n- 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Capsule, through Oral route, started on 2009-03-28, presumably until 2009-03-29\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-03-29, presumably until 2009-05-05, with quantity of 12.0, with intended 1 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route every 12 hours. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-29 00:00:00, ended at 2009-04-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-12-22 14:59:34, ended at 2009-12-22 15:35:38\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-12-23 00:00:00, ended at 2009-12-23 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-03-30 14:56:20, ended at 2010-03-30 15:29:38\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-04-26 00:00:00, ended at 2011-04-26 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, started on 2011-04-26, presumably until 2019-02-27, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-01-31 00:00:00, ended at 2012-01-31 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, started on 2012-01-31, presumably until 2012-01-31, with intended 0 refill(s). Instructions: take 1 capsule by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-24 00:00:00, ended at 2013-03-24 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, started on 2013-03-24, presumably until 2013-03-24, with intended 12 refill(s). Instructions: take 1 capsule by mouth once daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-16 09:41:27, ended at 2016-03-16 10:16:34\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n- Disorder of bone\n- Primary diagnosis: Thyrotoxicosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-15 15:52:00, ended at 2017-02-15 16:37:41\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute maxillary sinusitis\n- Acute bronchitis\n- Pure hypercholesterolemia\n- Essential hypertension\n- Disorder of kidney and/or ureter\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2017-02-15, presumably until 2017-03-10, with intended 0 refill(s). Instructions: take 5-10 mL by mouth 3 times a day as needed for Cough\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2017-02-15, presumably until 2017-02-18, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day for 3 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-10 10:21:02, ended at 2017-03-10 10:59:19\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n- Primary diagnosis: Essential hypertension\n- Multiple congenital cysts of kidney\n- Pure hypercholesterolemia\n- Disorder of kidney and/or ureter\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-02-18, presumably until 2018-10-03, with intended 0 refill(s). Instructions: take 50 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-16 09:54:53, ended at 2017-06-16 10:24:40\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic atrial fibrillation\n- Multiple congenital cysts of kidney\n- Primary diagnosis: Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-18 10:39:02, ended at 2017-10-18 11:11:21\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Multiple congenital cysts of kidney\n- Pure hypercholesterolemia\n- Disorder of kidney and/or ureter\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-14 10:35:48, ended at 2018-02-14 11:03:32\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n- Multiple congenital cysts of kidney\n- Pure hypercholesterolemia\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-06 10:17:54, ended at 2018-06-06 10:58:42\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Chronic atrial fibrillation\n- Primary diagnosis: Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-03 10:37:51, ended at 2018-10-03 11:08:47\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Pure hypercholesterolemia\n- Chronic atrial fibrillation\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-27 10:33:48, ended at 2019-02-27 11:19:33\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Acute upper respiratory infection\n- Chronic atrial fibrillation\n- Disorder of kidney and/or ureter\n- Pure hypercholesterolemia\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, started on 2018-03-10, presumably until 2018-03-10, with intended 0 refill(s). Instructions: take 1 tablet by mouth once daily\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2021-11-06, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n- 24 HR diltiazem hydrochloride 180 MG Extended Release Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 1 Capsule (180 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-22 16:29:37, ended at 2019-05-22 17:11:52\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n- Essential hypertension\n- Pure hypercholesterolemia\n- Primary malignant neoplasm of prostate\n- Primary diagnosis: Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-08-21 09:38:20, ended at 2019-08-21 11:05:55\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent atrial fibrillation\n- Primary diagnosis: Olecranon bursitis\n- Pure hypercholesterolemia\n- Disorder of shoulder\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-07 09:33:44, ended at 2020-03-07 10:23:33\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 2.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Persistent atrial fibrillation\n- Primary diagnosis: Impacted cerumen\n- Pure hypercholesterolemia\n\n### Drug\n- digoxin 0.25 MG Oral Tablet, through Oral route, started on 2019-10-29, presumably until 2021-12-31, with intended 0 refill(s). Instructions: take 0.25 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-20 09:21:49, ended at 2021-02-20 09:32:39\nThe patient in this visit was 76 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of breast\n- Essential hypertension\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8f2e79f7a26ebc21789068f764ef186abe4e075758186ae5afc95d766c62fcf8", "prompt_hash": "3051d9fb6f61bcafc97b74ac31596f70086a1973cae0447d60703aeabfb9db8e", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115971050, "visit_occurrence_id": 79873950, "death_date": "2017-02-04", "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2015-11-23 13:20:00", "visit_end_datetime": "2015-11-23 23:59:00", "visit_length_in_hours": 10.65, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-23 13:20:00, ended at 2015-11-23 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Prothrombin time (PT): 12.9 (second)\n- Thrombin time: 16.0 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.9 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 164 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 417 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 263 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 894, "patient_first_visit_date": "2013-12-15 11:16:00", "patient_last_visit_date": "2017-01-30 09:30:00", "end_obs_date": "2016-11-22", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 1, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 1, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 1, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 80, "cumulated_visit_num": 80, "cumulated_approximate_token_count": 30690, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-15 11:16:00, ended at 2013-12-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2015-09-18. Instructions: take 50 mg by mouth every morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-18 00:00:00, ended at 2013-12-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-22 10:00:00, ended at 2013-12-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Testis, NOS\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-30 00:00:00, ended at 2013-12-30 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-01 00:00:00, ended at 2014-01-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:08:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 654 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.18 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-19 19:02:00, ended at 2014-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of testis\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-21 00:00:00, ended at 2014-01-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-21 10:57:00, ended at 2014-01-21 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 246 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.2 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.37 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 146 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-11 08:09:00, ended at 2014-02-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n- Lymphadenopathy\n- Acquired absence of genital organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-18 10:23:00, ended at 2014-02-18 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 1 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 155 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 138 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-06-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-02-18\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-06-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. For nausea and vomiting\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-06-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea or vomiting\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-02-18, presumably until 2014-02-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-19 12:50:00, ended at 2014-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-02-19, presumably until 2014-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-11 09:34:00, ended at 2014-03-11 10:11:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 188 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.1 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.39 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.46 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-11 10:12:00, ended at 2014-03-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-12 14:30:00, ended at 2014-03-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-03-12, presumably until 2014-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-21 00:00:00, ended at 2014-05-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-27 16:02:00, ended at 2014-05-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of testis\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-03 10:25:00, ended at 2014-06-03 11:38:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 12:28:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-22 00:00:00, ended at 2014-12-22 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-22 00:00:00, ended at 2014-12-22 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-26 14:52:00, ended at 2015-01-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-27 00:00:00, ended at 2015-01-27 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 10:23:00, ended at 2015-01-28 12:11:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 12:12:00, ended at 2015-01-28 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.09 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 139 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 2 (milli-international unit per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 173 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.33 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-29 00:00:00, ended at 2015-07-29 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-29 10:26:00, ended at 2015-07-29 11:54:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.39 (thousand per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 77 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 14 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-29 10:40:51, ended at 2015-07-29 13:58:30\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 1 (milli-international unit per milliliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 3.2 (nanogram per milliliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 253 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-29 11:55:00, ended at 2015-07-29 12:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCV [Entitic volume] by Automated count: 97.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 75 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-29 12:04:00, ended at 2015-07-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 07:46:00, ended at 2015-08-06 10:09:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 605 (nanogram per milliliter)\n- Thrombin time: 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 12 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 56 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 191 (picogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Blasts/100 leukocytes in Blood by Manual count: 23 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 207 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.09 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.53 (micro-international unit per milliliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 127 (milli-international unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 283 (milligram per deciliter)\n- Folate [Mass/volume] in Serum or Plasma: >24.0 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Prothrombin time (PT): 13.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.01 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 68 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-06 08:06:52, ended at 2015-08-06 09:48:17\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 13.6 (micromole per liter)\n- Methylmalonate [Moles/volume] in Serum or Plasma: 0.15 (micromole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Pancytopenia\n\n### Drug\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 10:10:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.2 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Diagnostic bone marrow; biopsy(ies)\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Primary diagnosis: Pancytopenia\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 13:15:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Blasts/100 leukocytes in Blood by Manual count: 28 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.1 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.5 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.22 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 59 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 12 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 2 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- MCH [Entitic mass] by Automated count: 36.2 (picogram)\n- Thrombin time: 15.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 241 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 58 (percent)\n- MCV [Entitic volume] by Automated count: 101.4 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 650 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 288 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-20 13:40:03, ended at 2015-08-20 15:26:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.85\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-23 13:50:00, ended at 2015-09-18 16:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Blasts/100 leukocytes in Blood by Manual count: 9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 33 (microgram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Body height: 6' 1.819\" (inch (US))\n- Eosinophils [#/volume] in Blood by Manual count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.65 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 21 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 52 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 134 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- MCH [Entitic mass] by Automated count: 37.5 (picogram)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 88 (percent)\n- Thrombin time: 15.1 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.1 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: -5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 32.3 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 329 (unit per liter)\n- Left ventricular Ejection fraction: 1.5EF(MOD-sp4) (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.18 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 650 (nanogram per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.20 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 365 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 22.7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 7.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.32 (thousand per microliter)\n- Prothrombin time (PT): 17.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 767 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 67 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: <0.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.7 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Occupational therapy evaluation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Infusion chemotherapy for malignant neoplasm\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Physical therapy evaluation\n- Central venous catheter placement with guidance\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Platelet transfusion\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hospital discharge day management; more than 30 minutes\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Morphometric analysis, tumor\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Collection of venous blood by venipuncture\n- Packed blood cell transfusion\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Hypervolemia\n- Pancytopenia due to antineoplastic chemotherapy\n- Primary malignant neoplasm of testis\n- Right bundle branch block AND left anterior fascicular block\n- Septic shock\n- Severe sepsis\n- Acquired absence of organ\n- Antineoplastic poisoning\n- Dyspnea\n- Sepsis\n- Aphthous ulcer of mouth\n- Cardiac arrhythmia\n- Disease of liver\n- Jaundice\n- Acquired absence of genital organ\n- Acute renal failure syndrome\n- Primary diagnosis: Fever\n- Long QT syndrome\n- Pancytopenia\n- Constipation\n- Neoplasm defined only by topography: Testis, NOS\n- Pain in limb\n- Electrocardiogram abnormal\n- Primary diagnosis: Neutropenic disorder\n- Infective pneumonia\n- Acidosis\n- Candidiasis of mouth\n- Disorder of hematopoietic structure\n- Essential hypertension\n- Acute myeloid leukemia, disease\n- Syncope and collapse\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-12, presumably until 2015-09-12\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2015-09-14, presumably until 2015-09-14\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- benzocaine 0.2 MG/MG Oral Paste, through Submucosal route, started on 2015-09-11, presumably until 2015-09-15\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-08-29\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-08-26\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-09-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-15, presumably until 2015-09-18\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-09-09, presumably until 2015-09-15\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2015-08-26, presumably until 2015-08-26\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2015-09-13, presumably until 2015-09-13\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-08-23, presumably until 2015-09-17\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2016-01-29, with intended 0 refill(s). Instructions: take 1,000 mg by mouth every 8 hours as needed for Pain \n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-08-26, presumably until 2015-09-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-08-28\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-08-28, presumably until 2015-09-02\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-09-14, presumably until 2015-09-17\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2015-08-25, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-29\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-27, presumably until 2015-09-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-24, presumably until 2015-08-30\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- cefepime 2000 MG Injection, through Intravenous route, started on 2015-08-23, presumably until 2015-09-12\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-09-14, presumably until 2015-09-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-09-04, presumably until 2015-09-13\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-08-23, presumably until 2015-09-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-09-10, presumably until 2015-09-10\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-09, presumably until 2015-09-09\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2015-08-23, presumably until 2015-09-12\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-09-14, presumably until 2015-09-14\n- 20 ML idarubicin hydrochloride 1 MG/ML Injection, through Intravenous route, started on 2015-08-26, presumably until 2015-08-28\n- vardenafil 20 MG Oral Tablet, through Oral route, started on 2015-08-17, presumably until 2016-01-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed \n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2015-09-02, presumably until 2015-09-18\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2015-09-11, presumably until 2015-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-21 00:00:00, ended at 2015-09-21 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 07:37:30, ended at 2015-09-21 07:37:42\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-21 10:17:00, ended at 2015-09-21 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15 (percent)\n- Blasts/100 leukocytes in Blood by Manual count: 2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 719 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 28 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.84 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.74 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n- Pancytopenia\n- Anemia\n- Essential thrombocythemia\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2015-09-21, presumably until 2015-09-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-24 11:09:00, ended at 2015-09-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.94 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 845 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 70 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 464 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 303 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Thrombin time: 16.3 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.7 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 628 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-24 16:19:43, ended at 2015-09-24 17:45:24\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-29 00:00:00, ended at 2015-09-29 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2015-09-29, presumably until 2015-12-17, with intended 4 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day Instill 1 drop to both eyes four times daily.  Administer 12 hours prior to cytarabine until 12 hours after last dose.  Shake well prior to instillation.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 16:08:00, ended at 2015-10-03 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 389 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.2 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 803 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 239 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.53 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 71 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 379 (thousand per microliter)\n- Thrombin time: 16.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.16 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Prothrombin time (PT): 13.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-04 07:50:00, ended at 2015-10-04 16:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-04 16:33:00, ended at 2015-10-04 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2016-01-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2016-01-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-06 07:20:00, ended at 2015-10-06 17:01:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-10-06\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-10-06\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-06 11:13:58, ended at 2015-10-06 11:14:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Management of recipient hematopoietic progenitor cell donor search and cell acquisition\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-06 17:02:00, ended at 2015-10-06 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-07 00:00:00, ended at 2015-10-07 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-07 00:00:00, ended at 2015-10-07 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-08 07:50:00, ended at 2015-10-08 16:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2015-10-08, presumably until 2015-10-08\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-08, presumably until 2015-10-08\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-08, presumably until 2015-10-08\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-10-08, presumably until 2015-10-08\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-08, presumably until 2015-10-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-08 16:52:00, ended at 2015-10-08 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 97.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 304 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 283 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Thrombin time: 17.0 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 672 (nanogram per milliliter)\n- Prothrombin time (PT): 13.2 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-11 13:31:00, ended at 2015-10-11 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 393 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 146 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 91 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.9 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Thrombin time: 15.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 288 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 13:52:00, ended at 2015-10-15 14:12:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 319 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Thrombin time: 15.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 144 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 294 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Prothrombin time (PT): 13.1 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 13 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 14:13:00, ended at 2015-10-15 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-16 08:00:32, ended at 2015-10-16 08:00:46\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Management of recipient hematopoietic progenitor cell donor search and cell acquisition\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 13:29:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 318 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 6.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Prothrombin time (PT): 13.8 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.08 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.0 (second)\n- Thrombin time: 15.3 (second)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 243 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-19 12:25:00, ended at 2015-10-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-20 12:41:15, ended at 2015-10-20 14:36:43\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 13:31:00, ended at 2015-10-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.93 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 169 (unit per liter)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.59 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 602 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 582 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 169 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Thrombin time: 14.3 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-22 13:42:28, ended at 2015-10-22 15:55:08\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2015-10-22, presumably until 2015-11-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2015-10-22, presumably until 2016-01-29, with intended 6 refill(s). Instructions: take 10 mL by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-26 08:02:30, ended at 2015-10-26 08:02:45\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Management of recipient hematopoietic progenitor cell donor search and cell acquisition\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-26 13:40:00, ended at 2015-10-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 562 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.98 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.0 (second)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.68 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 536 (nanogram per milliliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 259 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 27 (percent)\n- Prothrombin time (PT): 14.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Thrombin time: 14.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-28 10:50:00, ended at 2015-10-28 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.58 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 672 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Thrombin time: 15.0 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 556 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.6 (second)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 22.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 190 (thousand per microliter)\n- Prothrombin time (PT): 13.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-02 12:44:00, ended at 2015-11-02 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.6 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 214 (unit per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Thrombin time: 15.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 402 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 319 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-05 12:42:00, ended at 2015-11-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 415 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Thrombin time: 16.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.4 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Prothrombin time (PT): 13.8 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 294 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-05 13:33:04, ended at 2015-11-05 15:33:25\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 13:26:00, ended at 2015-11-12 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.8 (percent)\n- Thrombin time: 16.9 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 231 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 368 (nanogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.65 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 331 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-15 07:00:00, ended at 2015-11-15 16:44:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.93 (thousand per microliter)\n- Body height: 6' 1.031\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.4 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-11-15\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-11-15\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-11-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-11-15, presumably until 2015-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-15 16:45:00, ended at 2015-11-15 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.031\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-17 07:00:00, ended at 2015-11-17 16:43:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.031\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2015-11-17, presumably until 2015-11-17\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-11-17\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-11-17\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-19 07:00:00, ended at 2015-11-19 16:41:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.031\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-19, presumably until 2015-11-19\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-19, presumably until 2015-11-19\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-11-19, presumably until 2015-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-19 16:42:00, ended at 2015-11-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-23 13:20:00, ended at 2015-11-23 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Prothrombin time (PT): 12.9 (second)\n- Thrombin time: 16.0 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.9 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 164 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 417 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 263 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-15 11:16:00, ended at 2013-12-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2015-09-18. Instructions: take 50 mg by mouth every morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-18 00:00:00, ended at 2013-12-18 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-22 10:00:00, ended at 2013-12-22 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm defined only by topography: Testis, NOS\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-30 00:00:00, ended at 2013-12-30 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-01 00:00:00, ended at 2014-01-01 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-16 08:08:00, ended at 2014-01-16 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 135 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 654 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.18 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-19 19:02:00, ended at 2014-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of testis\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-21 00:00:00, ended at 2014-01-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-21 10:57:00, ended at 2014-01-21 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 246 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.2 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- MCV [Entitic volume] by Automated count: 89.4 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.63 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.37 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 146 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-11 08:09:00, ended at 2014-02-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n- Lymphadenopathy\n- Acquired absence of genital organ\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-18 10:23:00, ended at 2014-02-18 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 1 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 155 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 138 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.87 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-06-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea and vomiting\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-02-18\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-06-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed. For nausea and vomiting\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2014-02-18, presumably until 2014-06-03, with intended 5 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed. For nausea or vomiting\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-02-18, presumably until 2014-02-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-19 12:50:00, ended at 2014-02-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-02-19, presumably until 2014-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-11 09:34:00, ended at 2014-03-11 10:11:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 188 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.1 (percent)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.39 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.46 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 104 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.1 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-03-11, presumably until 2014-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-11 10:12:00, ended at 2014-03-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-12 14:30:00, ended at 2014-03-12 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2014-03-12, presumably until 2014-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-21 00:00:00, ended at 2014-05-21 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-27 16:02:00, ended at 2014-05-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; without contrast material\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Primary malignant neoplasm of testis\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-03 10:25:00, ended at 2014-06-03 11:38:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-15 12:28:00, ended at 2014-06-15 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: <1 (milli-international unit per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.87 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 171 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.74 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-22 00:00:00, ended at 2014-12-22 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-22 00:00:00, ended at 2014-12-22 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-26 14:52:00, ended at 2015-01-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-27 00:00:00, ended at 2015-01-27 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-28 00:00:00, ended at 2015-01-28 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 10:23:00, ended at 2015-01-28 12:11:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-01-28 12:12:00, ended at 2015-01-28 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.09 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 139 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 2 (milli-international unit per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 173 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.33 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-15 00:00:00, ended at 2015-03-15 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-07-29 00:00:00, ended at 2015-07-29 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-29 10:26:00, ended at 2015-07-29 11:54:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.39 (thousand per microliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 2 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 77 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Neutrophils/100 leukocytes in Blood by Manual count: 14 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-07-29 10:40:51, ended at 2015-07-29 13:58:30\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma: 1 (milli-international unit per milliliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 3.2 (nanogram per milliliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 253 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-29 11:55:00, ended at 2015-07-29 12:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- MCV [Entitic volume] by Automated count: 97.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 75 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.54 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-07-29 12:04:00, ended at 2015-07-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary malignant neoplasm of testis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 07:46:00, ended at 2015-08-06 10:09:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 605 (nanogram per milliliter)\n- Thrombin time: 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.3 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 12 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 56 (percent)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 191 (picogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.7 (percent)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Blasts/100 leukocytes in Blood by Manual count: 23 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 207 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.09 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.53 (micro-international unit per milliliter)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 127 (milli-international unit per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 283 (milligram per deciliter)\n- Folate [Mass/volume] in Serum or Plasma: >24.0 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Prothrombin time (PT): 13.1 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Eosinophils [#/volume] in Blood by Manual count: 0.01 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 68 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.9 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-06 08:06:52, ended at 2015-08-06 09:48:17\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 13.6 (micromole per liter)\n- Methylmalonate [Moles/volume] in Serum or Plasma: 0.15 (micromole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Pancytopenia\n\n### Drug\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-08-06, presumably until 2015-08-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 14 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-06 10:10:00, ended at 2015-08-06 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 1.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.43 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.2 (femtoliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 67 (thousand per microliter)\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Diagnostic bone marrow; biopsy(ies)\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Acute myeloid leukemia, disease\n- Primary diagnosis: Pancytopenia\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2015-08-06, presumably until 2015-08-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-08-20 13:15:00, ended at 2015-08-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Blasts/100 leukocytes in Blood by Manual count: 28 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.1 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.5 (second)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.22 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 59 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 12 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.99 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 2 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- MCH [Entitic mass] by Automated count: 36.2 (picogram)\n- Thrombin time: 15.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 241 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 58 (percent)\n- MCV [Entitic volume] by Automated count: 101.4 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 650 (nanogram per milliliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 288 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-08-20 13:40:03, ended at 2015-08-20 15:26:38\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.85\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2015-08-23 13:50:00, ended at 2015-09-18 16:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Blasts/100 leukocytes in Blood by Manual count: 9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 33 (microgram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Body height: 6' 1.819\" (inch (US))\n- Eosinophils [#/volume] in Blood by Manual count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.65 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 21 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 52 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 134 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- MCH [Entitic mass] by Automated count: 37.5 (picogram)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 88 (percent)\n- Thrombin time: 15.1 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.1 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: -5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 2.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 32.3 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 329 (unit per liter)\n- Left ventricular Ejection fraction: 1.5EF(MOD-sp4) (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Blood: 1.18 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 650 (nanogram per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.20 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 9 (thousand per microliter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 365 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 22.7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 7.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.32 (thousand per microliter)\n- Prothrombin time (PT): 17.5 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 767 (milligram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 67 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: <0.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.7 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Occupational therapy evaluation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Infusion chemotherapy for malignant neoplasm\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Physical therapy evaluation\n- Central venous catheter placement with guidance\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Platelet transfusion\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Hospital discharge day management; more than 30 minutes\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Morphometric analysis, tumor\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Collection of venous blood by venipuncture\n- Packed blood cell transfusion\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n\n### Condition\n- Hypervolemia\n- Pancytopenia due to antineoplastic chemotherapy\n- Primary malignant neoplasm of testis\n- Right bundle branch block AND left anterior fascicular block\n- Septic shock\n- Severe sepsis\n- Acquired absence of organ\n- Antineoplastic poisoning\n- Dyspnea\n- Sepsis\n- Aphthous ulcer of mouth\n- Cardiac arrhythmia\n- Disease of liver\n- Jaundice\n- Acquired absence of genital organ\n- Acute renal failure syndrome\n- Primary diagnosis: Fever\n- Long QT syndrome\n- Pancytopenia\n- Constipation\n- Neoplasm defined only by topography: Testis, NOS\n- Pain in limb\n- Electrocardiogram abnormal\n- Primary diagnosis: Neutropenic disorder\n- Infective pneumonia\n- Acidosis\n- Candidiasis of mouth\n- Disorder of hematopoietic structure\n- Essential hypertension\n- Acute myeloid leukemia, disease\n- Syncope and collapse\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-09-12, presumably until 2015-09-12\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2015-09-14, presumably until 2015-09-14\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- benzocaine 0.2 MG/MG Oral Paste, through Submucosal route, started on 2015-09-11, presumably until 2015-09-15\n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-08-29\n- bisacodyl 5 MG Delayed Release Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-08-26\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-09-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-09-15, presumably until 2015-09-18\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-09-09, presumably until 2015-09-15\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2015-08-26, presumably until 2015-08-26\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2015-09-13, presumably until 2015-09-13\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-08-23, presumably until 2015-09-17\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2016-01-29, with intended 0 refill(s). Instructions: take 1,000 mg by mouth every 8 hours as needed for Pain \n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-08-26, presumably until 2015-09-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-08-26, presumably until 2015-08-28\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-08-28, presumably until 2015-09-02\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2015-09-14, presumably until 2015-09-17\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2015-08-25, presumably until 2015-08-25\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-08-24, presumably until 2015-08-29\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-08-27, presumably until 2015-09-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-08-24, presumably until 2015-08-30\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-12\n- cefepime 2000 MG Injection, through Intravenous route, started on 2015-08-23, presumably until 2015-09-12\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-09-14, presumably until 2015-09-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-09-04, presumably until 2015-09-13\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2015-09-12, presumably until 2015-09-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-08-23, presumably until 2015-09-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-09-10, presumably until 2015-09-10\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-09-09, presumably until 2015-09-09\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2015-08-23, presumably until 2015-09-12\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-09-14, presumably until 2015-09-14\n- 20 ML idarubicin hydrochloride 1 MG/ML Injection, through Intravenous route, started on 2015-08-26, presumably until 2015-08-28\n- vardenafil 20 MG Oral Tablet, through Oral route, started on 2015-08-17, presumably until 2016-01-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed \n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2015-09-02, presumably until 2015-09-18\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2015-09-11, presumably until 2015-09-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-21 00:00:00, ended at 2015-09-21 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-21 07:37:30, ended at 2015-09-21 07:37:42\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-21 10:17:00, ended at 2015-09-21 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15 (percent)\n- Blasts/100 leukocytes in Blood by Manual count: 2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 719 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 28 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.84 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.74 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.28 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n\n### Procedure\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n- Pancytopenia\n- Anemia\n- Essential thrombocythemia\n\n### Drug\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2015-09-21, presumably until 2015-09-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-24 11:09:00, ended at 2015-09-24 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.94 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 845 (nanogram per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 70 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 464 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 303 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 1.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Thrombin time: 16.3 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.7 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 628 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-24 16:19:43, ended at 2015-09-24 17:45:24\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-29 00:00:00, ended at 2015-09-29 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- prednisolone acetate 10 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2015-09-29, presumably until 2015-12-17, with intended 4 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day Instill 1 drop to both eyes four times daily.  Administer 12 hours prior to cytarabine until 12 hours after last dose.  Shake well prior to instillation.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 16:08:00, ended at 2015-10-03 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 389 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.2 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 803 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 239 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.53 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 71 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.51 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 379 (thousand per microliter)\n- Thrombin time: 16.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 1.16 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.0 (femtoliter)\n- Prothrombin time (PT): 13.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-04 07:50:00, ended at 2015-10-04 16:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2015-10-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-04 16:33:00, ended at 2015-10-04 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2016-01-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-10-04, presumably until 2016-01-29, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Nausea/Vomiting\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-06 07:20:00, ended at 2015-10-06 17:01:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-10-06\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-10-06\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-06 11:13:58, ended at 2015-10-06 11:14:22\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Management of recipient hematopoietic progenitor cell donor search and cell acquisition\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-06 17:02:00, ended at 2015-10-06 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-07 00:00:00, ended at 2015-10-07 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-07 00:00:00, ended at 2015-10-07 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-08 07:50:00, ended at 2015-10-08 16:51:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2015-10-08, presumably until 2015-10-08\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-08, presumably until 2015-10-08\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-08, presumably until 2015-10-08\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-10-08, presumably until 2015-10-08\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-08, presumably until 2015-10-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-08 16:52:00, ended at 2015-10-08 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 97.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 304 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 283 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Thrombin time: 17.0 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.45 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 672 (nanogram per milliliter)\n- Prothrombin time (PT): 13.2 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-11 13:31:00, ended at 2015-10-11 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 393 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 146 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 91 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.9 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Thrombin time: 15.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 288 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.8 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 75 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 13:52:00, ended at 2015-10-15 14:12:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 319 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Thrombin time: 15.6 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 144 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.0 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 294 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Prothrombin time (PT): 13.1 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 13 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 14:13:00, ended at 2015-10-15 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-16 08:00:32, ended at 2015-10-16 08:00:46\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Management of recipient hematopoietic progenitor cell donor search and cell acquisition\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-18 13:29:00, ended at 2015-10-18 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 318 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 0.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 6.2 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Prothrombin time (PT): 13.8 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 141 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.08 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 18.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.0 (second)\n- Thrombin time: 15.3 (second)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 243 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-19 12:25:00, ended at 2015-10-19 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Transfusion, blood or blood components\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-20 12:41:15, ended at 2015-10-20 14:36:43\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 13:31:00, ended at 2015-10-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.93 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 169 (unit per liter)\n- MCV [Entitic volume] by Automated count: 86.9 (femtoliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.59 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 602 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 40 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 582 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 61 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 25.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.41 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Prothrombin time (PT): 13.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 59 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 169 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 8.8 (gram per deciliter)\n- Thrombin time: 14.3 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 2 (milli-international unit per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.2 (second)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-22 13:42:28, ended at 2015-10-22 15:55:08\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2015-10-22, presumably until 2015-11-01, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 10 days\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Oral route, started on 2015-10-22, presumably until 2016-01-29, with intended 6 refill(s). Instructions: take 10 mL by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-26 08:02:30, ended at 2015-10-26 08:02:45\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Management of recipient hematopoietic progenitor cell donor search and cell acquisition\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-26 13:40:00, ended at 2015-10-26 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 562 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.98 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19 (percent)\n- Monocytes [#/volume] in Blood by Manual count: 1.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.0 (second)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 3 (milli-international unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.68 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 536 (nanogram per milliliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 259 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 27 (percent)\n- Prothrombin time (PT): 14.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Thrombin time: 14.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-28 10:50:00, ended at 2015-10-28 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.58 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 672 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Thrombin time: 15.0 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 556 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.6 (second)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 22.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 190 (thousand per microliter)\n- Prothrombin time (PT): 13.7 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.91 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-02 12:44:00, ended at 2015-11-02 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 33.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.6 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 214 (unit per liter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Thrombin time: 15.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 402 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.49 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Prothrombin time (PT): 13.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 319 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 192 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-05 12:42:00, ended at 2015-11-05 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 415 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Thrombin time: 16.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 32.4 (second)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.31 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Prothrombin time (PT): 13.8 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 294 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n- Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-05 13:33:04, ended at 2015-11-05 15:33:25\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 13:26:00, ended at 2015-11-12 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.8 (percent)\n- Thrombin time: 16.9 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 231 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 108 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 368 (nanogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.65 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 331 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 5.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-15 07:00:00, ended at 2015-11-15 16:44:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.93 (thousand per microliter)\n- Body height: 6' 1.031\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.4 (percent)\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-11-15\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-11-15\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-11-15, presumably until 2015-11-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-11-15, presumably until 2015-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-15 16:45:00, ended at 2015-11-15 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.031\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-17 07:00:00, ended at 2015-11-17 16:43:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.031\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- cytarabine 20 MG/ML Injectable Solution, started on 2015-11-17, presumably until 2015-11-17\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-11-17\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-11-17\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-11-17, presumably until 2015-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-19 07:00:00, ended at 2015-11-19 16:41:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.031\" (inch (US))\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Acute myeloid leukemia, disease\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-19, presumably until 2015-11-19\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-19, presumably until 2015-11-19\n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2015-11-19, presumably until 2015-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-19 16:42:00, ended at 2015-11-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-23 00:00:00, ended at 2015-11-23 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute myeloid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-23 13:20:00, ended at 2015-11-23 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.9 (femtoliter)\n- Prothrombin time (PT): 12.9 (second)\n- Thrombin time: 16.0 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.9 (second)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 164 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.39 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 115 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.29 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 417 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 263 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Pancytopenia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "3e53ff991ae3d8c8e7d8f5c09d8e3ff9a7d22b722684913d27cd5a0e2830fb78", "prompt_hash": "8e0e0bb667cc175e895f8eaacf524d2685e07f17c023918268179121ed2057f6", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115972520, "visit_occurrence_id": 176181632, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-04-14 00:00:00", "visit_end_datetime": "2021-04-14 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 94, "patient_first_visit_date": "2018-06-12 12:53:18", "patient_last_visit_date": "2022-06-30 00:00:00", "end_obs_date": "2022-04-14", "hypertension_type": "new", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 21, "cumulated_visit_num": 21, "cumulated_approximate_token_count": 8688, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2018-06-12 12:53:18, ended at 2018-06-12 13:38:22\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Raised prostate specific antigen\n- Erectile dysfunction\n- Umbilical hernia\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, presumably until 2019-08-04, with intended 0 refill(s). Instructions: take 800 mg by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-12 13:41:00, ended at 2018-06-12 23:59:00\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 15.8 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Raised prostate specific antigen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-04 09:47:00, ended at 2018-09-04 23:59:00\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Disorder of esophagus\n- Diverticulosis of large intestine without diverticulitis\n- Primary malignant neoplasm of prostate\n- Large liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-11 08:46:47, ended at 2018-09-11 09:49:52\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-11 09:49:00, ended at 2018-09-11 23:59:00\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-11 10:41:09, ended at 2018-09-11 11:29:23\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-08-04 09:38:00, ended at 2019-08-04 13:49:00\nThe patient in this visit was 61 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.39 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Collection of venous blood by venipuncture\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Synovial cyst of knee\n- Erectile dysfunction\n- Arthropathy of right knee joint\n- Chronic pain\n- Disorder of soft tissue\n- Nicotine dependence\n- Primary diagnosis: Pain of right knee joint\n\n### Drug\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2019-08-04, presumably until 2020-08-03, with intended 0 refill(s). Instructions: take 1 Tab (600 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-02-15 17:48:00, ended at 2020-02-15 18:49:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Radiologic examination, hand; minimum of 3 views\n- Application of short arm splint (forearm to hand); static\n\n### Condition\n- Closed fracture of neck of metacarpal bone\n- Injury of upper extremity\n- Pain in right hand\n- Nicotine dependence\n- Primary diagnosis: Wrist joint pain\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2020-02-15, presumably until 2020-02-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-26 00:00:00, ended at 2020-02-26 00:00:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-03-09 13:15:00, ended at 2020-03-09 16:50:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.76 (thousand per microliter)\n- Anion gap in Serum or Plasma: 21 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Collection of venous blood by venipuncture\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Cellulitis of right lower limb\n- Nicotine dependence\n- Pain in toe\n- Primary diagnosis: Cellulitis\n- Disorder of soft tissue\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2020-03-09\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2020-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2021-04-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed for Pain\n- docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2021-04-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (constipation)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-01 14:05:00, ended at 2020-04-01 23:59:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 24.7 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-09 00:00:00, ended at 2020-12-09 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-02-22 15:00:00, ended at 2021-02-22 15:44:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Primary diagnosis: Pain of right knee joint\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, through Topical route, started on 2021-02-22, presumably until 2021-04-07, with intended 0 refill(s). Instructions: 1 Squirt by Topical route 2 times a day as needed (To bilateral knees as needed)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 2401 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 440 (picogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 290 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypokalemia\n- Primary diagnosis: Blood chemistry abnormal\n\n### Drug\n- potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2021-04-12, with intended 0 refill(s). Instructions: take 2 Tabs (20 mEq total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-04-07 09:55:43, ended at 2021-04-07 11:01:32\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnos\n\n### Condition\n- Hip pain\n- Primary malignant neoplasm of prostate\n- Backache\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2021-04-09 12:22:00, ended at 2021-04-13 18:15:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Prothrombin time (PT): 12.6 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 9.9 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 271 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 5.88 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 316 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 245 (unit per liter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 25.9 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 367 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aldosterone [Mass/volume] in Serum or Plasma: <4.0 (nanogram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Chloride [Moles/volume] in Urine: <20 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 0.9 (millimole per liter)\n- Osmolality of Serum or Plasma: 279 (milliosmole per kilogram)\n- Potassium [Moles/volume] in 24 hour Urine: 7.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 33.5 (milliequivalent per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 9 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 32500 (per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.2 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 9 (nanogram per milliliter)\n- Body height: 5' 9.016\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 44 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.34 (milligram per milligram)\n- Sodium [Moles/volume] in Blood: 132 (millimole per liter)\n- Sodium/Creatinine [Molar ratio] in Urine: 20 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 28.8 (microgram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Glucose [Mass/volume] in Blood: 162 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 20.0 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.45 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 60.49 (milligram per deciliter)\n- Osmolality of Urine: 152 (milliosmole per kilogram)\n- Methylmalonate [Moles/volume] in Serum or Plasma: 0.80 (micromole per liter)\n\n### Procedure\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Hospital discharge day management; more than 30 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Ultrasound, abdominal, real time with image documentation; complete\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Drainage of Left Knee Joint, Percutaneous Approach, Diagnostic\n- Collection of venous blood by venipuncture\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Alkalosis\n- Disorder of gallbladder\n- Fever\n- Pain due to neoplastic disease\n- Secondary malignant neoplasm of bone\n- Steatosis of liver\n- Chronic fatigue syndrome\n- Gout\n- Large liver\n- Atelectasis\n- Atrial premature complex\n- Electrocardiogram abnormal\n- Primary diagnosis: Hypokalemia\n- Imaging of musculoskeletal system abnormal\n- Osteoarthritis of knee\n- Anemia of chronic disease\n- Backache\n- Bone necrosis\n- Degeneration of lumbar intervertebral disc\n- Disorder of esophagus\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Long QT syndrome\n- Lumbago with sciatica\n- Primary malignant neoplasm of prostate\n- Rhabdomyolysis\n- Ventricular premature complex\n- Disorder of phosphorus metabolism\n- Idiopathic aseptic necrosis of bone\n- Lumbar spondylosis\n- Tachycardia\n- Adult failure to thrive syndrome\n- Anemia in neoplastic disease\n- Erectile dysfunction\n- Nicotine dependence\n- Pain of right knee joint\n- Severe protein-calorie malnutrition (Gomez: less than 60 percent of standard weight)\n- Spinal stenosis of lumbar region\n- Disorder of bone\n- Disorder of fluid AND/OR electrolyte\n- Hepatic failure\n- Hyperlipidemia\n- Pain of knee region\n- Cyst of bursa\n\n### Drug\n- dibasic potassium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth daily\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2021-04-10, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 2 Tabs (200 mg total) by mouth daily\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2021-04-10, presumably until 2022-04-13, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- potassium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- tribasic potassium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-10, presumably until 2021-04-10\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2021-04-09, presumably until 2021-04-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-06-01, with intended 0 refill(s). Instructions: take 2 Tabs (650 mg total) by mouth every 6 hours as needed\n- ibuprofen 400 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2021-04-13\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-09\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-04-09, presumably until 2021-04-12\n- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2021-04-12, presumably until 2021-04-12\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2021-04-09, presumably until 2021-04-09\n- tribasic sodium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2021-05-13, with intended 0 refill(s). Instructions: take 1 Tab (800 mg total) by mouth every 8 hours\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-09\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2021-04-11, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Tab (0.6 mg total) by mouth daily\n- vitamin B12 0.5 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-04-13\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2021-04-09, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Cap (300 mg total) by mouth 3 times a day\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2021-04-09, presumably until 2021-04-09\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2021-04-09, presumably until 2021-05-20, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily\n- sodium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- sodium phosphate, monobasic, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2021-04-09, presumably until 2021-04-12\n- sodium phosphate, dibasic, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-04-12, presumably until 2021-05-20, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth every 4 hours as needed for Cough\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2021-04-09, presumably until 2022-04-13, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily Apply patch to low back for up to 12 hours in any 24 hour period.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2021-04-10, presumably until 2021-04-16, with intended 0 refill(s). Instructions: take 0.5-1 Tabs (2.5-5 mg total) by mouth Q3H PRN for Pain\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2021-04-10, presumably until 2021-04-11\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-04-10, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth Daily at night\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- vitamin B12 1 MG Oral Tablet, through Oral route, started on 2021-04-14, presumably until 2022-04-14, with intended 0 refill(s). Instructions: take 1 Tab (1,000 mcg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-12 10:00:00, ended at 2021-04-12 14:52:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n- Bone and/or joint imaging; whole body\n\n### Condition\n- No conditions.\n\n### Drug\n- medronate, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-12 12:53:18, ended at 2018-06-12 13:38:22\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Raised prostate specific antigen\n- Erectile dysfunction\n- Umbilical hernia\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, presumably until 2019-08-04, with intended 0 refill(s). Instructions: take 800 mg by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-12 13:41:00, ended at 2018-06-12 23:59:00\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 15.8 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Raised prostate specific antigen\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-04 09:47:00, ended at 2018-09-04 23:59:00\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Disorder of esophagus\n- Diverticulosis of large intestine without diverticulitis\n- Primary malignant neoplasm of prostate\n- Large liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-11 08:46:47, ended at 2018-09-11 09:49:52\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-11 09:49:00, ended at 2018-09-11 23:59:00\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.84 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.26 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-11 10:41:09, ended at 2018-09-11 11:29:23\nThe patient in this visit was 60 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2019-08-04 09:38:00, ended at 2019-08-04 13:49:00\nThe patient in this visit was 61 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.47 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.39 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 102 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Collection of venous blood by venipuncture\n- Radiologic examination, knee; 3 views\n\n### Condition\n- Synovial cyst of knee\n- Erectile dysfunction\n- Arthropathy of right knee joint\n- Chronic pain\n- Disorder of soft tissue\n- Nicotine dependence\n- Primary diagnosis: Pain of right knee joint\n\n### Drug\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2019-08-04, presumably until 2020-08-03, with intended 0 refill(s). Instructions: take 1 Tab (600 mg total) by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-02-15 17:48:00, ended at 2020-02-15 18:49:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n- Radiologic examination, hand; minimum of 3 views\n- Application of short arm splint (forearm to hand); static\n\n### Condition\n- Closed fracture of neck of metacarpal bone\n- Injury of upper extremity\n- Pain in right hand\n- Nicotine dependence\n- Primary diagnosis: Wrist joint pain\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2020-02-15, presumably until 2020-02-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-26 00:00:00, ended at 2020-02-26 00:00:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2020-03-09 13:15:00, ended at 2020-03-09 16:50:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 97.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.76 (thousand per microliter)\n- Anion gap in Serum or Plasma: 21 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n\n### Procedure\n- Radiologic examination, ankle; complete, minimum of 3 views\n- Collection of venous blood by venipuncture\n- Radiologic examination, foot; complete, minimum of 3 views\n\n### Condition\n- Cellulitis of right lower limb\n- Nicotine dependence\n- Pain in toe\n- Primary diagnosis: Cellulitis\n- Disorder of soft tissue\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2020-03-09\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2020-03-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2021-04-07, with intended 0 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every 4 hours as needed for Pain\n- docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2020-03-09, presumably until 2021-04-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily as needed (constipation)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-04-01 14:05:00, ended at 2020-04-01 23:59:00\nThe patient in this visit was 62 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 24.7 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-09 00:00:00, ended at 2020-12-09 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2021-02-22 15:00:00, ended at 2021-02-22 15:44:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nicotine dependence\n- Primary diagnosis: Pain of right knee joint\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, through Topical route, started on 2021-02-22, presumably until 2021-04-07, with intended 0 refill(s). Instructions: 1 Squirt by Topical route 2 times a day as needed (To bilateral knees as needed)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ferritin [Mass/volume] in Serum or Plasma: 2401 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 440 (picogram per milliliter)\n- Iron [Mass/volume] in Serum or Plasma: 290 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypokalemia\n- Primary diagnosis: Blood chemistry abnormal\n\n### Drug\n- potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2021-04-12, with intended 0 refill(s). Instructions: take 2 Tabs (20 mEq total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 25 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 00:00:00, ended at 2021-04-07 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypokalemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-04-07 09:55:43, ended at 2021-04-07 11:01:32\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n- Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnos\n\n### Condition\n- Hip pain\n- Primary malignant neoplasm of prostate\n- Backache\n- Osteoarthritis of knee\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2021-04-09 12:22:00, ended at 2021-04-13 18:15:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Prothrombin time (PT): 12.6 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 9.9 (milliequivalent per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 271 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Folate [Mass/volume] in Serum or Plasma: 5.88 (nanogram per milliliter)\n- Haptoglobin [Mass/volume] in Serum or Plasma: 316 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 245 (unit per liter)\n- Oxygen [Partial pressure] saturation adjusted to 0.5 in Venous blood: 25.9 (millimeter mercury column)\n- Platelets [#/volume] in Blood by Automated count: 367 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aldosterone [Mass/volume] in Serum or Plasma: <4.0 (nanogram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Chloride [Moles/volume] in Urine: <20 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 0.9 (millimole per liter)\n- Osmolality of Serum or Plasma: 279 (milliosmole per kilogram)\n- Potassium [Moles/volume] in 24 hour Urine: 7.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 33.5 (milliequivalent per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 9 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Leukocytes [#/volume] in Body fluid by Manual count: 32500 (per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.2 (second)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 9 (nanogram per milliliter)\n- Body height: 5' 9.016\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 44 (millimeter per hour)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Potassium [Moles/volume] in Blood: <2.0 (millimole per liter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.34 (milligram per milligram)\n- Sodium [Moles/volume] in Blood: 132 (millimole per liter)\n- Sodium/Creatinine [Molar ratio] in Urine: 20 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 28.8 (microgram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.14 (million per microliter)\n- Glucose [Mass/volume] in Blood: 162 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 20.0 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.017 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.45 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.69 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 60.49 (milligram per deciliter)\n- Osmolality of Urine: 152 (milliosmole per kilogram)\n- Methylmalonate [Moles/volume] in Serum or Plasma: 0.80 (micromole per liter)\n\n### Procedure\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Hospital discharge day management; more than 30 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Ultrasound, abdominal, real time with image documentation; complete\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Drainage of Left Knee Joint, Percutaneous Approach, Diagnostic\n- Collection of venous blood by venipuncture\n- Bone and/or joint imaging; whole body\n\n### Condition\n- Alkalosis\n- Disorder of gallbladder\n- Fever\n- Pain due to neoplastic disease\n- Secondary malignant neoplasm of bone\n- Steatosis of liver\n- Chronic fatigue syndrome\n- Gout\n- Large liver\n- Atelectasis\n- Atrial premature complex\n- Electrocardiogram abnormal\n- Primary diagnosis: Hypokalemia\n- Imaging of musculoskeletal system abnormal\n- Osteoarthritis of knee\n- Anemia of chronic disease\n- Backache\n- Bone necrosis\n- Degeneration of lumbar intervertebral disc\n- Disorder of esophagus\n- Intervertebral disc disorder of lumbar region with myelopathy\n- Long QT syndrome\n- Lumbago with sciatica\n- Primary malignant neoplasm of prostate\n- Rhabdomyolysis\n- Ventricular premature complex\n- Disorder of phosphorus metabolism\n- Idiopathic aseptic necrosis of bone\n- Lumbar spondylosis\n- Tachycardia\n- Adult failure to thrive syndrome\n- Anemia in neoplastic disease\n- Erectile dysfunction\n- Nicotine dependence\n- Pain of right knee joint\n- Severe protein-calorie malnutrition (Gomez: less than 60 percent of standard weight)\n- Spinal stenosis of lumbar region\n- Disorder of bone\n- Disorder of fluid AND/OR electrolyte\n- Hepatic failure\n- Hyperlipidemia\n- Pain of knee region\n- Cyst of bursa\n\n### Drug\n- dibasic potassium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Tab (1 mg total) by mouth daily\n- thiamine 100 MG Oral Tablet, through Oral route, started on 2021-04-10, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 2 Tabs (200 mg total) by mouth daily\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2021-04-10, presumably until 2022-04-13, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily\n- potassium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- tribasic potassium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2021-04-10, presumably until 2021-04-10\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2021-04-09, presumably until 2021-04-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-06-01, with intended 0 refill(s). Instructions: take 2 Tabs (650 mg total) by mouth every 6 hours as needed\n- ibuprofen 400 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2021-04-13\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-09\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2021-04-09, presumably until 2021-04-12\n- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2021-04-12, presumably until 2021-04-12\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2021-04-09, presumably until 2021-04-09\n- tribasic sodium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2021-05-13, with intended 0 refill(s). Instructions: take 1 Tab (800 mg total) by mouth every 8 hours\n- cyclobenzaprine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2021-04-09, presumably until 2021-04-09\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2021-04-12, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- colchicine 0.6 MG Oral Tablet, through Oral route, started on 2021-04-11, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Tab (0.6 mg total) by mouth daily\n- vitamin B12 0.5 MG Oral Tablet, through Oral route, started on 2021-04-13, presumably until 2021-04-13\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2021-04-09, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Cap (300 mg total) by mouth 3 times a day\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2021-04-09, presumably until 2021-04-09\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2021-04-09, presumably until 2021-05-20, with intended 0 refill(s). Instructions: take 1 Packet (17 g total) by mouth daily\n- sodium phosphate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- sodium phosphate, monobasic, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2021-04-09, presumably until 2021-04-12\n- sodium phosphate, dibasic, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2021-04-12, presumably until 2021-05-20, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth every 4 hours as needed for Cough\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2021-04-09, presumably until 2022-04-13, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily Apply patch to low back for up to 12 hours in any 24 hour period.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2021-04-10, presumably until 2021-04-16, with intended 0 refill(s). Instructions: take 0.5-1 Tabs (2.5-5 mg total) by mouth Q3H PRN for Pain\n- 50 ML magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2021-04-10, presumably until 2021-04-11\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-04-10, presumably until 2022-04-13, with intended 0 refill(s). Instructions: take 1 Tab (40 mg total) by mouth Daily at night\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2021-04-09, presumably until 2021-04-10\n- vitamin B12 1 MG Oral Tablet, through Oral route, started on 2021-04-14, presumably until 2022-04-14, with intended 0 refill(s). Instructions: take 1 Tab (1,000 mcg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-04-12 10:00:00, ended at 2021-04-12 14:52:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n- Bone and/or joint imaging; whole body\n\n### Condition\n- No conditions.\n\n### Drug\n- medronate, through Intravenous route, started on 2021-04-12, presumably until 2021-04-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-14 00:00:00, ended at 2021-04-14 00:00:00\nThe patient in this visit was 63 years old, Black or African American, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "7f6ca95f7ef4f18c540faf542d8fc938f8dd4b388b793b3063598d75e044c2b8", "prompt_hash": "ada1fa234ef6405d57c3daf248e6e1b53c980a228cbcc6c7d82c6c2ebcbfd259", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 4, "doc": {"person_id": 115968207, "visit_occurrence_id": 65769273, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2014-10-02 00:00:00", "visit_end_datetime": "2014-10-02 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 00:00:00, ended at 2014-10-02 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2014-10-02, presumably until 2014-10-02\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-02, presumably until 2014-10-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n\n", "approximate_token_count": 375, "patient_first_visit_date": "2012-11-03 11:22:00", "patient_last_visit_date": "2018-10-19 13:55:00", "end_obs_date": "2015-10-02", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 1, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 1, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 48, "cumulated_visit_num": 48, "cumulated_approximate_token_count": 13645, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-03 11:22:00, ended at 2012-11-03 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.33 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 44 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-11-26 00:00:00, ended at 2012-11-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Arteriosclerosis of arterial coronary artery bypass graft\n- Atrial fibrillation\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-10 00:00:00, ended at 2012-12-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-10 00:00:00, ended at 2012-12-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-12-10, presumably until 2013-01-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily. Refill ONLY if heartburn symptoms.\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2012-12-10, presumably until 2013-01-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day. Refill ONLY if heartburn symptoms.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-12-10, presumably until 2012-12-12, with intended 2 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours. Do not take morning of 12/13/2012\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 00:00:00, ended at 2012-12-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- cefazolin 1000 MG Injection, started on 2012-12-13, presumably until 2012-12-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 07:06:00, ended at 2012-12-14 11:49:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.6 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Prothrombin time (PT): 18.4 (second)\n- Sodium [Moles/volume] in Blood: 146 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 63.7 (second)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 41 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 46 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Cardiac mapping\n- Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, His bund\n- Excision or destruction of other lesion or tissue of heart, endovascular approach\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Transluminal intracardiac echocardiography\n- Catheter based invasive electrophysiologic testing\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)\n- Pre-surgery evaluation\n- Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure)\n- Intracardiac catheter ablation of arrhythmogenic focus; for treatment of supraventricular tachycardia by ablation of fast or slow atrioventricular pathways, accessory atrioventricular connections or other atrial foci, singly or in combination\n- Other electric countershock of heart\n\n### Condition\n- Aortocoronary bypass graft present\n- Immune thrombocytopenia\n- Primary diagnosis: Postprocedural state finding\n- Primary malignant neoplasm of prostate\n- Hyperlipidemia\n- Atrial fibrillation\n- Old myocardial infarction\n- Benign hypertensive renal disease with renal failure\n- Coronary atherosclerosis\n- Aortic valve disorder\n- Chronic kidney disease\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-14\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- fenofibrate 145 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-14\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-12-14, presumably until 2012-12-14. Instructions: inject  subcutaneous (under the skin) every 12 hours.  \n- eltrombopag 25 MG Oral Tablet, through Oral route, started on 2012-12-14, presumably until 2012-12-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-14 00:00:00, ended at 2012-12-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-12-14, presumably until 2013-02-10, with intended 1 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-17 00:00:00, ended at 2012-12-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-02-04 00:00:00, ended at 2013-02-04 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-04 13:10:00, ended at 2013-02-04 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; recording (includes connection, recording\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-09 00:00:00, ended at 2013-02-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-10 00:00:00, ended at 2013-02-10 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-10 00:00:00, ended at 2013-02-10 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-10 12:01:07, ended at 2013-02-10 14:36:16\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Immune thrombocytopenia\n- Gastroesophageal reflux disease\n- Coronary atherosclerosis\n- Hyperlipidemia\n- Primary diagnosis: Atrial fibrillation\n- Aortocoronary bypass graft present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-14 00:00:00, ended at 2013-02-14 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-23 12:32:00, ended at 2013-02-23 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2013-02-23, presumably until 2013-02-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-24 00:00:00, ended at 2013-02-24 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-03-09, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-24 00:00:00, ended at 2013-02-24 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-09 00:00:00, ended at 2013-03-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-09 00:00:00, ended at 2013-03-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aortic valve disorder\n- Coronary atherosclerosis\n- Primary diagnosis: Atrial fibrillation\n- Aortocoronary bypass graft present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-09 08:13:00, ended at 2013-03-09 12:23:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.9 (millimole per liter)\n- Body height: 5' 9.016\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Other electric countershock of heart\n- Cardioversion, elective, electrical conversion of arrhythmia; external\n\n### Condition\n- Old myocardial infarction\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Primary diagnosis: Atrial fibrillation\n- Essential hypertension\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-09, presumably until 2013-03-09\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-03-09, presumably until 2013-04-13, with intended 4 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-21 00:00:00, ended at 2013-03-21 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aortic valve disorder\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 07:13:00, ended at 2013-04-12 09:55:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Aortic valve disorder\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 09:56:00, ended at 2013-04-12 12:32:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Arterial puncture, withdrawal of blood for diagnosis\n- Respiratory flow volume loop\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal arterial blood gas\n- Atrial fibrillation\n- Cardiomegaly\n- Coronary atherosclerosis\n- Dyspnea\n- Aortocoronary bypass graft present\n- Abnormal breathing\n- Aortic valve disorder\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 12:33:00, ended at 2013-04-12 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-13 00:00:00, ended at 2013-04-13 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-04-13, presumably until 2013-04-27, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-05-04 11:39:00, ended at 2013-05-16 13:50:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 25.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Prothrombin time (PT): 33.9 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Body height: 5' 9\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 47.3 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 199 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 87 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.6 (ratio)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.0 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.96 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Pooling of platelets or other blood products\n- Insertion of pleural tube drain\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Open and other replacement of aortic valve\n- Collection of venous blood by venipuncture\n- Packed blood cell transfusion\n- Controlled ventilation procedure and therapy, initiation and management\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Physical therapy evaluation\n- Transfusion of other serum\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Operative external blood circulation\n- Occupational therapy evaluation\n\n### Condition\n- Aortocoronary bypass graft present\n- Atelectasis\n- Hyperlipidemia\n- Chronic kidney disease stage 3\n- Abnormal glucose level\n- Benign hypertensive renal disease with renal failure\n- Leukocytosis\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Primary diagnosis: Aortic valve disorder\n- Blood chemistry abnormal\n- Ostium secundum type atrial septal defect\n- Pleural effusion\n- Acute posthemorrhagic anemia\n- Cardiomegaly\n- Chronic cor pulmonale\n- Chronic obstructive lung disease\n- Coronary atherosclerosis\n- Atrial fibrillation\n- Immune thrombocytopenia\n- Lung field abnormal\n- Cardiac arrhythmia\n- Pulmonary congestion and hypostasis\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, presumably until 2013-05-16. Instructions: take 200 mg by mouth daily. Takes 2 at 3pm\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2013-05-08, presumably until 2013-05-12\n- dibasic potassium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2013-05-06, presumably until 2013-05-06\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2013-05-05, presumably until 2013-05-05\n- potassium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- tribasic potassium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-05-04, presumably until 2013-05-16\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-05-07, presumably until 2013-05-07\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2013-05-11, presumably until 2013-05-14\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2013-05-13, presumably until 2013-05-13\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-06\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-05-07, presumably until 2013-05-15\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2013-05-07, presumably until 2013-05-07\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-05-15, presumably until 2013-05-15\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2013-05-06, presumably until 2013-05-10\n- tribasic sodium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- cefazolin 1000 MG Injection, started on 2013-05-05, presumably until 2013-05-06\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-05-09, presumably until 2013-05-16\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-05-06, presumably until 2013-05-07\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-05-06, presumably until 2013-05-11\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-05-10, presumably until 2013-11-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed (for constipation).\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2013-05-06, presumably until 2013-05-09\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-05-04, presumably until 2013-05-10\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-07\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2013-05-10, presumably until 2013-05-12\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2013-05-04, presumably until 2013-06-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2013-05-13\n- terazosin 1 MG Oral Capsule, through Oral route, started on 2013-05-08, presumably until 2013-05-12\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-05-06, presumably until 2013-05-10\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2013-05-04, presumably until 2013-05-04\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-05-08, presumably until 2013-05-12\n- sodium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- sodium phosphate, monobasic, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2013-05-06, presumably until 2013-05-13\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2013-05-14, presumably until 2013-06-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-05-06, presumably until 2013-05-11\n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2016-05-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed. Two mg daily, pt will follow Dr. Buscemi's and Sta Cruz Anticoag Clinic preop instructions\n- sodium phosphate, dibasic, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2013-05-15, presumably until 2013-05-15\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2013-05-09, presumably until 2013-05-13\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2013-05-05, presumably until 2013-05-05\n- eltrombopag 25 MG Oral Tablet, through Oral route, started on 2013-05-04, presumably until 2013-05-16\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2013-05-15, presumably until 2013-05-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-05-09, presumably until 2013-05-09\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2013-05-14, presumably until 2013-05-15\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2013-05-12, presumably until 2013-05-16\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-05-15, presumably until 2013-05-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Aortic valve disorder\n- Atrial fibrillation\n- Coronary atherosclerosis\n\n### Drug\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- cefazolin 1000 MG Injection, started on 2013-05-05, presumably until 2013-05-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- midazolam 1 MG/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-18 00:00:00, ended at 2013-05-18 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n- Primary diagnosis: Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-13 00:00:00, ended at 2013-06-13 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aortic valve disorder\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2013-06-13, presumably until 2014-04-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- metoprolol tartrate 50 MG Oral Tablet, started on 2013-06-13, presumably until 2014-04-21, with intended 0 refill(s). Instructions: Take one tablet orally two times daily. Hold dose if systolic blood pressure (top number) is <120, or heart rate is < 50.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-13 07:42:00, ended at 2013-06-13 08:32:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aortic valve disorder\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-13 09:11:00, ended at 2013-06-13 09:33:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Aortic valve disorder\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-13 09:34:00, ended at 2013-06-13 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 39 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- MCV [Entitic volume] by Automated count: 85.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-06-13 11:33:54, ended at 2013-06-13 11:49:34\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Second degree atrioventricular block\n- Electrocardiogram abnormal\n- Primary diagnosis: Aortic valve disorder\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-11 10:59:34, ended at 2013-11-11 11:56:23\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-04-07 00:00:00, ended at 2014-04-07 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Primary diagnosis: Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-21 00:00:00, ended at 2014-04-21 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-21 10:49:00, ended at 2014-04-21 11:35:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n- Chronic combined systolic and diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-21 11:36:00, ended at 2014-04-21 12:05:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-21 12:06:00, ended at 2014-04-21 23:59:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.20 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 361 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 74.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.76 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-21 13:14:52, ended at 2014-04-21 14:15:02\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- First degree atrioventricular block\n- Primary diagnosis: Aortic valve disorder\n- Atrial flutter\n- Chronic combined systolic and diastolic heart failure\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2016-05-02. Instructions: take 50 mg by mouth daily.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2015-06-13. Instructions: take 50 mg by mouth every bedtime.\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, presumably until 2015-07-03. Instructions: take 25 mg by mouth 2 times a day.\n- 60 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler, through Inhalation. Instructions: 2 Puffs by Inhalation route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-08 00:00:00, ended at 2014-08-08 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-08 12:45:00, ended at 2014-08-08 23:59:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Atrial fibrillation\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-09-29, presumably until 2014-10-03, with intended 1 refill(s). Instructions: take 1 tablet by mouth daily. REFILL x1 ONLY IF HEARTBURN SYMPTOMS\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2014-09-29, presumably until 2014-10-03, with intended 1 refill(s). Instructions: take 1 tablet by mouth 4 times a day. REFILL x1 ONLY IF HEARTBURN SYMPTOMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-29 13:38:00, ended at 2014-09-29 23:59:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 00:00:00, ended at 2014-10-02 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2014-10-02, presumably until 2014-10-02\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-02, presumably until 2014-10-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-11-03 11:22:00, ended at 2012-11-03 23:59:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.33 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 44 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-11-26 00:00:00, ended at 2012-11-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Arteriosclerosis of arterial coronary artery bypass graft\n- Atrial fibrillation\n- Primary diagnosis: Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-10 00:00:00, ended at 2012-12-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-10 00:00:00, ended at 2012-12-10 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-12-10, presumably until 2013-01-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily. Refill ONLY if heartburn symptoms.\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2012-12-10, presumably until 2013-01-09, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day. Refill ONLY if heartburn symptoms.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-12-10, presumably until 2012-12-12, with intended 2 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours. Do not take morning of 12/13/2012\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 00:00:00, ended at 2012-12-13 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- cefazolin 1000 MG Injection, started on 2012-12-13, presumably until 2012-12-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-13 07:06:00, ended at 2012-12-14 11:49:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.6 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.0 (millimole per liter)\n- Prothrombin time (PT): 18.4 (second)\n- Sodium [Moles/volume] in Blood: 146 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 63.7 (second)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 41 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 46 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 130 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Cardiac mapping\n- Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, His bund\n- Excision or destruction of other lesion or tissue of heart, endovascular approach\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Transluminal intracardiac echocardiography\n- Catheter based invasive electrophysiologic testing\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Intracardiac echocardiography during therapeutic/diagnostic intervention, including imaging supervision and interpretation (List separately in addition to code for primary procedure)\n- Pre-surgery evaluation\n- Intracardiac electrophysiologic 3-dimensional mapping (List separately in addition to code for primary procedure)\n- Intracardiac catheter ablation of arrhythmogenic focus; for treatment of supraventricular tachycardia by ablation of fast or slow atrioventricular pathways, accessory atrioventricular connections or other atrial foci, singly or in combination\n- Other electric countershock of heart\n\n### Condition\n- Aortocoronary bypass graft present\n- Immune thrombocytopenia\n- Primary diagnosis: Postprocedural state finding\n- Primary malignant neoplasm of prostate\n- Hyperlipidemia\n- Atrial fibrillation\n- Old myocardial infarction\n- Benign hypertensive renal disease with renal failure\n- Coronary atherosclerosis\n- Aortic valve disorder\n- Chronic kidney disease\n\n### Drug\n- warfarin sodium 5 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-14\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- fenofibrate 145 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-13\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-14\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-12-13, presumably until 2012-12-13\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-12-13, presumably until 2012-12-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-12-13, presumably until 2012-12-13\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-12-14, presumably until 2012-12-14. Instructions: inject  subcutaneous (under the skin) every 12 hours.  \n- eltrombopag 25 MG Oral Tablet, through Oral route, started on 2012-12-14, presumably until 2012-12-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-14 00:00:00, ended at 2012-12-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-12-14, presumably until 2013-02-10, with intended 1 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-17 00:00:00, ended at 2012-12-17 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-02-04 00:00:00, ended at 2013-02-04 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-04 13:10:00, ended at 2013-02-04 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- External patient and, when performed, auto activated electrocardiographic rhythm derived event recording with symptom-related memory loop with remote download capability up to 30 days, 24-hour attended monitoring; recording (includes connection, recording\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-09 00:00:00, ended at 2013-02-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-10 00:00:00, ended at 2013-02-10 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-10 00:00:00, ended at 2013-02-10 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-10 12:01:07, ended at 2013-02-10 14:36:16\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Immune thrombocytopenia\n- Gastroesophageal reflux disease\n- Coronary atherosclerosis\n- Hyperlipidemia\n- Primary diagnosis: Atrial fibrillation\n- Aortocoronary bypass graft present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-14 00:00:00, ended at 2013-02-14 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-23 12:32:00, ended at 2013-02-23 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2013-02-23, presumably until 2013-02-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-24 00:00:00, ended at 2013-02-24 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-03-09, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-24 00:00:00, ended at 2013-02-24 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-09 00:00:00, ended at 2013-03-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-09 00:00:00, ended at 2013-03-09 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aortic valve disorder\n- Coronary atherosclerosis\n- Primary diagnosis: Atrial fibrillation\n- Aortocoronary bypass graft present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-03-09 08:13:00, ended at 2013-03-09 12:23:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood by calculation: 15.0 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.9 (millimole per liter)\n- Body height: 5' 9.016\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood: 44 (percent)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Other electric countershock of heart\n- Cardioversion, elective, electrical conversion of arrhythmia; external\n\n### Condition\n- Old myocardial infarction\n- Coronary atherosclerosis\n- Aortocoronary bypass graft present\n- Primary diagnosis: Atrial fibrillation\n- Essential hypertension\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-03-09, presumably until 2013-03-09\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-03-09, presumably until 2013-04-13, with intended 4 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-21 00:00:00, ended at 2013-03-21 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aortic valve disorder\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 07:13:00, ended at 2013-04-12 09:55:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Aortic valve disorder\n- Dyspnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 09:56:00, ended at 2013-04-12 12:32:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Arterial puncture, withdrawal of blood for diagnosis\n- Respiratory flow volume loop\n- Diffusing capacity (eg, carbon monoxide, membrane) (List separately in addition to code for primary procedure)\n\n### Condition\n- Abnormal arterial blood gas\n- Atrial fibrillation\n- Cardiomegaly\n- Coronary atherosclerosis\n- Dyspnea\n- Aortocoronary bypass graft present\n- Abnormal breathing\n- Aortic valve disorder\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-12 12:33:00, ended at 2013-04-12 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-04-13 00:00:00, ended at 2013-04-13 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2013-04-13, presumably until 2013-04-27, with intended 1 refill(s). Instructions: take 2 Tabs by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-05-04 11:39:00, ended at 2013-05-16 13:50:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 25.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.36 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Prothrombin time (PT): 33.9 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Body height: 5' 9\" (inch (US))\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 47.3 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 1.12 (thousand per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 199 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.0 (femtoliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 87 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.6 (ratio)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Base deficit in Blood: 4.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 52.0 (millimeter mercury column)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.96 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.80 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Pooling of platelets or other blood products\n- Insertion of pleural tube drain\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Open and other replacement of aortic valve\n- Collection of venous blood by venipuncture\n- Packed blood cell transfusion\n- Controlled ventilation procedure and therapy, initiation and management\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Physical therapy evaluation\n- Transfusion of other serum\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Operative external blood circulation\n- Occupational therapy evaluation\n\n### Condition\n- Aortocoronary bypass graft present\n- Atelectasis\n- Hyperlipidemia\n- Chronic kidney disease stage 3\n- Abnormal glucose level\n- Benign hypertensive renal disease with renal failure\n- Leukocytosis\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Primary diagnosis: Aortic valve disorder\n- Blood chemistry abnormal\n- Ostium secundum type atrial septal defect\n- Pleural effusion\n- Acute posthemorrhagic anemia\n- Cardiomegaly\n- Chronic cor pulmonale\n- Chronic obstructive lung disease\n- Coronary atherosclerosis\n- Atrial fibrillation\n- Immune thrombocytopenia\n- Lung field abnormal\n- Cardiac arrhythmia\n- Pulmonary congestion and hypostasis\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, presumably until 2013-05-16. Instructions: take 200 mg by mouth daily. Takes 2 at 3pm\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2013-05-08, presumably until 2013-05-12\n- dibasic potassium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2013-05-06, presumably until 2013-05-06\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2013-05-05, presumably until 2013-05-05\n- potassium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- tribasic potassium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-05-04, presumably until 2013-05-16\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-05-07, presumably until 2013-05-07\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2013-05-11, presumably until 2013-05-14\n- warfarin sodium 3 MG Oral Tablet, through Oral route, started on 2013-05-13, presumably until 2013-05-13\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-06\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-05-07, presumably until 2013-05-15\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2013-05-07, presumably until 2013-05-07\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-05-15, presumably until 2013-05-15\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2013-05-06, presumably until 2013-05-10\n- tribasic sodium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- cefazolin 1000 MG Injection, started on 2013-05-05, presumably until 2013-05-06\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-05-09, presumably until 2013-05-16\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-05-06, presumably until 2013-05-07\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-05-06, presumably until 2013-05-11\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-05-10, presumably until 2013-11-11, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed (for constipation).\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2013-05-06, presumably until 2013-05-09\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-05-04, presumably until 2013-05-10\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-07\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2013-05-10, presumably until 2013-05-12\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2013-05-04, presumably until 2013-06-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2013-05-13\n- terazosin 1 MG Oral Capsule, through Oral route, started on 2013-05-08, presumably until 2013-05-12\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-05-06, presumably until 2013-05-10\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2013-05-04, presumably until 2013-05-04\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-05-08, presumably until 2013-05-12\n- sodium phosphate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- sodium phosphate, monobasic, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2013-05-06, presumably until 2013-05-13\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2013-05-14, presumably until 2013-06-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-06\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-05-06, presumably until 2013-05-11\n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2016-05-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed. Two mg daily, pt will follow Dr. Buscemi's and Sta Cruz Anticoag Clinic preop instructions\n- sodium phosphate, dibasic, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- warfarin sodium 1 MG Oral Tablet, through Oral route, started on 2013-05-15, presumably until 2013-05-15\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2013-05-09, presumably until 2013-05-13\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2013-05-05, presumably until 2013-05-05\n- eltrombopag 25 MG Oral Tablet, through Oral route, started on 2013-05-04, presumably until 2013-05-16\n- dibasic sodium phosphate heptahydrate, through Oral route, started on 2013-05-06, presumably until 2013-05-06\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2013-05-15, presumably until 2013-05-15\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2013-05-09, presumably until 2013-05-09\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2013-05-14, presumably until 2013-05-15\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2013-05-12, presumably until 2013-05-16\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-05-15, presumably until 2013-05-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Aortic valve disorder\n- Atrial fibrillation\n- Coronary atherosclerosis\n\n### Drug\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- cefazolin 1000 MG Injection, started on 2013-05-05, presumably until 2013-05-05\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n- midazolam 1 MG/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-05-05, presumably until 2013-05-05\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2013-05-05, presumably until 2013-05-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-05-18 00:00:00, ended at 2013-05-18 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n- Primary diagnosis: Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-13 00:00:00, ended at 2013-06-13 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aortic valve disorder\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- lisinopril 10 MG Oral Tablet, through Oral route, started on 2013-06-13, presumably until 2014-04-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- metoprolol tartrate 50 MG Oral Tablet, started on 2013-06-13, presumably until 2014-04-21, with intended 0 refill(s). Instructions: Take one tablet orally two times daily. Hold dose if systolic blood pressure (top number) is <120, or heart rate is < 50.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-13 07:42:00, ended at 2013-06-13 08:32:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Aortic valve disorder\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-13 09:11:00, ended at 2013-06-13 09:33:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Aortic valve disorder\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-06-13 09:34:00, ended at 2013-06-13 23:59:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 39 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- MCV [Entitic volume] by Automated count: 85.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-06-13 11:33:54, ended at 2013-06-13 11:49:34\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Second degree atrioventricular block\n- Electrocardiogram abnormal\n- Primary diagnosis: Aortic valve disorder\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-11 10:59:34, ended at 2013-11-11 11:56:23\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-04-07 00:00:00, ended at 2014-04-07 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Primary diagnosis: Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-21 00:00:00, ended at 2014-04-21 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-21 10:49:00, ended at 2014-04-21 11:35:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n- Chronic combined systolic and diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-21 11:36:00, ended at 2014-04-21 12:05:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-21 12:06:00, ended at 2014-04-21 23:59:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.16 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.20 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 361 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.7 (picogram)\n- MCV [Entitic volume] by Automated count: 74.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.76 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-21 13:14:52, ended at 2014-04-21 14:15:02\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Electrocardiogram abnormal\n- First degree atrioventricular block\n- Primary diagnosis: Aortic valve disorder\n- Atrial flutter\n- Chronic combined systolic and diastolic heart failure\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2016-05-02. Instructions: take 50 mg by mouth daily.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2015-06-13. Instructions: take 50 mg by mouth every bedtime.\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, presumably until 2015-07-03. Instructions: take 25 mg by mouth 2 times a day.\n- 60 ACTUAT aclidinium bromide 0.4 MG/ACTUAT Dry Powder Inhaler, through Inhalation. Instructions: 2 Puffs by Inhalation route 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-08-08 00:00:00, ended at 2014-08-08 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-08-08 12:45:00, ended at 2014-08-08 23:59:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Atrial flutter\n- Atrial fibrillation\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-09-29, presumably until 2014-10-03, with intended 1 refill(s). Instructions: take 1 tablet by mouth daily. REFILL x1 ONLY IF HEARTBURN SYMPTOMS\n- sucralfate 1000 MG Oral Tablet, through Oral route, started on 2014-09-29, presumably until 2014-10-03, with intended 1 refill(s). Instructions: take 1 tablet by mouth 4 times a day. REFILL x1 ONLY IF HEARTBURN SYMPTOMS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-26 00:00:00, ended at 2014-09-26 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-29 13:38:00, ended at 2014-09-29 23:59:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial flutter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-10-02 00:00:00, ended at 2014-10-02 00:00:00\nThe patient in this visit was 82 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for cardiac electrophysiologic procedures including radiofrequency ablation\n\n### Condition\n- Atrial fibrillation\n- Atrial flutter\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2014-10-02, presumably until 2014-10-02\n- remifentanil 2 MG Injection, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-10-02, presumably until 2014-10-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-10-02, presumably until 2014-10-02\n- midazolam 1 MG/ML Injectable Solution, started on 2014-10-02, presumably until 2014-10-02\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8cbb8868a3efce1fa0ec62419073c6478728230695aeadc2d046bfbff01e3eb2", "prompt_hash": "74446c2b574c5b3d419eb8fa31c8ec1e779f56c5d2604585406f49a396257325", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 5, "doc": {"person_id": 115969371, "visit_occurrence_id": 186784270, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2021-09-08 00:00:00", "visit_end_datetime": "2021-09-08 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-08 00:00:00, ended at 2021-09-08 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2021-09-11, presumably until 2021-11-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n", "approximate_token_count": 116, "patient_first_visit_date": "2020-09-05 00:00:00", "patient_last_visit_date": "2023-01-30 10:00:00", "end_obs_date": "2022-09-08", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 31, "cumulated_visit_num": 31, "cumulated_approximate_token_count": 3753, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-05 00:00:00, ended at 2020-09-05 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 3.7 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-12 00:00:00, ended at 2020-10-12 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-12 12:00:00, ended at 2020-10-12 23:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Secondary malignant neoplasm of lymph nodes of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-12 13:54:34, ended at 2020-10-12 14:58:44\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Neoplasm defined only by topography: Prostate gland\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2020-07-03, presumably until 2020-11-10, with intended 0 refill(s). Instructions: take by mouth\n- 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe, through Intramuscular route, started on 2020-05-11, presumably until 2021-03-14, with intended 0 refill(s). Instructions: inject 45 mg into a muscle\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-06-15, presumably until 2020-11-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-08-22, presumably until 2021-11-05, with intended 11 refill(s). Instructions: take 5 mg by mouth\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2020-10-12, presumably until 2021-10-12, with intended 3 refill(s). Instructions: take 1 Kinn (0.4 mg total) by mouth daily\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2020-08-22, presumably until 2020-10-18, with intended 11 refill(s). Instructions: take 250 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-17 00:00:00, ended at 2020-10-17 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-18 00:00:00, ended at 2020-10-18 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2020-10-18, presumably until 2021-11-05, with intended 11 refill(s). Instructions: take 1 Tab (250 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-30 00:00:00, ended at 2020-10-30 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-06 00:00:00, ended at 2020-11-06 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-11-06, presumably until 2021-09-11, with intended 11 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-09 00:00:00, ended at 2020-11-09 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-11-09, presumably until 2022-11-09, with intended 11 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-13 13:13:10, ended at 2020-11-13 13:42:46\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-11 07:28:00, ended at 2020-12-11 08:32:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of mediastinum\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of prostate\n- Disorder of pancreas\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-11 08:33:00, ended at 2020-12-11 11:56:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-12 13:19:33, ended at 2020-12-12 13:19:37\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-14 14:56:00, ended at 2020-12-14 23:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe, through Intramuscular route, started on 2020-12-14, presumably until 2020-12-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-14 10:59:54, ended at 2021-02-14 11:16:03\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-07 00:00:00, ended at 2021-03-07 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-12 13:29:52, ended at 2021-03-12 13:29:56\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-14 14:26:57, ended at 2021-03-14 15:06:58\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-11 12:23:01, ended at 2021-06-11 12:23:07\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-14 13:24:38, ended at 2021-06-14 13:34:02\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-14 14:51:00, ended at 2021-06-14 23:59:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.63\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- 1.5 ML leuprolide acetate 15 MG/ML Prefilled Syringe, through Intramuscular route, started on 2021-06-14, presumably until 2021-06-14\n- 100 ML zoledronic acid 0.04 MG/ML Injection, through Intravenous route, started on 2021-06-14, presumably until 2021-06-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2021-06-14, presumably until 2021-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-06-27 00:00:00, ended at 2021-06-27 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- megestrol acetate 20 MG Oral Tablet, through Oral route, started on 2021-06-27, presumably until 2021-11-13, with intended 3 refill(s). Instructions: TAKE 1 TAB (20 MG TOTAL) BY MOUTH DAILY FOR HOT FLASHES\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-07-24 00:00:00, ended at 2021-07-24 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-07-25 00:00:00, ended at 2021-07-25 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-07-26 00:00:00, ended at 2021-07-26 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sildenafil 25 MG Oral Tablet, through Oral route, started on 2021-07-26, presumably until 2022-07-26, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth as needed for Erectile dysfunction\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-08-16 08:26:00, ended at 2021-08-16 09:41:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-08-16 09:42:00, ended at 2021-08-16 13:15:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n\n### Condition\n- Pathological fracture\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of prostate\n\n### Drug\n- medronate, through Intravenous route, started on 2021-08-16, presumably until 2021-08-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-08-22 00:00:00, ended at 2021-08-22 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-09-04 00:00:00, ended at 2021-09-04 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-08 00:00:00, ended at 2021-09-08 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2021-09-11, presumably until 2021-11-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-05 00:00:00, ended at 2020-09-05 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 3.7 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-12 00:00:00, ended at 2020-10-12 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-12 12:00:00, ended at 2020-10-12 23:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Secondary malignant neoplasm of lymph nodes of lower limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-12 13:54:34, ended at 2020-10-12 14:58:44\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Neoplasm defined only by topography: Prostate gland\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2020-07-03, presumably until 2020-11-10, with intended 0 refill(s). Instructions: take by mouth\n- 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe, through Intramuscular route, started on 2020-05-11, presumably until 2021-03-14, with intended 0 refill(s). Instructions: inject 45 mg into a muscle\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-06-15, presumably until 2020-11-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2020-08-22, presumably until 2021-11-05, with intended 11 refill(s). Instructions: take 5 mg by mouth\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2020-10-12, presumably until 2021-10-12, with intended 3 refill(s). Instructions: take 1 Kinn (0.4 mg total) by mouth daily\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2020-08-22, presumably until 2020-10-18, with intended 11 refill(s). Instructions: take 250 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-17 00:00:00, ended at 2020-10-17 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-18 00:00:00, ended at 2020-10-18 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2020-10-18, presumably until 2021-11-05, with intended 11 refill(s). Instructions: take 1 Tab (250 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-30 00:00:00, ended at 2020-10-30 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-06 00:00:00, ended at 2020-11-06 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-11-06, presumably until 2021-09-11, with intended 11 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-11-09 00:00:00, ended at 2020-11-09 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2020-11-09, presumably until 2022-11-09, with intended 11 refill(s). Instructions: take 1 Tab (10 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-13 13:13:10, ended at 2020-11-13 13:42:46\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-29 00:00:00, ended at 2020-11-29 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-11 07:28:00, ended at 2020-12-11 08:32:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Disorder of mediastinum\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of prostate\n- Disorder of pancreas\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-11 08:33:00, ended at 2020-12-11 11:56:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-12 13:19:33, ended at 2020-12-12 13:19:37\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-12-14 14:56:00, ended at 2020-12-14 23:59:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe, through Intramuscular route, started on 2020-12-14, presumably until 2020-12-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-14 10:59:54, ended at 2021-02-14 11:16:03\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-03-07 00:00:00, ended at 2021-03-07 00:00:00\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-03-12 13:29:52, ended at 2021-03-12 13:29:56\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-03-14 14:26:57, ended at 2021-03-14 15:06:58\nThe patient in this visit was 63 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .008\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-11 12:23:01, ended at 2021-06-11 12:23:07\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-14 13:24:38, ended at 2021-06-14 13:34:02\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-14 14:51:00, ended at 2021-06-14 23:59:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.63\" (inch (US))\n\n### Procedure\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- 1.5 ML leuprolide acetate 15 MG/ML Prefilled Syringe, through Intramuscular route, started on 2021-06-14, presumably until 2021-06-14\n- 100 ML zoledronic acid 0.04 MG/ML Injection, through Intravenous route, started on 2021-06-14, presumably until 2021-06-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2021-06-14, presumably until 2021-06-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-06-27 00:00:00, ended at 2021-06-27 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- megestrol acetate 20 MG Oral Tablet, through Oral route, started on 2021-06-27, presumably until 2021-11-13, with intended 3 refill(s). Instructions: TAKE 1 TAB (20 MG TOTAL) BY MOUTH DAILY FOR HOT FLASHES\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-07-24 00:00:00, ended at 2021-07-24 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-07-25 00:00:00, ended at 2021-07-25 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-07-26 00:00:00, ended at 2021-07-26 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sildenafil 25 MG Oral Tablet, through Oral route, started on 2021-07-26, presumably until 2022-07-26, with intended 0 refill(s). Instructions: take 1 Tablet (25 mg total) by mouth as needed for Erectile dysfunction\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-08-16 08:26:00, ended at 2021-08-16 09:41:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-08-16 09:42:00, ended at 2021-08-16 13:15:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Bone and/or joint imaging; whole body\n- Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transm\n\n### Condition\n- Pathological fracture\n- Secondary malignant neoplasm of bone\n- Primary malignant neoplasm of prostate\n\n### Drug\n- medronate, through Intravenous route, started on 2021-08-16, presumably until 2021-08-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-08-22 00:00:00, ended at 2021-08-22 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-09-04 00:00:00, ended at 2021-09-04 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-09-08 00:00:00, ended at 2021-09-08 00:00:00\nThe patient in this visit was 64 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2021-09-11, presumably until 2021-11-13, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "7e0b818916943f66796e2bc21f46cde439db35c48b5b709728f2aaa37c37245a", "prompt_hash": "600b60a81136834312da22205923423042aade16c91402f4ef85062818aadb71", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 6, "doc": {"person_id": 115968639, "visit_occurrence_id": 45510980, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2011-11-03 09:30:00", "visit_end_datetime": "2011-11-03 23:59:00", "visit_length_in_hours": 14.483333333333333, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-03 09:30:00, ended at 2011-11-03 23:59:00\nThe patient in this visit was 68 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 86, "patient_first_visit_date": "2009-08-08 05:40:00", "patient_last_visit_date": "2013-04-28 15:00:00", "end_obs_date": "2012-11-02", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 2, "cumulated_visit_num": 2, "cumulated_approximate_token_count": 1010, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2009-08-08 05:40:00, ended at 2009-08-09 15:00:00\nThe patient in this visit was 65 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.5 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.53 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.15 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.32 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Body height: 6' 1\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-08-08, presumably until 2009-08-08\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2009-08-08, presumably until 2009-08-09\n- ezetimibe 10 MG Oral Tablet, through Oral route, started on 2009-08-09, presumably until 2009-08-09\n- cefazolin 1000 MG Injection, started on 2009-08-08, presumably until 2009-08-09\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-08-08, presumably until 2009-08-09\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-08, presumably until 2009-08-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-08-08, presumably until 2009-08-08\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-08, presumably until 2009-08-08\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2009-08-08, presumably until 2009-08-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-08-08, presumably until 2009-08-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-03 09:30:00, ended at 2011-11-03 23:59:00\nThe patient in this visit was 68 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-08-08 05:40:00, ended at 2009-08-09 15:00:00\nThe patient in this visit was 65 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.5 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.5 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.27 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.53 (million per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.15 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.9 (percent)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.32 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Body height: 6' 1\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-08-08, presumably until 2009-08-08\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2009-08-08, presumably until 2009-08-09\n- ezetimibe 10 MG Oral Tablet, through Oral route, started on 2009-08-09, presumably until 2009-08-09\n- cefazolin 1000 MG Injection, started on 2009-08-08, presumably until 2009-08-09\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-08-08, presumably until 2009-08-09\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-08, presumably until 2009-08-08\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-08-08, presumably until 2009-08-08\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-08-08, presumably until 2009-08-08\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2009-08-08, presumably until 2009-08-08\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-08-08, presumably until 2009-08-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-03 09:30:00, ended at 2011-11-03 23:59:00\nThe patient in this visit was 68 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "aed2f2b6950deea2cc8f49025832eef81a3067ef7f23437f7f343ffae536b63b", "prompt_hash": "3ff7775ac015e89167df22b780a657a0c6100ead0d850674fc9d77ae6107780d", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 7, "doc": {"person_id": 115968873, "visit_occurrence_id": 84281432, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2016-03-12 07:22:00", "visit_end_datetime": "2016-03-12 09:34:00", "visit_length_in_hours": 2.2, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 07:22:00, ended at 2016-03-12 09:34:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 67.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Fatigue\n- Hyperlipidemia\n- Disorder of transplanted heart\n- Transplanted heart present\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 428, "patient_first_visit_date": "2008-02-25 00:00:00", "patient_last_visit_date": "2023-02-07 00:00:00", "end_obs_date": "2017-03-12", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "recurrent", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 105, "cumulated_visit_num": 105, "cumulated_approximate_token_count": 38376, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2008-02-25 00:00:00, ended at 2008-02-25 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 41 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.03 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Digoxin [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 12.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 357 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 235 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-02-28 16:08:00, ended at 2008-04-04 15:06:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 7.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 27.2 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.52 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 54.5 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 530 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 405 (thousand per microliter)\n- Base deficit in Blood: 8.0 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 148 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 195 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 98.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 44.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Prothrombin time (PT): 17.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Effect of exposure to physical force\n- Leukocytosis\n- Tricuspid valve disorder\n- Urinary complication\n- Chronic ischemic heart disease\n- Sinus node dysfunction\n- Chronic kidney disease\n- Hyperkalemia\n- Mitral valve disorder\n- Acquired hemolytic anemia\n- Ascites\n- Chronic cor pulmonale\n- Chronic kidney disease stage 5 due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-04 15:26:00, ended at 2008-04-07 17:51:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.74 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-07 17:55:00, ended at 2008-04-27 16:50:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 55 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.50 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 8.25 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 328 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 162 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.8 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.9 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Anion gap in Serum or Plasma: 98 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Vomiting\n- Chronic cor pulmonale\n- Gout\n- Hematemesis\n- Disorder of kidney and/or ureter\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-01 00:00:00, ended at 2008-05-01 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 351 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 44 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.67 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.86 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 12.3 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 97.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-04 00:00:00, ended at 2008-05-04 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.91 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 347 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 21.7 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-11 00:00:00, ended at 2008-05-11 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.63 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 304 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 3.3 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-25 00:00:00, ended at 2008-05-25 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 18.8 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-26 00:00:00, ended at 2008-05-26 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 15.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-01 00:00:00, ended at 2008-06-01 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-05 00:00:00, ended at 2008-06-05 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.16 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.99 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-15 00:00:00, ended at 2008-06-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.68 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-06-16 11:32:00, ended at 2008-06-16 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-06-20 14:59:00, ended at 2008-06-26 15:40:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 260 (microgram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.18 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.78 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Prothrombin time (PT): 14.7 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 270 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 737 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Iron [Mass/volume] in Serum or Plasma: 85 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 33 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.10 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.1 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Body height: 6' .008\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 55.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, presumably until 2009-04-06. Instructions: take 2 mg by mouth daily. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2008-06-20, presumably until 2008-06-26\n- magnesium lactate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium amino acid chelate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2008-06-26\n- magnesium sulfate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- sildenafil 20 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2008-06-26\n- posaconazole 40 MG/ML Oral Suspension, through Oral route, started on 2008-06-21, presumably until 2009-04-06, with quantity of 120.0, with intended 1 refill(s). Instructions: take 5 mL by mouth 4 times a day with meals and bedtime. \n- stearate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium carbonate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe, started on 2008-06-24, presumably until 2008-06-24\n- pyroglutamate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium aspartate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium glutamate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2008-06-20, presumably until 2009-04-06, with quantity of 30.0, with intended 0 refill(s). Instructions: take by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-06-22, presumably until 2008-06-22\n- magnesium citrate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2008-06-22\n- magnesium glycinate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium sulfate heptahydrate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2008-06-21, presumably until 2009-04-06. Instructions: take 10 mg by mouth 5 times a day. \n- temazepam 15 MG Oral Capsule, through Oral route, started on 2008-06-21, presumably until 2009-04-06. Instructions: take 15 mg by mouth every bedtime as needed \n- magnesium oxide, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium malate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium orotate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2009-07-25. Instructions: take 5 mg by mouth 2 times a day. \n- magnesium phosphate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment, through Topical route, started on 2008-06-21, presumably until 2008-06-23\n- magnesium ascorbate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2008-06-21, presumably until 2009-07-25. Instructions: take 0.5 mg by mouth daily. \n- fluoxetine 10 MG Oral Tablet, through Oral route, presumably until 2008-06-26. Instructions: take 20 mg by mouth daily. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-06-22, presumably until 2008-06-22\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-06-20, presumably until 2008-06-22\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2008-06-21, presumably until 2010-05-13. Instructions: take 1 Tab by mouth daily. \n- magnesium gluconogluceptate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium chloride, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2009-04-06. Instructions: take 1 mg by mouth every bedtime. \n- magnesium acetate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-04-06. Instructions: take 1000 mg by mouth every bedtime. \n- magnesium gluconate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-29 00:00:00, ended at 2008-06-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.66 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.30 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-03 00:00:00, ended at 2008-07-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.35 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.02 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-31 00:00:00, ended at 2008-07-31 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 5.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.52 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-31 00:00:00, ended at 2008-08-31 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-06 00:00:00, ended at 2008-11-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.99 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-11 00:00:00, ended at 2009-01-11 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.0 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.05 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.2 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-05 00:00:00, ended at 2009-04-05 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 123 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: <1.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.91 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 18.8 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Prothrombin time (PT): 12.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 122 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: <3.0 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-06 05:51:00, ended at 2009-04-06 14:30:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- fluoxetine 20 MG Oral Capsule, through Oral route, presumably until 2011-09-01. Instructions: take 2 Caps by mouth daily. \n- diazepam 5 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-06, presumably until 2009-04-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- docusate sodium 100 MG Oral Tablet, through Oral route, presumably until 2010-02-14. Instructions: take by mouth as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-25 00:00:00, ended at 2009-07-25 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- posaconazole 40 MG/ML Oral Suspension, through Oral route, started on 2009-07-25, presumably until 2009-07-26, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day with meals and bedtime. \n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-25, presumably until 2012-03-02, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth every bedtime. \n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-07-25, presumably until 2009-08-10, with quantity of 60.0, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day. \n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2009-07-25, presumably until 2011-08-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 mg by mouth daily. \n- calcium carbonate 625 MG / ergocalciferol 125 UNT Oral Tablet, through Oral route, started on 2009-07-25, presumably until 2017-03-13, with quantity of 120.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-26 00:00:00, ended at 2009-07-26 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 17.0 (micromole per liter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.39 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 4.22 (milligram per deciliter)\n- Prothrombin time (PT): 13.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 89 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-08-10 00:00:00, ended at 2009-08-10 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-08-10, presumably until 2009-11-08, with quantity of 60.0, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-08 07:12:00, ended at 2009-11-08 08:22:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-08 08:56:10, ended at 2009-11-08 09:42:14\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Essential hypertension\n- Primary diagnosis: Transplanted heart present\n- Pure hypercholesterolemia\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-11-08, presumably until 2010-11-08, with quantity of 60.0, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-09 00:00:00, ended at 2009-11-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-13 00:00:00, ended at 2010-02-13 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 09:22:00, ended at 2010-02-13 09:22:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 102 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Prothrombin time (PT): 13.3 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 287 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.71 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 40.9 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 09:23:00, ended at 2010-02-13 10:18:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 10:19:00, ended at 2010-02-13 10:33:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 10:34:00, ended at 2010-02-13 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 12:32:18, ended at 2010-02-13 12:32:36\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Pure hypercholesterolemia\n- Coronary arteriosclerosis in artery of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 05:49:00, ended at 2010-02-14 13:57:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 38 (percent)\n- Body height: 6' .835\" (inch (US))\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.03 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 12.9 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n\n### Procedure\n- Intravascular imaging of coronary vessels\n- Endomyocardial biopsy\n- Coronary arteriography using single catheter\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Catheterization of right heart\n- Biopsy of heart\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Other nonoperative cardiac and vascular measurements\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n\n### Condition\n- Sinus node dysfunction\n- Congenital anomaly of coronary artery\n- Effect of exposure to physical force\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-02-14, presumably until 2010-02-14\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-02-14, presumably until 2010-02-14\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-02-14, presumably until 2010-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-05-13 00:00:00, ended at 2010-05-13 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2010-05-13, presumably until 2013-01-20, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact: Stanford Heart Transplant, 1101 397 N2490 Rd, Longdale OK , phone: 999-999-9999, fax: 999-999-9999. PLEASE DO NOT CONTACT CARDIOVASCULAR MED LISTED ABOVE. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-16 11:16:00, ended at 2010-05-16 12:39:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-16 12:40:00, ended at 2010-05-16 13:46:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-06 00:00:00, ended at 2010-11-06 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-07 08:17:37, ended at 2010-11-07 17:19:22\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-07 08:47:17, ended at 2010-11-07 09:59:50\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2011-12-10. Instructions: take 70 mg by mouth every 7 days. \n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2011-09-01. Instructions: take 2 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-07 10:00:33, ended at 2010-11-07 15:28:35\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-07 10:49:00, ended at 2010-11-07 13:10:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n\n### Condition\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-15 00:00:00, ended at 2010-11-15 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-02-04 00:00:00, ended at 2011-02-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-20 07:46:00, ended at 2011-02-20 08:14:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 15.7 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Prothrombin time (PT): 13.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.93 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.4 (ratio)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-20 08:15:00, ended at 2011-02-20 08:46:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-20 08:47:00, ended at 2011-02-20 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-20 12:56:30, ended at 2011-02-20 13:54:58\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-21 06:00:00, ended at 2011-02-21 15:35:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Blood: 151 (millimole per liter)\n- Body height: 6' 0\" (inch (US))\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 40 (percent)\n\n### Procedure\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Intravascular imaging of coronary vessels\n- Biopsy of heart\n- Catheterization of right heart\n- Collection of venous blood by venipuncture\n- Injection or infusion of other therapeutic or prophylactic substance\n- Coronary arteriography using two catheters\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Endomyocardial biopsy\n\n### Condition\n- Chronic ischemic heart disease\n- Transplanted heart present\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-02-21, presumably until 2011-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-08-04 00:00:00, ended at 2011-08-04 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2011-08-04, presumably until 2013-01-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-29 00:00:00, ended at 2011-08-29 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-01 08:25:34, ended at 2011-09-01 14:47:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-01 09:09:28, ended at 2011-09-01 14:57:40\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Cardiomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-01 09:28:42, ended at 2011-09-01 12:58:58\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Essential hypertension\n- Effect of exposure to physical force\n- Transplanted heart present\n- Primary diagnosis: Disorder of lung\n- Coronary arteriosclerosis in artery of transplanted heart\n\n### Drug\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-09-01, presumably until 2015-11-28. Instructions: take 1 Cap by mouth daily.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-09-01, presumably until 2013-02-28. Instructions: take 1-1.5 mg by mouth as directed. 1mg qam, 1.5mg qpm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 10:50:00, ended at 2011-09-01 15:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.93 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.5 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Diarrhea\n- Localized swelling, mass and lump, trunk\n- Lung field abnormal\n- Pleural effusion\n- Pulmonary emphysema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 06:05:00, ended at 2011-09-02 14:10:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Biopsy, lung or mediastinum, percutaneous needle\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Percutaneous needle biopsy lung\n- CT of thorax with contrast\n\n### Condition\n- Transplanted heart present\n- Lung field abnormal\n- Disorder of lung\n- Primary malignant neoplasm of respiratory tract\n- Localized swelling, mass and lump, trunk\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-09-02, presumably until 2011-09-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-03 00:00:00, ended at 2011-09-03 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-03 00:00:00, ended at 2011-09-03 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-03 00:00:00, ended at 2011-09-03 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-04 13:49:00, ended at 2011-09-04 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Localized swelling, mass and lump, trunk\n- Primary malignant neoplasm of respiratory tract\n- Abnormal finding on evaluation procedure\n- Transplanted heart present\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-14 00:00:00, ended at 2011-10-14 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-14 00:00:00, ended at 2011-10-14 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-10 00:00:00, ended at 2011-12-10 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2012-03-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-01 09:57:00, ended at 2012-03-01 10:11:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Squamous cell carcinoma of skin of trunk\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-01 10:12:00, ended at 2012-03-01 10:56:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 87 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 70 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.4 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 15.7 (micromole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Prothrombin time (PT): 13.3 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 218 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-01 10:57:00, ended at 2012-03-01 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coag./bleeding tests abnormal\n- Effect of exposure to physical force\n- Transplanted heart present\n- Heart failure\n- Hyperlipidemia\n- Essential hypertension\n- Squamous cell carcinoma of skin of trunk\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-01 12:52:11, ended at 2012-03-01 12:54:51\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-03-01, presumably until 2012-03-03, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2012-03-01, presumably until 2013-01-20, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-03-01, presumably until 2012-03-02, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-02 08:31:00, ended at 2012-03-02 15:25:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.6 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 144 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 4.4 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 40 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Coronary arteriography using two catheters\n- Catheterization of right heart\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n\n### Condition\n- Chronic obstructive lung disease\n- Chronic ischemic heart disease\n- Hyperlipidemia\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2012-03-02, presumably until 2012-03-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-21 00:00:00, ended at 2012-04-21 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2012-04-21, presumably until 2013-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-18 00:00:00, ended at 2012-10-18 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-20 00:00:00, ended at 2013-01-20 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Solitary nodule of lung\n- Effect of exposure to physical force\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. 1mg qam, 1.5mg qpm\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- tacrolimus 0.5 MG Oral Capsule, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: Take 0.5mg twice daily along with 1 mg capsule twice daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact: Stanford Heart Transplant, 1101 791 Vye Ln, Spring Brook WI , phone: 999-999-9999, fax: 999-999-9999. PLEASE DO NOT CONTACT CARDIOVASCULAR MED LISTED ABOVE.\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-28 00:00:00, ended at 2013-02-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 08:45:00, ended at 2013-02-28 09:28:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 14.3 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Prothrombin time (PT): 13.3 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.73 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.0 (second)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 72 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 207 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: <5.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 09:29:00, ended at 2013-02-28 09:47:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 09:48:00, ended at 2013-02-28 11:08:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Chronic cor pulmonale\n- Anemia\n- Effect of exposure to physical force\n- Essential hypertension\n- Congestive heart failure\n- Primary malignant neoplasm of respiratory tract\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-28 13:26:06, ended at 2013-02-28 14:36:23\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Coronary arteriosclerosis in artery of transplanted heart\n- Pure hypercholesterolemia\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-17 00:00:00, ended at 2013-11-17 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Solitary nodule of lung\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2013-11-17, presumably until 2013-11-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-30 00:00:00, ended at 2014-01-30 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hyperglyceridemia\n- Transplanted heart present\n- Primary diagnosis: Solitary nodule of lung\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-01-30, presumably until 2015-11-27, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. 1mg qam, 1.5mg qpm\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- tacrolimus 0.5 MG Oral Capsule, started on 2014-01-30, presumably until 2015-11-27, with intended 3 refill(s). Instructions: Take 0.5mg twice daily along with 1 mg capsule twice daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2014-05-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact:\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2014-11-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-30 00:00:00, ended at 2014-01-30 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Transplanted heart present\n\n### Drug\n- 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-15 00:00:00, ended at 2014-02-15 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-16 08:33:00, ended at 2014-02-16 09:13:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.89 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 90 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 302 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 11.4 (micromole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-16 09:14:00, ended at 2014-02-16 09:30:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-16 09:40:00, ended at 2014-02-16 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Effect of exposure to physical force\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-02 00:00:00, ended at 2014-05-02 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2014-05-02, presumably until 2017-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact:\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-05 00:00:00, ended at 2014-05-05 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-20 00:00:00, ended at 2014-11-20 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2014-11-20, presumably until 2015-01-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-23 00:00:00, ended at 2015-01-23 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2015-01-23, presumably until 2016-01-22, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-26 00:00:00, ended at 2015-01-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2015-01-26, presumably until 2015-11-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-20 00:00:00, ended at 2015-02-20 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart present\n- Electrocardiogram abnormal\n- Primary diagnosis: Pure hyperglyceridemia\n- Supraventricular premature beats\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-22 08:25:00, ended at 2015-02-22 08:47:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 11.7 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.24 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: No result (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 1.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pure hyperglyceridemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-22 08:48:00, ended at 2015-02-22 09:10:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-22 09:12:00, ended at 2015-02-22 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.0 (percent)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-06 00:00:00, ended at 2015-06-06 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-06-06, presumably until 2015-06-06, with intended 1 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY FOR 15 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-15 00:00:00, ended at 2015-08-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-27 00:00:00, ended at 2015-11-27 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-11-27, presumably until 2015-12-04, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day 1mg qam, 1.5mg qpm\n- tacrolimus 0.5 MG Oral Capsule, started on 2015-11-27, presumably until 2015-12-04, with intended 3 refill(s). Instructions: Takes 0.5 mg po in the AM and 1 mg po in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-28 00:00:00, ended at 2015-11-28 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Solitary nodule of lung\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2015-11-28, presumably until 2018-06-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2015-11-28, presumably until 2016-01-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2015-11-28, presumably until 2017-02-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-12-04 00:00:00, ended at 2015-12-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-12-04, presumably until 2016-12-01, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 1.5mg BID\n- tacrolimus 0.5 MG Oral Capsule, started on 2015-12-04, presumably until 2016-12-01, with intended 3 refill(s). Instructions: Total dose of 1.5mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-22 00:00:00, ended at 2016-01-22 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2016-01-23, presumably until 2016-01-23, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-23 00:00:00, ended at 2016-01-23 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2016-01-23, presumably until 2017-03-12, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-28 00:00:00, ended at 2016-01-28 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2016-01-29, presumably until 2017-02-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-07 00:00:00, ended at 2016-03-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Fatigue\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-12 00:00:00, ended at 2016-03-12 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart present\n- Electrocardiogram abnormal\n- Disorder of transplanted heart\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 07:22:00, ended at 2016-03-12 09:34:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 67.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Fatigue\n- Hyperlipidemia\n- Disorder of transplanted heart\n- Transplanted heart present\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-02-25 00:00:00, ended at 2008-02-25 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.77 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 41 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.03 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Digoxin [Mass/volume] in Serum or Plasma: 1.4 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.0 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 12.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 357 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 235 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.7 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-02-28 16:08:00, ended at 2008-04-04 15:06:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 7.0 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 27.2 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.52 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 54.5 (millimeter mercury column)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 530 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 405 (thousand per microliter)\n- Base deficit in Blood: 8.0 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 59 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 148 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 195 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 98.2 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 44.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 99 (millimeter mercury column)\n- Prothrombin time (PT): 17.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Effect of exposure to physical force\n- Leukocytosis\n- Tricuspid valve disorder\n- Urinary complication\n- Chronic ischemic heart disease\n- Sinus node dysfunction\n- Chronic kidney disease\n- Hyperkalemia\n- Mitral valve disorder\n- Acquired hemolytic anemia\n- Ascites\n- Chronic cor pulmonale\n- Chronic kidney disease stage 5 due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-04 15:26:00, ended at 2008-04-07 17:51:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.21 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.74 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-04-07 17:55:00, ended at 2008-04-27 16:50:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 55 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.50 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 8.25 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 328 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 162 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 9.8 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.65 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.9 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Anion gap in Serum or Plasma: 98 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Prothrombin time (PT): 13.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Effect of exposure to physical force\n- Vomiting\n- Chronic cor pulmonale\n- Gout\n- Hematemesis\n- Disorder of kidney and/or ureter\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-01 00:00:00, ended at 2008-05-01 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 351 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 44 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.67 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.6 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.86 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.1 (percent)\n- Tacrolimus [Mass/volume] in Blood: 12.3 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 97.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-04 00:00:00, ended at 2008-05-04 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.91 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 347 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 21.7 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-11 00:00:00, ended at 2008-05-11 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.63 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 304 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 93.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 3.3 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-25 00:00:00, ended at 2008-05-25 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.46 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.33 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 117 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 18.8 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-26 00:00:00, ended at 2008-05-26 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 15.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-01 00:00:00, ended at 2008-06-01 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 10.7 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.90 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-05 00:00:00, ended at 2008-06-05 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.16 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.99 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 13.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-15 00:00:00, ended at 2008-06-15 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 95.4 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.68 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 144 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-06-16 11:32:00, ended at 2008-06-16 23:59:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ascites\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-06-20 14:59:00, ended at 2008-06-26 15:40:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 260 (microgram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.18 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.78 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.8 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Prothrombin time (PT): 14.7 (second)\n- Glucose [Mass/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 270 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 737 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 81 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Iron [Mass/volume] in Serum or Plasma: 85 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 33 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.10 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.1 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 137 (unit per liter)\n- Body height: 6' .008\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.11 (million per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 55.2 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Localized infection of skin AND/OR subcutaneous tissue\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, presumably until 2009-04-06. Instructions: take 2 mg by mouth daily. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2008-06-20, presumably until 2008-06-26\n- magnesium lactate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium amino acid chelate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2008-06-26\n- magnesium sulfate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- sildenafil 20 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2008-06-26\n- posaconazole 40 MG/ML Oral Suspension, through Oral route, started on 2008-06-21, presumably until 2009-04-06, with quantity of 120.0, with intended 1 refill(s). Instructions: take 5 mL by mouth 4 times a day with meals and bedtime. \n- stearate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium carbonate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- 0.4 ML darbepoetin alfa 0.5 MG/ML Prefilled Syringe, started on 2008-06-24, presumably until 2008-06-24\n- pyroglutamate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium aspartate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium glutamate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2008-06-20, presumably until 2009-04-06, with quantity of 30.0, with intended 0 refill(s). Instructions: take by mouth daily. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-06-22, presumably until 2008-06-22\n- magnesium citrate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2008-06-22\n- magnesium glycinate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium sulfate heptahydrate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- clotrimazole 10 MG Oral Lozenge, through Submucosal route, started on 2008-06-21, presumably until 2009-04-06. Instructions: take 10 mg by mouth 5 times a day. \n- temazepam 15 MG Oral Capsule, through Oral route, started on 2008-06-21, presumably until 2009-04-06. Instructions: take 15 mg by mouth every bedtime as needed \n- magnesium oxide, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium malate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium orotate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2009-07-25. Instructions: take 5 mg by mouth 2 times a day. \n- magnesium phosphate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- bacitracin 0.5 UNT/MG / polymyxin B 10 UNT/MG Topical Ointment, through Topical route, started on 2008-06-21, presumably until 2008-06-23\n- magnesium ascorbate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2008-06-21, presumably until 2009-07-25. Instructions: take 0.5 mg by mouth daily. \n- fluoxetine 10 MG Oral Tablet, through Oral route, presumably until 2008-06-26. Instructions: take 20 mg by mouth daily. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-06-22, presumably until 2008-06-22\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-06-20, presumably until 2008-06-22\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2008-06-21, presumably until 2010-05-13. Instructions: take 1 Tab by mouth daily. \n- magnesium gluconogluceptate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium chloride, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2008-06-20, presumably until 2009-04-06. Instructions: take 1 mg by mouth every bedtime. \n- magnesium acetate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-04-06. Instructions: take 1000 mg by mouth every bedtime. \n- magnesium gluconate, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n- magnesium, through Oral route, presumably until 2009-04-06. Instructions: take by mouth. Pt not sure of dose\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-29 00:00:00, ended at 2008-06-29 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.66 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.30 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-03 00:00:00, ended at 2008-07-03 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.35 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.5 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.02 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 275 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-31 00:00:00, ended at 2008-07-31 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 5.1 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.52 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.6 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-31 00:00:00, ended at 2008-08-31 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.66 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.2 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-06 00:00:00, ended at 2008-11-06 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.99 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.5 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-11 00:00:00, ended at 2009-01-11 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.0 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 237 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 110 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 92.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.05 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.2 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-05 00:00:00, ended at 2009-04-05 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 123 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 114 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 8.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- MCV [Entitic volume] by Automated count: 91.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: <1.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.91 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 18.8 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Prothrombin time (PT): 12.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.8 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 122 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: <3.0 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-06 05:51:00, ended at 2009-04-06 14:30:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Body height: 6' .835\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- fluoxetine 20 MG Oral Capsule, through Oral route, presumably until 2011-09-01. Instructions: take 2 Caps by mouth daily. \n- diazepam 5 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- prednisone 1 MG Oral Tablet, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-06, presumably until 2009-04-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-04-06, presumably until 2009-04-06\n- docusate sodium 100 MG Oral Tablet, through Oral route, presumably until 2010-02-14. Instructions: take by mouth as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-25 00:00:00, ended at 2009-07-25 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- posaconazole 40 MG/ML Oral Suspension, through Oral route, started on 2009-07-25, presumably until 2009-07-26, with intended 0 refill(s). Instructions: take 5 mL by mouth 4 times a day with meals and bedtime. \n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-07-25, presumably until 2012-03-02, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth every bedtime. \n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-07-25, presumably until 2009-08-10, with quantity of 60.0, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day. \n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2009-07-25, presumably until 2011-08-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 mg by mouth daily. \n- calcium carbonate 625 MG / ergocalciferol 125 UNT Oral Tablet, through Oral route, started on 2009-07-25, presumably until 2017-03-13, with quantity of 120.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-26 00:00:00, ended at 2009-07-26 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 17.0 (micromole per liter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.39 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 4.22 (milligram per deciliter)\n- Prothrombin time (PT): 13.7 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 89 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 198 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-08-10 00:00:00, ended at 2009-08-10 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-08-10, presumably until 2009-11-08, with quantity of 60.0, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-08 07:12:00, ended at 2009-11-08 08:22:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-08 08:56:10, ended at 2009-11-08 09:42:14\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Essential hypertension\n- Primary diagnosis: Transplanted heart present\n- Pure hypercholesterolemia\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2009-11-08, presumably until 2010-11-08, with quantity of 60.0, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-11-09 00:00:00, ended at 2009-11-09 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-02-13 00:00:00, ended at 2010-02-13 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 09:22:00, ended at 2010-02-13 09:22:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 102 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Prothrombin time (PT): 13.3 (second)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 287 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.71 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 40.9 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.1 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 09:23:00, ended at 2010-02-13 10:18:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 10:19:00, ended at 2010-02-13 10:33:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-13 10:34:00, ended at 2010-02-13 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 12:32:18, ended at 2010-02-13 12:32:36\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n- Pure hypercholesterolemia\n- Coronary arteriosclerosis in artery of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-14 05:49:00, ended at 2010-02-14 13:57:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood: 38 (percent)\n- Body height: 6' .835\" (inch (US))\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.03 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 12.9 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n\n### Procedure\n- Intravascular imaging of coronary vessels\n- Endomyocardial biopsy\n- Coronary arteriography using single catheter\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Catheterization of right heart\n- Biopsy of heart\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Other nonoperative cardiac and vascular measurements\n- Catheter placement in coronary artery(s), arterial coronary conduit(s), and/or venous coronary bypass graft(s) for coronary angiography without concomitant left heart catheterization\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n\n### Condition\n- Sinus node dysfunction\n- Congenital anomaly of coronary artery\n- Effect of exposure to physical force\n\n### Drug\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-02-14, presumably until 2010-02-14\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-02-14, presumably until 2010-02-14\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-02-14, presumably until 2010-02-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-05-13 00:00:00, ended at 2010-05-13 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2010-05-13, presumably until 2013-01-20, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact: Stanford Heart Transplant, 1101 397 N2490 Rd, Longdale OK , phone: 999-999-9999, fax: 999-999-9999. PLEASE DO NOT CONTACT CARDIOVASCULAR MED LISTED ABOVE. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-16 11:16:00, ended at 2010-05-16 12:39:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-05-16 12:40:00, ended at 2010-05-16 13:46:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Biopsy of heart\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-06 00:00:00, ended at 2010-11-06 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-07 08:17:37, ended at 2010-11-07 17:19:22\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-07 08:47:17, ended at 2010-11-07 09:59:50\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2011-12-10. Instructions: take 70 mg by mouth every 7 days. \n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2011-09-01. Instructions: take 2 mg by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-07 10:00:33, ended at 2010-11-07 15:28:35\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-07 10:49:00, ended at 2010-11-07 13:10:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Biopsy of heart\n\n### Condition\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-11-15 00:00:00, ended at 2010-11-15 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-02-04 00:00:00, ended at 2011-02-04 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-20 07:46:00, ended at 2011-02-20 08:14:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 43 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 15.7 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Prothrombin time (PT): 13.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCV [Entitic volume] by Automated count: 89.9 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.20 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.93 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.4 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 142 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.4 (ratio)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-20 08:15:00, ended at 2011-02-20 08:46:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-20 08:47:00, ended at 2011-02-20 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-20 12:56:30, ended at 2011-02-20 13:54:58\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-02-21 06:00:00, ended at 2011-02-21 15:35:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Blood: 151 (millimole per liter)\n- Body height: 6' 0\" (inch (US))\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 40 (percent)\n\n### Procedure\n- Endoluminal imaging of coronary vessel or graft using intravascular ultrasound (IVUS) or optical coherence tomography (OCT) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vess\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Intravascular imaging of coronary vessels\n- Biopsy of heart\n- Catheterization of right heart\n- Collection of venous blood by venipuncture\n- Injection or infusion of other therapeutic or prophylactic substance\n- Coronary arteriography using two catheters\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Endomyocardial biopsy\n\n### Condition\n- Chronic ischemic heart disease\n- Transplanted heart present\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-02-21, presumably until 2011-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-08-04 00:00:00, ended at 2011-08-04 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2011-08-04, presumably until 2013-01-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-08-29 00:00:00, ended at 2011-08-29 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-01 08:25:34, ended at 2011-09-01 14:47:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-01 09:09:28, ended at 2011-09-01 14:57:40\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Cardiomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-01 09:28:42, ended at 2011-09-01 12:58:58\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Essential hypertension\n- Effect of exposure to physical force\n- Transplanted heart present\n- Primary diagnosis: Disorder of lung\n- Coronary arteriosclerosis in artery of transplanted heart\n\n### Drug\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-09-01, presumably until 2015-11-28. Instructions: take 1 Cap by mouth daily.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2011-09-01, presumably until 2013-02-28. Instructions: take 1-1.5 mg by mouth as directed. 1mg qam, 1.5mg qpm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-01 10:50:00, ended at 2011-09-01 15:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.93 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCV [Entitic volume] by Automated count: 92.7 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.5 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 210 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Collection of venous blood by venipuncture\n- Long-term drug therapy\n\n### Condition\n- Transplanted heart present\n- Diarrhea\n- Localized swelling, mass and lump, trunk\n- Lung field abnormal\n- Pleural effusion\n- Pulmonary emphysema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-02 06:05:00, ended at 2011-09-02 14:10:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Biopsy, lung or mediastinum, percutaneous needle\n- Computed tomography guidance for needle placement (eg, biopsy, aspiration, injection, localization device), radiological supervision and interpretation\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Percutaneous needle biopsy lung\n- CT of thorax with contrast\n\n### Condition\n- Transplanted heart present\n- Lung field abnormal\n- Disorder of lung\n- Primary malignant neoplasm of respiratory tract\n- Localized swelling, mass and lump, trunk\n\n### Drug\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-09-02, presumably until 2011-09-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-03 00:00:00, ended at 2011-09-03 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-03 00:00:00, ended at 2011-09-03 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-03 00:00:00, ended at 2011-09-03 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of respiratory tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-04 13:49:00, ended at 2011-09-04 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Localized swelling, mass and lump, trunk\n- Primary malignant neoplasm of respiratory tract\n- Abnormal finding on evaluation procedure\n- Transplanted heart present\n- Disorder of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-14 00:00:00, ended at 2011-10-14 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-10-14 00:00:00, ended at 2011-10-14 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-12-10 00:00:00, ended at 2011-12-10 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2012-03-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-01 09:57:00, ended at 2012-03-01 10:11:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Squamous cell carcinoma of skin of trunk\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-01 10:12:00, ended at 2012-03-01 10:56:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 87 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 70 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.4 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 38 (milliliter per minute per square meter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 15.7 (micromole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 37.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Prothrombin time (PT): 13.3 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 218 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 246 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-01 10:57:00, ended at 2012-03-01 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Coag./bleeding tests abnormal\n- Effect of exposure to physical force\n- Transplanted heart present\n- Heart failure\n- Hyperlipidemia\n- Essential hypertension\n- Squamous cell carcinoma of skin of trunk\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-01 12:52:11, ended at 2012-03-01 12:54:51\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2012-03-01, presumably until 2012-03-03, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2012-03-01, presumably until 2013-01-20, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-03-01, presumably until 2012-03-02, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-02 08:31:00, ended at 2012-03-02 15:25:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.6 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 144 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 4.4 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 40 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Coronary arteriography using two catheters\n- Catheterization of right heart\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n\n### Condition\n- Chronic obstructive lung disease\n- Chronic ischemic heart disease\n- Hyperlipidemia\n- Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2012-03-02, presumably until 2012-03-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-21 00:00:00, ended at 2012-04-21 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2012-04-21, presumably until 2013-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-18 00:00:00, ended at 2012-10-18 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-20 00:00:00, ended at 2013-01-20 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Solitary nodule of lung\n- Effect of exposure to physical force\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days.\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. 1mg qam, 1.5mg qpm\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- tacrolimus 0.5 MG Oral Capsule, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: Take 0.5mg twice daily along with 1 mg capsule twice daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact: Stanford Heart Transplant, 1101 791 Vye Ln, Spring Brook WI , phone: 999-999-9999, fax: 999-999-9999. PLEASE DO NOT CONTACT CARDIOVASCULAR MED LISTED ABOVE.\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2014-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-28 00:00:00, ended at 2013-02-28 00:00:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 08:45:00, ended at 2013-02-28 09:28:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.4 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 14.3 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Prothrombin time (PT): 13.3 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.73 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 126 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.0 (second)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 129 (unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 72 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.8 (ratio)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 207 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 219 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: <5.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 09:29:00, ended at 2013-02-28 09:47:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-28 09:48:00, ended at 2013-02-28 11:08:00\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Chronic cor pulmonale\n- Anemia\n- Effect of exposure to physical force\n- Essential hypertension\n- Congestive heart failure\n- Primary malignant neoplasm of respiratory tract\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-28 13:26:06, ended at 2013-02-28 14:36:23\nThe patient in this visit was 68 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Coronary arteriosclerosis in artery of transplanted heart\n- Pure hypercholesterolemia\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-17 00:00:00, ended at 2013-11-17 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Solitary nodule of lung\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2013-11-17, presumably until 2013-11-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-06 00:00:00, ended at 2013-12-06 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-30 00:00:00, ended at 2014-01-30 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hyperglyceridemia\n- Transplanted heart present\n- Primary diagnosis: Solitary nodule of lung\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2014-01-30, presumably until 2015-11-27, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. 1mg qam, 1.5mg qpm\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- tacrolimus 0.5 MG Oral Capsule, started on 2014-01-30, presumably until 2015-11-27, with intended 3 refill(s). Instructions: Take 0.5mg twice daily along with 1 mg capsule twice daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2014-05-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact:\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2014-11-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-30 00:00:00, ended at 2014-01-30 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Transplanted heart present\n\n### Drug\n- 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-15 00:00:00, ended at 2014-02-15 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 58 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-16 08:33:00, ended at 2014-02-16 09:13:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 88.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.89 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.3 (ratio)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 90 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 302 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Homocysteine [Moles/volume] in Serum or Plasma: 11.4 (micromole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-16 09:14:00, ended at 2014-02-16 09:30:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Transplanted heart present\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-16 09:40:00, ended at 2014-02-16 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Effect of exposure to physical force\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-02 00:00:00, ended at 2014-05-02 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Solitary nodule of lung\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2014-05-02, presumably until 2017-03-13, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. For questions regarding this order and urgent results please contact:\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-05 00:00:00, ended at 2014-05-05 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-11-20 00:00:00, ended at 2014-11-20 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2014-11-20, presumably until 2015-01-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-23 00:00:00, ended at 2015-01-23 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, through Oral route, started on 2015-01-23, presumably until 2016-01-22, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-01-26 00:00:00, ended at 2015-01-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2015-01-26, presumably until 2015-11-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-02-20 00:00:00, ended at 2015-02-20 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart present\n- Electrocardiogram abnormal\n- Primary diagnosis: Pure hyperglyceridemia\n- Supraventricular premature beats\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-22 08:25:00, ended at 2015-02-22 08:47:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 11.7 (micromole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.24 (thousand per microliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: No result (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 1.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.70 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pure hyperglyceridemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-22 08:48:00, ended at 2015-02-22 09:10:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-02-22 09:12:00, ended at 2015-02-22 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 61.0 (percent)\n\n### Procedure\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n\n### Condition\n- Transplanted heart present\n- Effect of exposure to physical force\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-06 00:00:00, ended at 2015-06-06 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2015-06-06, presumably until 2015-06-06, with intended 1 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE DAILY FOR 15 DAYS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-08-15 00:00:00, ended at 2015-08-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Effect of exposure to physical force\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-27 00:00:00, ended at 2015-11-27 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-11-27, presumably until 2015-12-04, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day 1mg qam, 1.5mg qpm\n- tacrolimus 0.5 MG Oral Capsule, started on 2015-11-27, presumably until 2015-12-04, with intended 3 refill(s). Instructions: Takes 0.5 mg po in the AM and 1 mg po in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-28 00:00:00, ended at 2015-11-28 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Solitary nodule of lung\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2015-11-28, presumably until 2018-06-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2015-11-28, presumably until 2016-01-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n- sirolimus 1 MG Oral Tablet, through Oral route, started on 2015-11-28, presumably until 2017-02-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-12-04 00:00:00, ended at 2015-12-04 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2015-12-04, presumably until 2016-12-01, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 1.5mg BID\n- tacrolimus 0.5 MG Oral Capsule, started on 2015-12-04, presumably until 2016-12-01, with intended 3 refill(s). Instructions: Total dose of 1.5mg BID\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-22 00:00:00, ended at 2016-01-22 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2016-01-23, presumably until 2016-01-23, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-23 00:00:00, ended at 2016-01-23 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 2.5 MG Oral Tablet, started on 2016-01-23, presumably until 2017-03-12, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-28 00:00:00, ended at 2016-01-28 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, started on 2016-01-29, presumably until 2017-02-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-07 00:00:00, ended at 2016-03-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Fatigue\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-12 00:00:00, ended at 2016-03-12 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Transplanted heart present\n- Electrocardiogram abnormal\n- Disorder of transplanted heart\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 07:22:00, ended at 2016-03-12 09:34:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 67.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete\n\n### Condition\n- Fatigue\n- Hyperlipidemia\n- Disorder of transplanted heart\n- Transplanted heart present\n- Disorder affecting transplanted structure\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "181ea5e1d470ef50dd6bba773dfd667c6bdbe16bfe45b3d97cec9e6ca2351b5c", "prompt_hash": "481d0e13e07abb7f71c32f73fc5948706eb39df0bd4eec8feed1091e3f12f0c8", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115968990, "visit_occurrence_id": 131528679, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2019-01-23 12:32:55", "visit_end_datetime": "2019-01-23 13:37:07", "visit_length_in_hours": 1.07, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2019-01-23 12:32:55, ended at 2019-01-23 13:37:07\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 87, "patient_first_visit_date": "2015-09-19 10:15:00", "patient_last_visit_date": "2022-06-18 00:00:00", "end_obs_date": "2020-01-23", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "recurrent", "dementia_one_year_diagnosis": 1, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 48, "cumulated_visit_num": 48, "cumulated_approximate_token_count": 15914, "visit_cumulated": "## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 10:15:00, ended at 2015-09-19 16:05:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Blood: 137 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n\n### Procedure\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Collection of blood specimen from a completely implantable venous access device\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Coronary arteriosclerosis\n- Dyspnea\n- Hypothyroidism\n- Primary diagnosis: Angina pectoris\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2019-09-17, with intended 0 refill(s). Instructions: take 20 mg by mouth daily \n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 50 mcg by mouth every morning before breakfast\n- fatty acids, omega-6, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-09-19\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-09-19\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 0.1 mg by mouth 2 times a day\n- fluocinonide 0.5 MG/ML Topical Cream, through Topical route, presumably until 2015-09-19, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day as needed (dermatitis)\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2015-11-01, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-09-19, presumably until 2015-09-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-09-19, presumably until 2015-09-19\n- astaxanthin, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- omega-3 acid ethyl esters (USP), through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- docosahexaenoate, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n- gabapentin 600 MG Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 600 mg by mouth 2 times a day\n- eicosapentaenoate, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- omega-3 fatty acids, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 100 mg by mouth daily\n- krill oil, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- dicyclomine hydrochloride 10 MG Oral Capsule, through Oral route, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 10 mg by mouth 3 times a day as needed (cramping or GI distress)\n- egg yolk phospholipids, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2015-10-10, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2015-10-17 18:20:00, ended at 2015-10-17 23:15:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Prothrombin time (PT): 13.1 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.7 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary diagnosis: Chest pain\n- Primary malignant neoplasm of prostate\n- Hyperlipidemia\n- Hypothyroidism\n- Nicotine dependence\n- Bradycardia\n- Dyspnea\n- Coronary artery graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-17, presumably until 2015-10-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-11-01 00:00:00, ended at 2015-11-01 00:00:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-11-01, presumably until 2015-11-01\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-11-01, presumably until 2015-11-01\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2015-11-01, presumably until 2015-11-01\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2015-11-01, presumably until 2015-11-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-11-01 07:07:00, ended at 2015-11-12 13:00:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 43.4 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 536 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.16 (microliter per milliliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.70 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Prothrombin time (PT): 21.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 50.2 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 380 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Base excess in Arterial blood by calculation: 2.4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 5.2 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 27.6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 98 (millimeter mercury column)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.43 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lidocaine [Mass/volume] in Serum or Plasma: 3.2 (microgram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 98 (thousand per microliter)\n- Thrombin time: 13.9 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 86.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n\n### Procedure\n- Drainage of Left Pleura with Drainage Device, Percutaneous Approach\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Controlled ventilation procedure and therapy, initiation and management\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Performance of Cardiac Output, Continuous\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Bypass Coronary Artery, Three Arteries from Aorta with Autologous Venous Tissue, Open Approach\n- Bypass Coronary Artery, One Artery from Left Internal Mammary, Open Approach\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Radiologic examination, abdomen; single anteroposterior view\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Evaluation of oral and pharyngeal swallowing function\n- Occupational therapy evaluation\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Abdominal pain\n- Chronic pulmonary edema\n- Delirium\n- Abnormal findings on diagnostic imaging of lung\n- Acute renal failure syndrome\n- Abdominal aortic aneurysm without rupture\n- Acquired absence of organ\n- Acute posthemorrhagic anemia\n- Psychotic disorder\n- Aortocoronary bypass graft present\n- Atelectasis\n- Atrial fibrillation\n- Chronic kidney disease stage 2\n- Disorder of digestive system\n- Hyperlipidemia\n- Hypovolemic shock\n- Angina pectoris\n- Disorientated\n- Essential hypertension\n- Old myocardial infarction\n- Primary malignant neoplasm of prostate\n- Sleep apnea\n- Atherosclerosis of coronary artery without angina pectoris\n- Coronary artery graft present\n- Persistent pain following procedure\n- Pneumothorax\n- Electrocardiogram abnormal\n- Gastroesophageal reflux disease without esophagitis\n- Hypothyroidism\n- Pleural effusion\n- Retention of urine\n- Primary diagnosis: Angina co-occurrent and due to coronary arteriosclerosis\n- Bradycardia\n- Chronic kidney disease due to hypertension\n- Hypoxemia\n- Iatrogenic hypotension\n- Postoperative state\n- Spinal stenosis of lumbar region\n- Paroxysmal atrial fibrillation\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-11-02, presumably until 2015-11-02\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 2 weeks. Than take 1 tab by mouth 1 time a day for 2 weeks. Then stop.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-03\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-03\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-11\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-11-03, presumably until 2015-11-04\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2015-11-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-11-08, presumably until 2015-11-08\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2015-11-02, presumably until 2015-11-12\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2015-11-02, presumably until 2015-11-03\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2015-11-02, presumably until 2015-11-04\n- haloperidol 5 MG/ML Injectable Solution, started on 2015-11-02, presumably until 2015-11-08\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-12-09, with intended 0 refill(s). Instructions: Take 20 mg daily for 10 days, then stop\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-04, presumably until 2015-11-11\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-02\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-11-05, presumably until 2015-11-12\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed for Pain\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-11-09, presumably until 2015-11-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-11-07, presumably until 2015-11-07\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-11-03, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2015-11-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2015-11-11, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n- cefazolin 1000 MG Injection, started on 2015-11-01, presumably until 2015-11-02\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-11-07, presumably until 2015-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 3 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2015-11-19, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-12-05, with intended 0 refill(s). Instructions: Take 25 mg for 5 days, then stop\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2015-11-03, presumably until 2015-11-11\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-11-03, presumably until 2015-11-06\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-02\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-11-03, presumably until 2015-11-09\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-05\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2015-11-08, presumably until 2015-11-09\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2015-11-04, presumably until 2015-11-05\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-12-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- levothyroxine sodium 0.1 MG Injection, through Intravenous route, started on 2015-11-03, presumably until 2015-11-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-05, presumably until 2015-11-07\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-11-08, presumably until 2015-11-12\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2015-11-06, presumably until 2015-11-07\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2015-11-05, presumably until 2015-11-11\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-11-03, presumably until 2015-11-06\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-11-11, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-05\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2015-11-07, presumably until 2015-11-07\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-11-03, presumably until 2015-11-09\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2015-11-01, presumably until 2015-11-01\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-11-03, presumably until 2015-11-05\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-08\n- 1 ML methylene blue 10 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-02\n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2015-11-10, presumably until 2015-11-10\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-11-07, presumably until 2015-11-07\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2015-11-08, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-11-02, presumably until 2015-11-04\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2015-11-03, presumably until 2015-11-05\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-07\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2015-11-06, presumably until 2015-11-06\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2015-11-05, presumably until 2015-11-12\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-11-02, presumably until 2016-05-09, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 4 hours as needed for Pain\n- doxylamine succinate 25 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2015-11-11\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2015-11-01, presumably until 2015-11-01\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2015-11-12\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2015-11-02, presumably until 2015-11-02\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2015-11-08, presumably until 2015-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-05 13:05:15, ended at 2015-12-05 13:59:51\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative state\n- Primary diagnosis: Aortocoronary bypass graft present\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, presumably until 2016-12-09, with intended 0 refill(s). Instructions: take 20 mEq by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-09-03 14:11:00, ended at 2016-09-03 18:42:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.61 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.37 (thousand per microliter)\n- Prothrombin time (PT): 13.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.60 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Melena\n- Left upper quadrant pain\n- Primary malignant neoplasm of prostate\n- Acute posthemorrhagic anemia\n- Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperlipidemia\n- Atrial fibrillation\n- Hypothyroidism\n- Bradycardia\n- Gastritis\n- Primary diagnosis: Stool finding\n- Aortocoronary bypass graft present\n- Electrocardiogram abnormal\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-09-03, presumably until 2016-12-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-09-03, presumably until 2016-09-03\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2016-09-03, presumably until 2016-09-03\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2016-09-03, presumably until 2016-09-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-16 11:24:35, ended at 2016-09-16 14:49:48\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Degeneration of lumbosacral intervertebral disc\n- Spinal stenosis of lumbar region\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-07 13:55:24, ended at 2016-12-07 15:58:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Minimal cognitive impairment\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-09 00:00:00, ended at 2016-12-09 00:00:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2016-12-09, presumably until 2016-12-09\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2016-12-09, presumably until 2016-12-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-12-09, presumably until 2016-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-09 08:46:00, ended at 2016-12-09 10:39:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure)\n- Introduction of Anti-inflammatory into Peripheral Nerves and Plexi, Percutaneous Approach\n- Fluoroscopy of Lumbar Facet Joint(s) using Other Contrast\n- Introduction of Anesthetic Agent into Peripheral Nerves and Plexi, Percutaneous Approach\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level\n\n### Condition\n- Chronic pain\n- Coronary artery graft present\n- Essential hypertension\n- Hyperlipidemia\n- Atherosclerosis of coronary artery without angina pectoris\n- Low back pain\n- Hypothyroidism\n- Lumbar spondylosis\n- Disorder of musculoskeletal system\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2016-08-12, presumably until 2022-01-11, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 0 refill(s). Instructions: take 100 mg by mouth daily\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2016-04-14, presumably until 2017-04-07, with intended 0 refill(s). Instructions: take 600 mg by mouth every bedtime\n- 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet, through Oral route, started on 2016-07-24, presumably until 2019-05-07, with intended 0 refill(s). Instructions: take 50 mg by mouth daily \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-09 09:49:23, ended at 2016-12-09 10:01:16\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of musculoskeletal system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-10 00:00:00, ended at 2017-01-10 00:00:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-11 11:51:00, ended at 2017-01-11 14:06:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 870 (picogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 160.9 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Iron [Mass/volume] in Serum or Plasma: 113 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 146 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 54.6 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 37 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 16.9 (milli-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.34 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Primary malignant neoplasm of prostate\n- Anemia of chronic disease\n- Blood chemistry abnormal\n- Flushing\n- Generalized hyperhidrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-11 14:07:00, ended at 2017-01-11 23:59:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Generalized hyperhidrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-25 12:50:00, ended at 2017-03-25 12:50:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-04-01 00:00:00, ended at 2017-04-01 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2017-04-01, presumably until 2017-04-01\n- 1 ML dexamethasone phosphate 10 MG/ML Injection, started on 2017-04-01, presumably until 2017-04-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 11:54:00, ended at 2017-04-01 14:50:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach\n- Introduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperlipidemia\n- Lumbar radiculopathy\n- Coronary artery graft present\n- Hypothyroidism\n- Low back pain\n- Lumbosacral stenosis\n- Lumbosacral radiculopathy\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 13:57:34, ended at 2017-04-01 14:18:02\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-07 14:25:58, ended at 2017-04-07 15:09:26\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbar radiculopathy\n- Chronic pain\n- Lumbago with sciatica\n\n### Drug\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2017-04-07, presumably until 2018-04-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- gabapentin 800 MG Oral Tablet, through Oral route, started on 2017-04-07, presumably until 2018-04-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-11 14:23:00, ended at 2017-04-11 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Degeneration of lumbar intervertebral disc\n- Lumbar radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-31 00:00:00, ended at 2017-05-31 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-02 12:24:00, ended at 2017-06-02 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n\n### Condition\n- Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-10 09:52:13, ended at 2017-06-10 10:51:15\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Haptoglobin [Mass/volume] in Serum or Plasma: 283 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n\n### Condition\n- Generalized hyperhidrosis\n- Bradycardia\n- Anemia of chronic disease\n- Primary malignant neoplasm of prostate\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-10 10:54:00, ended at 2017-06-10 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 83.3 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 196 (unit per liter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 98.6 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.23 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Anemia\n- Amnesia\n- Anemia of chronic disease\n- Generalized hyperhidrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-10 11:58:45, ended at 2017-06-10 12:48:59\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-09-08 00:00:00, ended at 2017-09-08 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2017-09-08, presumably until 2017-09-08\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-09-08, presumably until 2017-09-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-08 07:50:00, ended at 2017-09-08 11:08:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Introduction of Anesthetic Agent into Peripheral Nerves and Plexi, Percutaneous Approach\n- Fluoroscopy of Lumbar Facet Joint(s) using Other Contrast\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure)\n\n### Condition\n- Hypothyroidism\n- Pain\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperlipidemia\n- Lumbar spondylosis\n- Coronary artery graft present\n- Primary diagnosis: Low back pain\n- Primary diagnosis: Chronic pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-19 00:00:00, ended at 2017-09-19 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2017-09-22, presumably until 2017-09-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 07:33:00, ended at 2017-09-22 11:48:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Introduction of Destructive Agent into Peripheral Nerves and Plexi, Percutaneous Approach\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure)\n- Fluoroscopy of Lumbar Facet Joint(s) using Low Osmolar Contrast\n- Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Lumbar spondylosis\n- Hyperlipidemia\n- Low back pain\n- Arthropathy\n- Hypothyroidism\n- Primary malignant neoplasm of prostate\n- Chronic pain\n- Essential hypertension\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-09-22, presumably until 2017-09-22\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, presumably until 2019-02-27, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every day \n- tadalafil 20 MG Oral Tablet, through Oral route, started on 2015-08-11, presumably until 2019-02-27, with intended 0 refill(s). Instructions: 20 mg by Swish & Swallow route\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 08:02:00, ended at 2017-09-22 13:58:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-22 12:41:20, ended at 2017-09-22 15:40:38\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Anemia of chronic disease\n- Generalized hyperhidrosis\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 13:59:00, ended at 2017-09-22 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-04 10:41:32, ended at 2017-10-04 11:06:12\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Primary diagnosis: Chronic pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-14 14:06:24, ended at 2018-03-14 14:06:34\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-04-07 00:00:00, ended at 2018-04-07 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- donepezil hydrochloride 5 MG Oral Tablet, started on 2018-04-07, presumably until 2018-05-09, with intended 0 refill(s). Instructions: 1/2 tablet each morning x2 weeks, then have EKG check.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- donepezil hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-05-11, presumably until 2018-09-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily in the morning with food\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-19 00:00:00, ended at 2018-05-19 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-26 09:30:00, ended at 2018-05-26 23:59:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral, with pelvis when performed; 1 view\n\n### Condition\n- Bone necrosis\n- Hip pain\n- Bone cyst\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-26 09:46:10, ended at 2018-05-26 12:02:47\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bone cyst\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-07 00:00:00, ended at 2018-07-07 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- 24 HR rivastigmine 0.192 MG/HR Transdermal System, through Transdermal route, started on 2018-07-07, presumably until 2018-09-26, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-12 00:00:00, ended at 2018-07-12 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR rivastigmine 0.192 MG/HR Transdermal System, through Transdermal route, started on 2018-08-11, presumably until 2018-08-11, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-01 11:02:49, ended at 2018-09-01 12:14:45\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n- Dementia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-05 09:32:00, ended at 2018-09-05 23:59:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n- Fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device) (List separately in addition to code for primary procedure)\n\n### Condition\n- Hip pain\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2018-09-05, presumably until 2018-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-25 00:00:00, ended at 2018-09-25 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- 24 HR rivastigmine 0.396 MG/HR Transdermal System, through Transdermal route, started on 2018-09-26, presumably until 2019-02-27, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-06 00:00:00, ended at 2018-12-06 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-06 15:17:00, ended at 2018-12-06 23:59:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral, with pelvis when performed; 1 view\n\n### Condition\n- Disorder of thigh\n- Aseptic necrosis of bone of hip\n- Hip pain\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-23 12:32:55, ended at 2019-01-23 13:37:07\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-19 10:15:00, ended at 2015-09-19 16:05:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Sodium [Moles/volume] in Blood: 137 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- Body height: 5' 6\" (inch (US))\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- Potassium [Moles/volume] in Blood: 3.8 (millimole per liter)\n\n### Procedure\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Collection of blood specimen from a completely implantable venous access device\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Collection of venous blood by venipuncture\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Primary diagnosis: Coronary arteriosclerosis\n- Dyspnea\n- Hypothyroidism\n- Primary diagnosis: Angina pectoris\n- Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, presumably until 2019-09-17, with intended 0 refill(s). Instructions: take 20 mg by mouth daily \n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 50 mcg by mouth every morning before breakfast\n- fatty acids, omega-6, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-09-19\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2015-09-19, presumably until 2015-09-19\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 0.1 mg by mouth 2 times a day\n- fluocinonide 0.5 MG/ML Topical Cream, through Topical route, presumably until 2015-09-19, with intended 0 refill(s). Instructions: 1 Application by Topical route 2 times a day as needed (dermatitis)\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2015-11-01, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-09-19, presumably until 2015-09-19\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-09-19, presumably until 2015-09-19\n- astaxanthin, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- omega-3 acid ethyl esters (USP), through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- docosahexaenoate, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 20 mg by mouth daily\n- gabapentin 600 MG Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 600 mg by mouth 2 times a day\n- eicosapentaenoate, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- omega-3 fatty acids, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 100 mg by mouth daily\n- krill oil, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- dicyclomine hydrochloride 10 MG Oral Capsule, through Oral route, presumably until 2015-09-19, with intended 0 refill(s). Instructions: take 10 mg by mouth 3 times a day as needed (cramping or GI distress)\n- egg yolk phospholipids, through Oral route, presumably until 2015-11-12, with intended 0 refill(s). Instructions: take 1 Cap by mouth\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2015-10-10, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2015-10-17 18:20:00, ended at 2015-10-17 23:15:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Prothrombin time (PT): 13.1 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.7 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.45 (million per microliter)\n- MCV [Entitic volume] by Automated count: 89.2 (femtoliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary diagnosis: Chest pain\n- Primary malignant neoplasm of prostate\n- Hyperlipidemia\n- Hypothyroidism\n- Nicotine dependence\n- Bradycardia\n- Dyspnea\n- Coronary artery graft present\n- Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n\n### Drug\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-10-17, presumably until 2015-10-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2015-11-01 00:00:00, ended at 2015-11-01 00:00:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2015-11-01, presumably until 2015-11-01\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-01\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2015-11-01, presumably until 2015-11-01\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2015-11-01, presumably until 2015-11-01\n- epinephrine 1 MG/ML Injectable Solution, through Intravenous route, started on 2015-11-01, presumably until 2015-11-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-11-01 07:07:00, ended at 2015-11-12 13:00:00\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 43.4 (millimeter mercury column)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 536 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.3 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: 0.16 (microliter per milliliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.70 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 115 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.57 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Prothrombin time (PT): 21.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 6\" (inch (US))\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 50.2 (millimeter mercury column)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 380 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Base excess in Arterial blood by calculation: 2.4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 5.2 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 27.6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.6 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 98 (millimeter mercury column)\n- Base excess in Blood by calculation: 5 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.43 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lidocaine [Mass/volume] in Serum or Plasma: 3.2 (microgram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 98 (thousand per microliter)\n- Thrombin time: 13.9 (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 86.1 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n\n### Procedure\n- Drainage of Left Pleura with Drainage Device, Percutaneous Approach\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Ultrasound, chest (includes mediastinum), real time with image documentation\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Controlled ventilation procedure and therapy, initiation and management\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Performance of Cardiac Output, Continuous\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Bypass Coronary Artery, Three Arteries from Aorta with Autologous Venous Tissue, Open Approach\n- Bypass Coronary Artery, One Artery from Left Internal Mammary, Open Approach\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Radiologic examination, abdomen; single anteroposterior view\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Evaluation of oral and pharyngeal swallowing function\n- Occupational therapy evaluation\n- Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n\n### Condition\n- Abdominal pain\n- Chronic pulmonary edema\n- Delirium\n- Abnormal findings on diagnostic imaging of lung\n- Acute renal failure syndrome\n- Abdominal aortic aneurysm without rupture\n- Acquired absence of organ\n- Acute posthemorrhagic anemia\n- Psychotic disorder\n- Aortocoronary bypass graft present\n- Atelectasis\n- Atrial fibrillation\n- Chronic kidney disease stage 2\n- Disorder of digestive system\n- Hyperlipidemia\n- Hypovolemic shock\n- Angina pectoris\n- Disorientated\n- Essential hypertension\n- Old myocardial infarction\n- Primary malignant neoplasm of prostate\n- Sleep apnea\n- Atherosclerosis of coronary artery without angina pectoris\n- Coronary artery graft present\n- Persistent pain following procedure\n- Pneumothorax\n- Electrocardiogram abnormal\n- Gastroesophageal reflux disease without esophagitis\n- Hypothyroidism\n- Pleural effusion\n- Retention of urine\n- Primary diagnosis: Angina co-occurrent and due to coronary arteriosclerosis\n- Bradycardia\n- Chronic kidney disease due to hypertension\n- Hypoxemia\n- Iatrogenic hypotension\n- Postoperative state\n- Spinal stenosis of lumbar region\n- Paroxysmal atrial fibrillation\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2015-11-02, presumably until 2015-11-02\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 2 weeks. Than take 1 tab by mouth 1 time a day for 2 weeks. Then stop.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-03\n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-03\n- rosuvastatin calcium 10 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-11\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2015-11-03, presumably until 2015-11-04\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2015-11-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-11-08, presumably until 2015-11-08\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2015-11-02, presumably until 2015-11-12\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2015-11-02, presumably until 2015-11-03\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2015-11-02, presumably until 2015-11-04\n- haloperidol 5 MG/ML Injectable Solution, started on 2015-11-02, presumably until 2015-11-08\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-12-09, with intended 0 refill(s). Instructions: Take 20 mg daily for 10 days, then stop\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-04, presumably until 2015-11-11\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-02\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2015-11-05, presumably until 2015-11-12\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed for Pain\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2015-11-09, presumably until 2015-11-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2015-11-07, presumably until 2015-11-07\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2015-11-03, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2015-11-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2015-11-11, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n- cefazolin 1000 MG Injection, started on 2015-11-01, presumably until 2015-11-02\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2015-11-07, presumably until 2015-11-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 3 days\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2015-11-19, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- quetiapine 25 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-12-05, with intended 0 refill(s). Instructions: Take 25 mg for 5 days, then stop\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2015-11-03, presumably until 2015-11-11\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2015-11-03, presumably until 2015-11-06\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-02\n- 10 ML furosemide 10 MG/ML Injection, started on 2015-11-03, presumably until 2015-11-09\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-05\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2015-11-08, presumably until 2015-11-09\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth 2 times a day\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2015-11-04, presumably until 2015-11-05\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2016-12-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- levothyroxine sodium 0.1 MG Injection, through Intravenous route, started on 2015-11-03, presumably until 2015-11-03\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2015-11-05, presumably until 2015-11-07\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2015-11-08, presumably until 2015-11-12\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2015-11-06, presumably until 2015-11-07\n- ipratropium bromide 0.2 MG/ML Inhalation Solution, through Inhalation, started on 2015-11-05, presumably until 2015-11-11\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2015-11-03, presumably until 2015-11-06\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2015-11-11, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-05\n- warfarin sodium 2.5 MG Oral Tablet, through Oral route, started on 2015-11-07, presumably until 2015-11-07\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2015-11-03, presumably until 2015-11-09\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2015-11-01, presumably until 2015-11-01\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2015-11-03, presumably until 2015-11-05\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-08\n- 1 ML methylene blue 10 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-02\n- warfarin sodium 2 MG Oral Tablet, through Oral route, started on 2015-11-10, presumably until 2015-11-10\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2015-11-07, presumably until 2015-11-07\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2015-11-08, presumably until 2016-11-10, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2015-11-02, presumably until 2015-11-04\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2015-11-03, presumably until 2015-11-05\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2015-11-02, presumably until 2015-11-07\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2015-11-06, presumably until 2015-11-06\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2015-11-05, presumably until 2015-11-12\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2015-11-02, presumably until 2016-05-09, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 4 hours as needed for Pain\n- doxylamine succinate 25 MG Oral Tablet, through Oral route, started on 2015-11-11, presumably until 2015-11-11\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2015-11-01, presumably until 2015-11-01\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-12\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2015-11-06, presumably until 2015-11-12\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2015-11-02, presumably until 2015-11-02\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2015-11-01, presumably until 2015-11-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2015-11-08, presumably until 2015-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-05 13:05:15, ended at 2015-12-05 13:59:51\nThe patient in this visit was 75 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative state\n- Primary diagnosis: Aortocoronary bypass graft present\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, presumably until 2016-12-09, with intended 0 refill(s). Instructions: take 20 mEq by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2016-09-03 14:11:00, ended at 2016-09-03 18:42:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.61 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.37 (thousand per microliter)\n- Prothrombin time (PT): 13.3 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.60 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.4 (second)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Collection of venous blood by venipuncture\n\n### Condition\n- Melena\n- Left upper quadrant pain\n- Primary malignant neoplasm of prostate\n- Acute posthemorrhagic anemia\n- Atherosclerosis of coronary artery without angina pectoris\n- Essential hypertension\n- Hyperlipidemia\n- Atrial fibrillation\n- Hypothyroidism\n- Bradycardia\n- Gastritis\n- Primary diagnosis: Stool finding\n- Aortocoronary bypass graft present\n- Electrocardiogram abnormal\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2016-09-03, presumably until 2016-12-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-09-03, presumably until 2016-09-03\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2016-09-03, presumably until 2016-09-03\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2016-09-03, presumably until 2016-09-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-16 11:24:35, ended at 2016-09-16 14:49:48\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Degeneration of lumbosacral intervertebral disc\n- Spinal stenosis of lumbar region\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-07 13:55:24, ended at 2016-12-07 15:58:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Minimal cognitive impairment\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-12-09 00:00:00, ended at 2016-12-09 00:00:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2016-12-09, presumably until 2016-12-09\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2016-12-09, presumably until 2016-12-09\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-12-09, presumably until 2016-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-09 08:46:00, ended at 2016-12-09 10:39:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure)\n- Introduction of Anti-inflammatory into Peripheral Nerves and Plexi, Percutaneous Approach\n- Fluoroscopy of Lumbar Facet Joint(s) using Other Contrast\n- Introduction of Anesthetic Agent into Peripheral Nerves and Plexi, Percutaneous Approach\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level\n\n### Condition\n- Chronic pain\n- Coronary artery graft present\n- Essential hypertension\n- Hyperlipidemia\n- Atherosclerosis of coronary artery without angina pectoris\n- Low back pain\n- Hypothyroidism\n- Lumbar spondylosis\n- Disorder of musculoskeletal system\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2016-08-12, presumably until 2022-01-11, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- losartan potassium 100 MG Oral Tablet, through Oral route, started on 2016-01-02, presumably until 2016-01-02, with intended 0 refill(s). Instructions: take 100 mg by mouth daily\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2016-04-14, presumably until 2017-04-07, with intended 0 refill(s). Instructions: take 600 mg by mouth every bedtime\n- 24 HR metoprolol succinate 100 MG Extended Release Oral Tablet, through Oral route, started on 2016-07-24, presumably until 2019-05-07, with intended 0 refill(s). Instructions: take 50 mg by mouth daily \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-12-09 09:49:23, ended at 2016-12-09 10:01:16\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of musculoskeletal system\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-10 00:00:00, ended at 2017-01-10 00:00:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-11 11:51:00, ended at 2017-01-11 14:06:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 870 (picogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 160.9 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Iron [Mass/volume] in Serum or Plasma: 113 (microgram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 146 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 54.6 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- MCV [Entitic volume] by Automated count: 86.7 (femtoliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 37 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythropoietin (EPO) [Units/volume] in Serum or Plasma: 16.9 (milli-international unit per milliliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.6 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.07 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 1.34 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n- Primary malignant neoplasm of prostate\n- Anemia of chronic disease\n- Blood chemistry abnormal\n- Flushing\n- Generalized hyperhidrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-01-11 14:07:00, ended at 2017-01-11 23:59:00\nThe patient in this visit was 76 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Generalized hyperhidrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-25 12:50:00, ended at 2017-03-25 12:50:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-04-01 00:00:00, ended at 2017-04-01 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2017-04-01, presumably until 2017-04-01\n- 1 ML dexamethasone phosphate 10 MG/ML Injection, started on 2017-04-01, presumably until 2017-04-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 11:54:00, ended at 2017-04-01 14:50:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Introduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach\n- Introduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach\n- Injection(s), anesthetic agent(s) and/or steroid; transforaminal epidural, with imaging guidance (fluoroscopy or CT), lumbar or sacral, single level\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperlipidemia\n- Lumbar radiculopathy\n- Coronary artery graft present\n- Hypothyroidism\n- Low back pain\n- Lumbosacral stenosis\n- Lumbosacral radiculopathy\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 13:57:34, ended at 2017-04-01 14:18:02\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-07 14:25:58, ended at 2017-04-07 15:09:26\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lumbar radiculopathy\n- Chronic pain\n- Lumbago with sciatica\n\n### Drug\n- ibuprofen 600 MG Oral Tablet, through Oral route, started on 2017-04-07, presumably until 2018-04-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed\n- gabapentin 800 MG Oral Tablet, through Oral route, started on 2017-04-07, presumably until 2018-04-07, with intended 2 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-11 14:23:00, ended at 2017-04-11 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, spinal canal and contents, lumbar; without contrast material\n\n### Condition\n- Degeneration of lumbar intervertebral disc\n- Lumbar radiculopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-31 00:00:00, ended at 2017-05-31 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-02 12:24:00, ended at 2017-06-02 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), with qualified health care professional interpretation and report, administered by technician, per hour of technician time\n- Neuropsychological testing (eg, Halstead-Reitan Neuropsychological Battery, Wechsler Memory Scales and Wisconsin Card Sorting Test), per hour of the psychologist's or physician's time, both face-to-face time administering tests to the patient and time int\n- Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professio\n\n### Condition\n- Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-10 09:52:13, ended at 2017-06-10 10:51:15\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n- Haptoglobin [Mass/volume] in Serum or Plasma: 283 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n\n### Condition\n- Generalized hyperhidrosis\n- Bradycardia\n- Anemia of chronic disease\n- Primary malignant neoplasm of prostate\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-10 10:54:00, ended at 2017-06-10 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Reticulocytes [#/volume] in Blood by Automated count: 83.3 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 196 (unit per liter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 98.6 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 279 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 2.23 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Anemia\n- Amnesia\n- Anemia of chronic disease\n- Generalized hyperhidrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-10 11:58:45, ended at 2017-06-10 12:48:59\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-09-08 00:00:00, ended at 2017-09-08 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2017-09-08, presumably until 2017-09-08\n- 10 ML bupivacaine hydrochloride 5 MG/ML Injection, started on 2017-09-08, presumably until 2017-09-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-08 07:50:00, ended at 2017-09-08 11:08:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Introduction of Anesthetic Agent into Peripheral Nerves and Plexi, Percutaneous Approach\n- Fluoroscopy of Lumbar Facet Joint(s) using Other Contrast\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; single level\n- Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with image guidance (fluoroscopy or CT), lumbar or sacral; second level (List separately in addition to code for primary procedure)\n\n### Condition\n- Hypothyroidism\n- Pain\n- Essential hypertension\n- Atherosclerosis of coronary artery without angina pectoris\n- Hyperlipidemia\n- Lumbar spondylosis\n- Coronary artery graft present\n- Primary diagnosis: Low back pain\n- Primary diagnosis: Chronic pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-19 00:00:00, ended at 2017-09-19 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2017-09-22, presumably until 2017-09-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 07:33:00, ended at 2017-09-22 11:48:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- Introduction of Destructive Agent into Peripheral Nerves and Plexi, Percutaneous Approach\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, each additional facet joint (List separately in addition to code for primary procedure)\n- Fluoroscopy of Lumbar Facet Joint(s) using Low Osmolar Contrast\n- Destruction by neurolytic agent, paravertebral facet joint nerve(s), with imaging guidance (fluoroscopy or CT); lumbar or sacral, single facet joint\n\n### Condition\n- Atherosclerosis of coronary artery without angina pectoris\n- Lumbar spondylosis\n- Hyperlipidemia\n- Low back pain\n- Arthropathy\n- Hypothyroidism\n- Primary malignant neoplasm of prostate\n- Chronic pain\n- Essential hypertension\n- Lumbosacral spondylosis without myelopathy\n\n### Drug\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-09-22, presumably until 2017-09-22\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, presumably until 2019-02-27, with intended 0 refill(s). Instructions: take 0.1 mg by mouth every day \n- tadalafil 20 MG Oral Tablet, through Oral route, started on 2015-08-11, presumably until 2019-02-27, with intended 0 refill(s). Instructions: 20 mg by Swish & Swallow route\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 08:02:00, ended at 2017-09-22 13:58:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-22 12:41:20, ended at 2017-09-22 15:40:38\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.984\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anemia\n- Primary diagnosis: Anemia of chronic disease\n- Generalized hyperhidrosis\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-22 13:59:00, ended at 2017-09-22 23:59:00\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 84.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.29 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-04 10:41:32, ended at 2017-10-04 11:06:12\nThe patient in this visit was 77 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Low back pain\n- Primary diagnosis: Chronic pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-14 14:06:24, ended at 2018-03-14 14:06:34\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-04-07 00:00:00, ended at 2018-04-07 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- donepezil hydrochloride 5 MG Oral Tablet, started on 2018-04-07, presumably until 2018-05-09, with intended 0 refill(s). Instructions: 1/2 tablet each morning x2 weeks, then have EKG check.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-09 00:00:00, ended at 2018-05-09 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- donepezil hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-05-11, presumably until 2018-09-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily in the morning with food\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-19 00:00:00, ended at 2018-05-19 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-26 09:30:00, ended at 2018-05-26 23:59:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral, with pelvis when performed; 1 view\n\n### Condition\n- Bone necrosis\n- Hip pain\n- Bone cyst\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-26 09:46:10, ended at 2018-05-26 12:02:47\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5.354\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bone cyst\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-07 00:00:00, ended at 2018-07-07 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- 24 HR rivastigmine 0.192 MG/HR Transdermal System, through Transdermal route, started on 2018-07-07, presumably until 2018-09-26, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-12 00:00:00, ended at 2018-07-12 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR rivastigmine 0.192 MG/HR Transdermal System, through Transdermal route, started on 2018-08-11, presumably until 2018-08-11, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-01 11:02:49, ended at 2018-09-01 12:14:45\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n- Dementia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-05 09:32:00, ended at 2018-09-05 23:59:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arthrocentesis, aspiration and/or injection, major joint or bursa (eg, shoulder, hip, knee, subacromial bursa); without ultrasound guidance\n- Fluoroscopic guidance for needle placement (eg, biopsy, aspiration, injection, localization device) (List separately in addition to code for primary procedure)\n\n### Condition\n- Hip pain\n\n### Drug\n- iopamidol, through Intrathecal route, started on 2018-09-05, presumably until 2018-09-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-25 00:00:00, ended at 2018-09-25 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Amnesia\n\n### Drug\n- 24 HR rivastigmine 0.396 MG/HR Transdermal System, through Transdermal route, started on 2018-09-26, presumably until 2019-02-27, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-06 00:00:00, ended at 2018-12-06 00:00:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-06 15:17:00, ended at 2018-12-06 23:59:00\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral, with pelvis when performed; 1 view\n\n### Condition\n- Disorder of thigh\n- Aseptic necrosis of bone of hip\n- Hip pain\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-01-23 12:32:55, ended at 2019-01-23 13:37:07\nThe patient in this visit was 78 years old, unknown race, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hip pain\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "88bf64acece35f9807b793e6d451886c3c6e227e6c2ed35f6fc618b43cdd991f", "prompt_hash": "37bc9df1fb05ed250e745b5c30e10bf39304ecebd8bac37d7e32e1db5deffd38", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
{"doc_id": 9, "doc": {"person_id": 115967278, "visit_occurrence_id": 91200237, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2016-09-14 09:23:00", "visit_end_datetime": "2016-09-14 23:59:00", "visit_length_in_hours": 14.6, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-14 09:23:00, ended at 2016-09-14 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 141, "patient_first_visit_date": "2011-09-07 10:26:11", "patient_last_visit_date": "2022-04-28 08:03:00", "end_obs_date": "2017-09-14", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "new", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "recurrent", "gastric_cancer_one_year_diagnosis": 1, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 116, "cumulated_visit_num": 116, "cumulated_approximate_token_count": 30872, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2011-09-07 10:26:11, ended at 2011-09-07 12:46:41\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, presumably until 2016-01-29. Instructions: take 40 mg by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-07 10:35:00, ended at 2011-09-07 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-27 10:58:10, ended at 2011-10-27 11:56:39\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- Prosthetic arthroplasty of hip\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Gout\n- Pure hypercholesterolemia\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-11 05:10:00, ended at 2011-11-15 12:18:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 101.7 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.94 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 165 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- Total replacement of hip\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Radiologic examination, pelvis; 1 or 2 views\n- Prosthetic arthroplasty of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n\n### Condition\n- Hyperlipidemia\n- Asthma\n- Arthropathy of pelvis\n- Gout\n- Localized osteoarthrosis uncertain if primary OR secondary\n- Pure hypercholesterolemia\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous gluconate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous fumarate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-11-14, presumably until 2011-11-14\n- ferrous ascorbate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- iron,peptonized, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous succinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous bisglycinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous cysteine glycinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous aspartate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ammonium ferrous sulfate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-15\n- soy protein-iron complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-11, presumably until 2011-11-11\n- ferrous carbonate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-13, presumably until 2011-11-13\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-14. Instructions: take 40 mg by mouth every bedtime.\n- ferrous glycine sulfate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- folic acid, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-12, presumably until 2011-12-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-11-11, presumably until 2011-11-12\n- iron succinyl milk protein complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- iron-dextran complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- teferrol, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-11-13, presumably until 2011-11-14\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-12, presumably until 2011-12-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- probenecid 500 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-15\n- ferrous asparto glycinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous cacodylate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-11-11, presumably until 2011-11-15\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2011-11-15, presumably until 2011-11-15\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-11, presumably until 2011-11-13\n- iron, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-11, presumably until 2011-11-12\n- ferrous oxalate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-11-11, presumably until 2011-11-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-11, presumably until 2011-11-11\n- iron sucrose, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous sulfate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- iron carbonyl, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous lactate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous chloride, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-12, presumably until 2011-11-15\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-11-14, presumably until 2011-11-15\n- iron sorbitex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous phosphate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-11-11, presumably until 2011-11-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-21 09:52:00, ended at 2011-12-21 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Degenerative joint disease of pelvis\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-08-31 00:00:00, ended at 2012-08-31 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2012-08-31, presumably until 2012-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-08-31 05:15:00, ended at 2012-09-04 16:15:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Body height: 5' 11\" (inch (US))\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Prosthetic arthroplasty of hip\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Total replacement of hip\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Occupational therapy evaluation\n\n### Condition\n- Degenerative joint disease of pelvis\n- Right bundle branch block AND left anterior fascicular block\n- Pure hypercholesterolemia\n- Disorder of cardiovascular system\n- Hyperlipidemia\n- Raised prostate specific antigen\n- Chronic kidney disease\n- Asthma\n- Gout\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-09-04\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-08-31, presumably until 2012-09-03\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-09-02, presumably until 2012-10-10, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) Every Day.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-08-31, presumably until 2012-08-31\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-09-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-09-01, presumably until 2012-10-10, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- probenecid 500 MG Oral Tablet, through Oral route, started on 2012-08-31, presumably until 2012-09-04\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2012-09-03, presumably until 2012-09-03\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-09-04, presumably until 2012-09-04\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-09-03\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-09-01, presumably until 2012-09-03\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-08-31, presumably until 2012-08-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-08-31, presumably until 2012-08-31\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-09-01, presumably until 2012-09-04\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2012-08-31, presumably until 2012-10-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-10-10, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-08-31, presumably until 2012-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-10 09:35:00, ended at 2012-10-10 10:05:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-10 10:00:24, ended at 2012-10-10 12:13:11\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-10 10:06:00, ended at 2012-10-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-11-12 13:45:00, ended at 2014-11-12 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-24 09:43:23, ended at 2015-09-24 13:57:21\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-30 11:36:00, ended at 2015-09-30 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 100 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-01 07:35:10, ended at 2015-10-01 11:30:51\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.764\" (inch (US))\n\n### Procedure\n- Morphometric analysis, tumor\n- Consultation and report on referred material requiring preparation of slides\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-02 00:00:00, ended at 2015-10-02 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-02 11:03:55, ended at 2015-10-02 14:32:58\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-02 15:17:03, ended at 2015-10-02 15:17:32\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2016-03-05, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-12-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2016-02-18, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-02 15:34:00, ended at 2015-10-02 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 13 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 12:37:00, ended at 2015-10-03 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Hyperlipidemia\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-07 19:00:00, ended at 2015-10-07 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology treatment planning; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-09 06:55:00, ended at 2015-10-09 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Respiratory motion management simulation (List separately in addition to code for primary procedure)\n- Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications\n- Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan\n- Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, onl\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-13 13:25:00, ended at 2015-10-13 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-14 08:08:00, ended at 2015-10-14 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 10:04:00, ended at 2015-10-15 10:26:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 10:27:00, ended at 2015-10-15 12:09:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.38 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 102.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-15 10:48:24, ended at 2015-10-15 12:21:46\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.291\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 12:10:00, ended at 2015-10-15 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-10-15, presumably until 2015-10-15\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-10-15, presumably until 2015-10-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-10-15, presumably until 2015-10-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-15, presumably until 2015-10-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-16 08:24:00, ended at 2015-10-16 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Esophagitis\n- Primary malignant neoplasm of prostate\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-17 08:29:00, ended at 2015-10-17 09:22:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-17 09:23:00, ended at 2015-10-17 14:14:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- MCV [Entitic volume] by Automated count: 101.2 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.08 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-20 08:34:00, ended at 2015-10-20 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-21 08:35:00, ended at 2015-10-21 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 07:40:00, ended at 2015-10-22 08:05:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 13 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 08:40:00, ended at 2015-10-22 08:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-10-22, presumably until 2015-10-22\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-22, presumably until 2015-10-22\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-22, presumably until 2015-10-22\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-10-22, presumably until 2015-10-22\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-22, presumably until 2015-10-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 09:00:00, ended at 2015-10-22 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-23 08:33:00, ended at 2015-10-23 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-24 08:33:00, ended at 2015-10-24 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-27 08:40:00, ended at 2015-10-27 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-28 08:38:00, ended at 2015-10-28 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-29 08:10:00, ended at 2015-10-29 08:36:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- MCV [Entitic volume] by Automated count: 101.1 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-29 08:37:00, ended at 2015-10-29 11:29:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-29 09:31:13, ended at 2015-10-29 10:36:42\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophagitis\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-29 11:30:00, ended at 2015-10-29 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-29, presumably until 2015-10-29\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-29, presumably until 2015-10-29\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-10-29, presumably until 2015-10-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-29, presumably until 2015-10-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-10-29, presumably until 2015-10-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-30 08:36:00, ended at 2015-10-30 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-31 08:27:00, ended at 2015-10-31 10:08:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-31 10:09:00, ended at 2015-10-31 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-10-31, presumably until 2015-10-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-01 10:04:00, ended at 2015-11-01 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-01, presumably until 2015-11-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-02 10:01:00, ended at 2015-11-02 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-02, presumably until 2015-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-03 09:00:00, ended at 2015-11-03 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-04 09:00:00, ended at 2015-11-04 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-05 08:38:00, ended at 2015-11-05 10:58:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-05 10:59:00, ended at 2015-11-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 136 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-05\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-05\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-11-05, presumably until 2015-11-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-11-05, presumably until 2015-11-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-11-05, presumably until 2015-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-06 08:23:00, ended at 2015-11-06 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-07 00:00:00, ended at 2015-11-07 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-07 08:38:00, ended at 2015-11-07 10:03:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-07 10:04:00, ended at 2015-11-07 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-07, presumably until 2015-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-08 11:04:00, ended at 2015-11-08 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-08, presumably until 2015-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-09 10:03:00, ended at 2015-11-09 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-09, presumably until 2015-11-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-10 08:32:00, ended at 2015-11-10 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-11 08:36:00, ended at 2015-11-11 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 07:40:00, ended at 2015-11-12 07:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- MCV [Entitic volume] by Automated count: 100.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 132 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.14 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 08:00:00, ended at 2015-11-12 11:46:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-12 09:13:07, ended at 2015-11-12 14:41:47\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 11:47:00, ended at 2015-11-12 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-12, presumably until 2015-11-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-12, presumably until 2015-11-12\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-11-12, presumably until 2015-11-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-11-12, presumably until 2015-11-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-11-12, presumably until 2015-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-13 08:32:58, ended at 2015-11-13 13:20:29\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 08:48:00, ended at 2015-11-14 09:34:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:35:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-14, presumably until 2015-11-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-15 11:06:00, ended at 2015-11-15 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-15, presumably until 2015-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-16 10:08:00, ended at 2015-11-16 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-16, presumably until 2015-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 07:29:00, ended at 2015-12-24 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 110 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Primary malignant neoplasm of cardia of stomach\n- Thoracic aortic aneurysm without rupture\n- Lymphadenopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 07:29:00, ended at 2015-12-24 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-24 12:10:50, ended at 2015-12-24 13:48:55\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Right bundle branch block\n- Left anterior fascicular block\n- Electrocardiogram abnormal\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-25 13:57:42, ended at 2015-12-25 14:29:23\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.984\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic gout without tophus\n- Primary malignant neoplasm of cardia of stomach\n- Hyperlipidemia\n- Acute pulmonary edema\n- Uncomplicated asthma\n- Low blood pressure\n- Atrial fibrillation\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-25 15:04:51, ended at 2015-12-25 16:05:28\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-01-20 00:00:00, ended at 2016-01-20 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for all procedures on esophagus, thyroid, larynx, trachea and lymphatic system of neck; not otherwise specified, age 1 year or older\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2016-01-20, presumably until 2016-01-20\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-01-20, presumably until 2016-01-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- midazolam 1 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-01-20 00:00:00, ended at 2016-01-20 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2016-01-20, presumably until 2016-01-20\n- onabotulinumtoxinA 100 UNT Injection, started on 2016-01-20, presumably until 2016-01-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-01-20 05:25:00, ended at 2016-01-29 12:39:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 49.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 251 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.4 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 20.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.4 (picogram)\n- MCV [Entitic volume] by Automated count: 104.4 (femtoliter)\n- Prothrombin time (PT): 14.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 206 (milligram per deciliter)\n- Oxygen [Partial pressure] in Arterial blood: 80.1 (millimeter mercury column)\n- aPTT in Platelet poor plasma by Coagulation assay: 63.8 (second)\n- Body height: 5' 11\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Unlisted procedure, esophagus\n- Excision of Stomach, Open Approach\n- Physical therapy evaluation\n- Radiologic examination, chest; single view, frontal\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Insertion of Feeding Device into Jejunum, Open Approach\n- Inspection of Pleura, Percutaneous Endoscopic Approach\n- Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Resection of Esophagogastric Junction, Open Approach\n- Daily hospital management of epidural or subarachnoid continuous drug administration\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- Disorder of digestive system\n- Hyperlipidemia\n- Electrocardiogram abnormal\n- Persistent pain following procedure\n- Pleural effusion\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Acquired absence of organ\n- Low blood pressure\n- Pneumothorax\n- Postoperative state\n- Uncomplicated asthma\n- Atelectasis\n- Primary malignant neoplasm of cardia of stomach\n- Abnormal findings on diagnostic imaging of lung\n- Cardiomegaly\n- Chronic pulmonary edema\n- Acute pulmonary edema\n- Chronic gout without tophus\n- Atrial fibrillation\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2016-01-24, presumably until 2016-03-03, with intended 0 refill(s). Instructions: 2 Tabs by Feeding Tube route 2 times a day 2 tabs by Sonn BID til 02/07/2016, 400mg daily x 14days, 200mg BID x 14 days, 200mg daily x 14 days\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2016-01-22, presumably until 2016-01-26\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-21\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-24\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2016-01-25, presumably until 2016-03-03, with intended 1 refill(s). Instructions: 20 mL by Feeding Tube route 2 times a day\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-01-24, presumably until 2016-01-24\n- cefazolin 1000 MG Injection, started on 2016-01-20, presumably until 2016-01-21\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-21\n- 10 ML furosemide 10 MG/ML Injection, started on 2016-01-24, presumably until 2016-01-27\n- oxycodone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2016-01-26, presumably until 2016-02-18, with intended 0 refill(s). Instructions: 5-10 mL by Feeding Tube route Q3H PRN\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2016-01-20, presumably until 2016-01-24\n- diltiazem hydrochloride 30 MG Oral Tablet, through Oral route, started on 2016-01-26, presumably until 2016-01-27\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2016-01-25, presumably until 2016-01-27\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-26\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-26\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-22\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-26, presumably until 2016-06-03, with intended 0 refill(s). Instructions: 1 Tab by Feeding Tube route every morning with breakfast\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2016-01-26, presumably until 2016-01-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-01-20, presumably until 2016-01-20\n- sennosides, USP 35.2 MG/ML Oral Solution, through Oral route, started on 2016-01-27, presumably until 2016-01-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-26\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2016-01-22, presumably until 2016-01-22\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-26\n- famotidine 8 MG/ML Oral Suspension, through Oral route, started on 2016-01-26, presumably until 2016-02-18, with intended 1 refill(s). Instructions: 2.5 mL by Sanai Loe route 2 times a day\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2016-01-25, presumably until 2016-01-25\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-18 09:40:00, ended at 2016-02-18 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-18 10:02:36, ended at 2016-02-18 14:18:58\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2016-04-21, with intended 0 refill(s). Instructions: take 1 mg by mouth q 6 hours prn\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-02-12, presumably until 2016-12-13, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- cholecalciferol 0.05 MG Oral Capsule, through Oral route, presumably until 2018-04-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day\n- ondansetron 4 MG Oral Tablet, through Oral route, presumably until 2016-06-03, with intended 0 refill(s). Instructions: take by mouth Prn; very rarely\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2016-02-12, presumably until 2016-02-18, with intended 0 refill(s). Instructions: take 200 mg by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-18 11:46:25, ended at 2016-02-18 12:24:31\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.606\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-03 09:19:13, ended at 2016-03-03 11:22:56\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-03 11:51:00, ended at 2016-03-03 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.77 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-03 12:38:13, ended at 2016-03-03 17:23:40\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-10 10:10:42, ended at 2016-03-10 11:50:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- amiodarone hydrochloride 100 MG Oral Tablet, through Oral route, started on 2016-02-23, presumably until 2017-03-22, with intended 0 refill(s). Instructions: take 100 mg by mouth daily \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-10 11:55:00, ended at 2016-03-10 13:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-10 13:30:00, ended at 2016-03-10 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-03-10, presumably until 2016-03-10\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-06-03, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2017-03-22, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting.\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-03-10, presumably until 2016-03-10\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2017-03-22, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-03-10, presumably until 2016-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 09:49:00, ended at 2016-03-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-03-12, presumably until 2016-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-31 10:50:00, ended at 2016-03-31 13:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-31 11:18:05, ended at 2016-03-31 17:12:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.291\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-31 13:30:00, ended at 2016-03-31 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-03-31, presumably until 2016-03-31\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-31, presumably until 2016-03-31\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-03-31, presumably until 2016-03-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-03-31, presumably until 2016-03-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-02 08:38:00, ended at 2016-04-02 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-04-02, presumably until 2016-04-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-21 08:40:00, ended at 2016-04-21 11:54:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.84 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-21 09:23:26, ended at 2016-04-21 10:45:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2016-04-09, presumably until 2017-03-21, with intended 0 refill(s). Instructions: take 15 mg by mouth Every Day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-21 11:55:00, ended at 2016-04-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-04-21, presumably until 2016-04-21\n- acetaminophen 325 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed (pain)\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-04-21, presumably until 2016-04-21\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-04-21, presumably until 2016-04-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-04-21, presumably until 2016-04-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-04-21, presumably until 2016-04-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-23 08:50:00, ended at 2016-04-23 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-04-23, presumably until 2016-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-12 08:40:00, ended at 2016-05-12 12:37:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-12 09:29:15, ended at 2016-05-12 11:10:15\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, presumably until 2018-09-21, with intended 0 refill(s). Instructions: take 800 mg by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-12 12:38:00, ended at 2016-05-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-05-12, presumably until 2016-05-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-05-12, presumably until 2016-05-12\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-05-12, presumably until 2016-05-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-14 08:49:00, ended at 2016-05-14 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-05-14, presumably until 2016-05-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-17 15:49:32, ended at 2016-05-17 16:38:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Stool finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 08:30:00, ended at 2016-05-31 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.6 (percent)\n- MCV [Entitic volume] by Automated count: 102.3 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 4 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 221 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-31 09:05:23, ended at 2016-05-31 10:23:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-02 09:20:00, ended at 2016-06-02 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-06-02, presumably until 2016-06-02\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-06-02, presumably until 2016-06-02\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-06-02, presumably until 2016-06-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-02, presumably until 2016-06-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-06-02, presumably until 2016-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-04 08:40:00, ended at 2016-06-04 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-06-04, presumably until 2016-06-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-21 08:09:00, ended at 2016-06-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.52 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 104.3 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-21 08:52:51, ended at 2016-06-21 14:57:18\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Changes in skin texture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-21 14:27:04, ended at 2016-06-21 16:24:12\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Actinic keratosis\n- Vitiligo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-09 11:59:00, ended at 2016-07-09 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Postoperative state\n- Primary malignant neoplasm of esophagus\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-21 00:00:00, ended at 2016-07-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-28 12:33:00, ended at 2016-07-28 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-30 00:00:00, ended at 2016-07-30 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-14 09:23:00, ended at 2016-09-14 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-07 10:26:11, ended at 2011-09-07 12:46:41\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, presumably until 2016-01-29. Instructions: take 40 mg by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-07 10:35:00, ended at 2011-09-07 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hip, unilateral; complete, minimum of 2 views\n- Radiologic examination, pelvis; 1 or 2 views\n\n### Condition\n- Joint pain of pelvic region\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-27 10:58:10, ended at 2011-10-27 11:56:39\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11\" (inch (US))\n\n### Procedure\n- Prosthetic arthroplasty of hip\n- Pre-surgery evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Gout\n- Pure hypercholesterolemia\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-11-11 05:10:00, ended at 2011-11-15 12:18:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 101.7 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.94 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 165 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 11\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- MCHC [Mass/volume] by Automated count: 35.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n\n### Procedure\n- Total replacement of hip\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Radiologic examination, pelvis; 1 or 2 views\n- Prosthetic arthroplasty of hip\n- Pre-surgery evaluation\n- Occupational therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n\n### Condition\n- Hyperlipidemia\n- Asthma\n- Arthropathy of pelvis\n- Gout\n- Localized osteoarthrosis uncertain if primary OR secondary\n- Pure hypercholesterolemia\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous gluconate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous fumarate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2011-11-14, presumably until 2011-11-14\n- ferrous ascorbate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- iron,peptonized, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous succinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous bisglycinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous cysteine glycinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous aspartate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ammonium ferrous sulfate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-15\n- soy protein-iron complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- tetrahydrozoline hydrochloride 0.5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-11, presumably until 2011-11-11\n- ferrous carbonate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-13, presumably until 2011-11-13\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-14. Instructions: take 40 mg by mouth every bedtime.\n- ferrous glycine sulfate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- folic acid, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-12, presumably until 2011-12-21, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) daily.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-11-11, presumably until 2011-11-12\n- iron succinyl milk protein complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- iron-dextran complex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- teferrol, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-11-13, presumably until 2011-11-14\n- acetaminophen 325 MG / oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-12-21, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-12, presumably until 2011-12-21, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- probenecid 500 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-15\n- ferrous asparto glycinate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous cacodylate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-11-11, presumably until 2011-11-15\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2011-11-15, presumably until 2011-11-15\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-11, presumably until 2011-11-13\n- iron, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- hypromellose 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-11-11, presumably until 2011-11-12\n- ferrous oxalate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2011-11-11, presumably until 2011-11-11\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-11-11, presumably until 2011-11-11\n- iron sucrose, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous sulfate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- iron carbonyl, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous lactate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous chloride, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-11-12, presumably until 2011-11-15\n- simethicone 80 MG Chewable Tablet, through Oral route, started on 2011-11-14, presumably until 2011-11-15\n- iron sorbitex, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ferrous phosphate, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2011-11-12, presumably until 2011-11-12\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-11-11, presumably until 2011-11-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-12-21 09:52:00, ended at 2011-12-21 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Degenerative joint disease of pelvis\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2012-08-31 00:00:00, ended at 2012-08-31 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sodium chloride 0.154 MEQ/ML Irrigation Solution, through Topical route, started on 2012-08-31, presumably until 2012-08-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-08-31 05:15:00, ended at 2012-09-04 16:15:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Body height: 5' 11\" (inch (US))\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n\n### Procedure\n- Radiologic examination, pelvis; 1 or 2 views\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Prosthetic arthroplasty of hip\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Physical therapy evaluation\n- Total replacement of hip\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Occupational therapy evaluation\n\n### Condition\n- Degenerative joint disease of pelvis\n- Right bundle branch block AND left anterior fascicular block\n- Pure hypercholesterolemia\n- Disorder of cardiovascular system\n- Hyperlipidemia\n- Raised prostate specific antigen\n- Chronic kidney disease\n- Asthma\n- Gout\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-09-04\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-08-31, presumably until 2012-09-03\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-09-02, presumably until 2012-10-10, with intended 0 refill(s). Instructions: inject 0.4 mL subcutaneous (under the skin) Every Day.\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2012-08-31, presumably until 2012-08-31\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-09-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-09-01, presumably until 2012-10-10, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- probenecid 500 MG Oral Tablet, through Oral route, started on 2012-08-31, presumably until 2012-09-04\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2012-09-03, presumably until 2012-09-03\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-09-04, presumably until 2012-09-04\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-09-03\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2012-09-01, presumably until 2012-09-03\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-08-31, presumably until 2012-08-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-08-31, presumably until 2012-08-31\n- 0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-09-01, presumably until 2012-09-04\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2012-08-31, presumably until 2012-10-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2012-09-01, presumably until 2012-10-10, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-08-31, presumably until 2012-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-10 09:35:00, ended at 2012-10-10 10:05:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-10 10:00:24, ended at 2012-10-10 12:13:11\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Degenerative joint disease of pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-10 10:06:00, ended at 2012-10-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2014-11-12 13:45:00, ended at 2014-11-12 23:59:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hips, bilateral, minimum of 2 views of each hip, including anteroposterior view of pelvis\n\n### Condition\n- Joint pain of pelvic region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-24 09:43:23, ended at 2015-09-24 13:57:21\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-09-30 11:36:00, ended at 2015-09-30 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 100 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Lymphadenopathy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-01 07:35:10, ended at 2015-10-01 11:30:51\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.764\" (inch (US))\n\n### Procedure\n- Morphometric analysis, tumor\n- Consultation and report on referred material requiring preparation of slides\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-10-02 00:00:00, ended at 2015-10-02 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-02 11:03:55, ended at 2015-10-02 14:32:58\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.764\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-02 15:17:03, ended at 2015-10-02 15:17:32\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2016-03-05, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2015-12-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting.\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2015-10-06, presumably until 2016-02-18, with intended 6 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-02 15:34:00, ended at 2015-10-02 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 13 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 167 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-03 12:37:00, ended at 2015-10-03 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology simulation-aided field setting; complex\n\n### Condition\n- Hyperlipidemia\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-07 19:00:00, ended at 2015-10-07 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic radiology treatment planning; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-09 06:55:00, ended at 2015-10-09 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Respiratory motion management simulation (List separately in addition to code for primary procedure)\n- Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications\n- Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan\n- Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, onl\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-13 13:25:00, ended at 2015-10-13 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-14 08:08:00, ended at 2015-10-14 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 10:04:00, ended at 2015-10-15 10:26:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 10:27:00, ended at 2015-10-15 12:09:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.38 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 102.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-15 10:48:24, ended at 2015-10-15 12:21:46\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.291\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-15 12:10:00, ended at 2015-10-15 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-10-15, presumably until 2015-10-15\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-10-15, presumably until 2015-10-15\n- 2 ML ondansetron 2 MG/ML Injection, started on 2015-10-15, presumably until 2015-10-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-15, presumably until 2015-10-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-16 08:24:00, ended at 2015-10-16 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Esophagitis\n- Primary malignant neoplasm of prostate\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-17 08:29:00, ended at 2015-10-17 09:22:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-17 09:23:00, ended at 2015-10-17 14:14:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- MCV [Entitic volume] by Automated count: 101.2 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.08 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 211 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-20 08:34:00, ended at 2015-10-20 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-21 08:35:00, ended at 2015-10-21 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 07:40:00, ended at 2015-10-22 08:05:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 13 (nanogram per milliliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.0 (percent)\n- MCV [Entitic volume] by Automated count: 100.7 (femtoliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.16 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 08:40:00, ended at 2015-10-22 08:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2015-10-22, presumably until 2015-10-22\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-22, presumably until 2015-10-22\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-22, presumably until 2015-10-22\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-10-22, presumably until 2015-10-22\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-22, presumably until 2015-10-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-22 09:00:00, ended at 2015-10-22 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-23 08:33:00, ended at 2015-10-23 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-24 08:33:00, ended at 2015-10-24 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-27 08:40:00, ended at 2015-10-27 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-28 08:38:00, ended at 2015-10-28 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-29 08:10:00, ended at 2015-10-29 08:36:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- MCV [Entitic volume] by Automated count: 101.1 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 161 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.39 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.0 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-29 08:37:00, ended at 2015-10-29 11:29:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-29 09:31:13, ended at 2015-10-29 10:36:42\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Esophagitis\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-29 11:30:00, ended at 2015-10-29 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-10-29, presumably until 2015-10-29\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-10-29, presumably until 2015-10-29\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-10-29, presumably until 2015-10-29\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-10-29, presumably until 2015-10-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-10-29, presumably until 2015-10-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-30 08:36:00, ended at 2015-10-30 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-31 08:27:00, ended at 2015-10-31 10:08:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-10-31 10:09:00, ended at 2015-10-31 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-10-31, presumably until 2015-10-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-01 10:04:00, ended at 2015-11-01 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-01, presumably until 2015-11-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-02 10:01:00, ended at 2015-11-02 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-02, presumably until 2015-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-03 09:00:00, ended at 2015-11-03 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiation treatment management, 5 treatments\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-04 09:00:00, ended at 2015-11-04 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-05 08:38:00, ended at 2015-11-05 10:58:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-05 10:59:00, ended at 2015-11-05 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCV [Entitic volume] by Automated count: 100.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 136 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.8 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.5 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-05\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-05, presumably until 2015-11-05\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-11-05, presumably until 2015-11-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-11-05, presumably until 2015-11-05\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-11-05, presumably until 2015-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-06 08:23:00, ended at 2015-11-06 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-07 00:00:00, ended at 2015-11-07 00:00:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-07 08:38:00, ended at 2015-11-07 10:03:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-07 10:04:00, ended at 2015-11-07 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-07, presumably until 2015-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-08 11:04:00, ended at 2015-11-08 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-08, presumably until 2015-11-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-09 10:03:00, ended at 2015-11-09 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-09, presumably until 2015-11-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-10 08:32:00, ended at 2015-11-10 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n- Radiation treatment management, 5 treatments\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-11 08:36:00, ended at 2015-11-11 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 07:40:00, ended at 2015-11-12 07:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- MCV [Entitic volume] by Automated count: 100.9 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.39 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 132 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 45 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.14 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 08:00:00, ended at 2015-11-12 11:46:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-12 09:13:07, ended at 2015-11-12 14:41:47\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-12 11:47:00, ended at 2015-11-12 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2015-11-12, presumably until 2015-11-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2015-11-12, presumably until 2015-11-12\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2015-11-12, presumably until 2015-11-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-11-12, presumably until 2015-11-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2015-11-12, presumably until 2015-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-11-13 08:32:58, ended at 2015-11-13 13:20:29\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 08:48:00, ended at 2015-11-14 09:34:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-14 09:35:00, ended at 2015-11-14 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-14, presumably until 2015-11-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-15 11:06:00, ended at 2015-11-15 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-15, presumably until 2015-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-11-16 10:08:00, ended at 2015-11-16 23:59:00\nThe patient in this visit was 74 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2015-11-16, presumably until 2015-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 07:29:00, ended at 2015-12-24 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 110 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Primary malignant neoplasm of cardia of stomach\n- Thoracic aortic aneurysm without rupture\n- Lymphadenopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-12-24 07:29:00, ended at 2015-12-24 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-24 12:10:50, ended at 2015-12-24 13:48:55\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Right bundle branch block\n- Left anterior fascicular block\n- Electrocardiogram abnormal\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-25 00:00:00, ended at 2015-12-25 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-25 13:57:42, ended at 2015-12-25 14:29:23\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10.984\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic gout without tophus\n- Primary malignant neoplasm of cardia of stomach\n- Hyperlipidemia\n- Acute pulmonary edema\n- Uncomplicated asthma\n- Low blood pressure\n- Atrial fibrillation\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n- Atelectasis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-12-25 15:04:51, ended at 2015-12-25 16:05:28\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-01-20 00:00:00, ended at 2016-01-20 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for all procedures on esophagus, thyroid, larynx, trachea and lymphatic system of neck; not otherwise specified, age 1 year or older\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2016-01-20, presumably until 2016-01-20\n- cefoxitin 1000 MG Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-01-20, presumably until 2016-01-20\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-20\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- midazolam 1 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2016-01-20, presumably until 2016-01-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2016-01-20 00:00:00, ended at 2016-01-20 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bacitracin 5000 UNT/ML Injectable Solution, through Intramuscular route, started on 2016-01-20, presumably until 2016-01-20\n- onabotulinumtoxinA 100 UNT Injection, started on 2016-01-20, presumably until 2016-01-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2016-01-20 05:25:00, ended at 2016-01-29 12:39:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 49.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 251 (thousand per microliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -7.4 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 20.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.4 (picogram)\n- MCV [Entitic volume] by Automated count: 104.4 (femtoliter)\n- Prothrombin time (PT): 14.6 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 206 (milligram per deciliter)\n- Oxygen [Partial pressure] in Arterial blood: 80.1 (millimeter mercury column)\n- aPTT in Platelet poor plasma by Coagulation assay: 63.8 (second)\n- Body height: 5' 11\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Unlisted procedure, esophagus\n- Excision of Stomach, Open Approach\n- Physical therapy evaluation\n- Radiologic examination, chest; single view, frontal\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Insertion of Feeding Device into Jejunum, Open Approach\n- Inspection of Pleura, Percutaneous Endoscopic Approach\n- Introduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Resection of Esophagogastric Junction, Open Approach\n- Daily hospital management of epidural or subarachnoid continuous drug administration\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Inspection of Upper Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- Disorder of digestive system\n- Hyperlipidemia\n- Electrocardiogram abnormal\n- Persistent pain following procedure\n- Pleural effusion\n- Secondary malignant neoplasm of intrathoracic lymph nodes\n- Acquired absence of organ\n- Low blood pressure\n- Pneumothorax\n- Postoperative state\n- Uncomplicated asthma\n- Atelectasis\n- Primary malignant neoplasm of cardia of stomach\n- Abnormal findings on diagnostic imaging of lung\n- Cardiomegaly\n- Chronic pulmonary edema\n- Acute pulmonary edema\n- Chronic gout without tophus\n- Atrial fibrillation\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2016-01-24, presumably until 2016-03-03, with intended 0 refill(s). Instructions: 2 Tabs by Feeding Tube route 2 times a day 2 tabs by Sonn BID til 02/07/2016, 400mg daily x 14days, 200mg BID x 14 days, 200mg daily x 14 days\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2016-01-22, presumably until 2016-01-26\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-21\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-24\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2016-01-25, presumably until 2016-03-03, with intended 1 refill(s). Instructions: 20 mL by Feeding Tube route 2 times a day\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2016-01-24, presumably until 2016-01-24\n- cefazolin 1000 MG Injection, started on 2016-01-20, presumably until 2016-01-21\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-21\n- 10 ML furosemide 10 MG/ML Injection, started on 2016-01-24, presumably until 2016-01-27\n- oxycodone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2016-01-26, presumably until 2016-02-18, with intended 0 refill(s). Instructions: 5-10 mL by Feeding Tube route Q3H PRN\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2016-01-20, presumably until 2016-01-24\n- diltiazem hydrochloride 30 MG Oral Tablet, through Oral route, started on 2016-01-26, presumably until 2016-01-27\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2016-01-25, presumably until 2016-01-27\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-26\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-26\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-22\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2016-01-26, presumably until 2016-06-03, with intended 0 refill(s). Instructions: 1 Tab by Feeding Tube route every morning with breakfast\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2016-01-26, presumably until 2016-01-28\n- 2 ML ondansetron 2 MG/ML Injection, started on 2016-01-20, presumably until 2016-01-20\n- sennosides, USP 35.2 MG/ML Oral Solution, through Oral route, started on 2016-01-27, presumably until 2016-01-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-01-20, presumably until 2016-01-26\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2016-01-22, presumably until 2016-01-22\n- 5 ML diltiazem hydrochloride 5 MG/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-26\n- famotidine 8 MG/ML Oral Suspension, through Oral route, started on 2016-01-26, presumably until 2016-02-18, with intended 1 refill(s). Instructions: 2.5 mL by Sanai Loe route 2 times a day\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2016-01-25, presumably until 2016-01-25\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2016-01-21, presumably until 2016-01-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-11 00:00:00, ended at 2016-02-11 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-18 09:40:00, ended at 2016-02-18 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-18 10:02:36, ended at 2016-02-18 14:18:58\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of esophagus\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, presumably until 2016-04-21, with intended 0 refill(s). Instructions: take 1 mg by mouth q 6 hours prn\n- omeprazole 40 MG Delayed Release Oral Capsule, through Oral route, started on 2016-02-12, presumably until 2016-12-13, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n- cholecalciferol 0.05 MG Oral Capsule, through Oral route, presumably until 2018-04-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day\n- ondansetron 4 MG Oral Tablet, through Oral route, presumably until 2016-06-03, with intended 0 refill(s). Instructions: take by mouth Prn; very rarely\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2016-02-12, presumably until 2016-02-18, with intended 0 refill(s). Instructions: take 200 mg by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-18 11:46:25, ended at 2016-02-18 12:24:31\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.606\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-03 09:19:13, ended at 2016-03-03 11:22:56\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-03 11:51:00, ended at 2016-03-03 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.77 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.51 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 98.5 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-03 12:38:13, ended at 2016-03-03 17:23:40\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-10 10:10:42, ended at 2016-03-10 11:50:36\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- amiodarone hydrochloride 100 MG Oral Tablet, through Oral route, started on 2016-02-23, presumably until 2017-03-22, with intended 0 refill(s). Instructions: take 100 mg by mouth daily \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-10 11:55:00, ended at 2016-03-10 13:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.41 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.6 (percent)\n- MCV [Entitic volume] by Automated count: 100.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.62 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-10 13:30:00, ended at 2016-03-10 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-03-10, presumably until 2016-03-10\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2016-06-03, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2017-03-22, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed For nausea and vomiting.\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-03-10, presumably until 2016-03-10\n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2016-03-10, presumably until 2017-03-22, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed For nausea and vomiting.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-03-10, presumably until 2016-03-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-12 09:49:00, ended at 2016-03-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-03-12, presumably until 2016-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-31 10:50:00, ended at 2016-03-31 13:29:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.41 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.85 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 101 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-31 11:18:05, ended at 2016-03-31 17:12:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.291\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-31 13:30:00, ended at 2016-03-31 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2016-03-31, presumably until 2016-03-31\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-03-31, presumably until 2016-03-31\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-03-31, presumably until 2016-03-31\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-03-31, presumably until 2016-03-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-02 08:38:00, ended at 2016-04-02 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-04-02, presumably until 2016-04-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-21 08:40:00, ended at 2016-04-21 11:54:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97.5 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.84 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 95 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.15 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-21 09:23:26, ended at 2016-04-21 10:45:54\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2016-04-09, presumably until 2017-03-21, with intended 0 refill(s). Instructions: take 15 mg by mouth Every Day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-21 11:55:00, ended at 2016-04-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-04-21, presumably until 2016-04-21\n- acetaminophen 325 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed (pain)\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-04-21, presumably until 2016-04-21\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-04-21, presumably until 2016-04-21\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-04-21, presumably until 2016-04-21\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-04-21, presumably until 2016-04-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-04-23 08:50:00, ended at 2016-04-23 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-04-23, presumably until 2016-04-23\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-12 08:40:00, ended at 2016-05-12 12:37:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.8 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.92 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of esophagus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-12 09:29:15, ended at 2016-05-12 11:10:15\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, presumably until 2018-09-21, with intended 0 refill(s). Instructions: take 800 mg by mouth every 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-12 12:38:00, ended at 2016-05-12 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-05-12, presumably until 2016-05-12\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-05-12, presumably until 2016-05-12\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-05-12, presumably until 2016-05-12\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-05-12, presumably until 2016-05-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-14 08:49:00, ended at 2016-05-14 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-05-14, presumably until 2016-05-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-17 15:49:32, ended at 2016-05-17 16:38:21\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Stool finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 08:30:00, ended at 2016-05-31 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.6 (percent)\n- MCV [Entitic volume] by Automated count: 102.3 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 103 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 4 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 221 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.25 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-31 09:05:23, ended at 2016-05-31 10:23:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.488\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-02 09:20:00, ended at 2016-06-02 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug\n- Chemotherapy administration, intravenous infusion technique; each additional sequential infusion (different substance/drug), up to 1 hour (List separately in addition to code for primary procedure)\n\n### Condition\n- Neutropenia due to and following chemotherapy\n- Primary malignant neoplasm of esophagus\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2016-06-02, presumably until 2016-06-02\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2016-06-02, presumably until 2016-06-02\n- 2 ML famotidine 10 MG/ML Injection, through Intravenous route, started on 2016-06-02, presumably until 2016-06-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2016-06-02, presumably until 2016-06-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2016-06-02, presumably until 2016-06-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-04 08:40:00, ended at 2016-06-04 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2016-06-04, presumably until 2016-06-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-21 08:09:00, ended at 2016-06-21 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.08 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.52 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 212 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.8 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Carcinoembryonic Ag [Mass/volume] in Serum or Plasma: 3 (nanogram per milliliter)\n- MCV [Entitic volume] by Automated count: 104.3 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Neutropenia due to and following chemotherapy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-21 08:52:51, ended at 2016-06-21 14:57:18\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Changes in skin texture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-21 14:27:04, ended at 2016-06-21 16:24:12\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.685\" (inch (US))\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); second through 14 lesions, each (List separately in addition to code for first lesion)\n\n### Condition\n- Primary diagnosis: Traumatic or non-traumatic injury\n- Actinic keratosis\n- Vitiligo\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-09 11:59:00, ended at 2016-07-09 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Lymphadenopathy\n- Postoperative state\n- Primary malignant neoplasm of esophagus\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-21 00:00:00, ended at 2016-07-21 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-22 00:00:00, ended at 2016-07-22 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-07-28 12:33:00, ended at 2016-07-28 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 111 (milligram per deciliter)\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-30 00:00:00, ended at 2016-07-30 00:00:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-09-14 09:23:00, ended at 2016-09-14 23:59:00\nThe patient in this visit was 75 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n\n### Condition\n- Primary malignant neoplasm of esophagus\n- Abnormal findings on diagnostic imaging of lung\n- Primary malignant neoplasm of cardia of stomach\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Malignant tumor of prostate within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of prostate_cancer means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "a73b993f1cc09a5407a8186931bcdcfe7b9c40571bab737fa04b3fa1ee1b269c", "prompt_hash": "efde5f69c9bc77241ff57fa31389b2040af3f72d7b9bc972eb46927da1c2ffbb", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 0.0, "f1_gu_yn": [1, 0], "recall_gu_yn": [1, 0]}
